annual report - Farmacias Ahumada
Transcription
annual report - Farmacias Ahumada
ANNUAL REPORT 2014 HOW TO NAVIGATE THIS PDF DOCUMENT TOOLS SELECT A SPECIFIC CHAPTER OR SUBSECTION INTRODUCTION Company Details Letter from the Chairman Home Previous page Next page Send by e-mail Print FASA website THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility This PDF is configured for use with Adobe Acrobat (version 9 or higher). Some features may not be available in other platforms. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility ANNUAL REPORT 2014 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility CONTENTS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People 7 INTRODUCTION 8 Company Details 10 Letter from the Chairman 13 THE COMPANY 14 History 16 Walgreens Boots Alliance 18 Regional Presence 24 Business Units 28 Creation and Development of Owned and Licensed Brands 34 Corporate Social Responsibility 37 OWNERSHIP AND MANAGEMENT 38 Shareholders 40 Board of Directors 42 Corporate Management 44 Regional Management 45 Corporate Structure 46 Training Our People GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 49 PERFORMANCE 50 Consolidated Indicators 52 Investment and Financing FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 57 GENERAL INFORMATION PERFORMANCE Consolidated Indicators Investment and Financing 58 Regarding Shareholders and the Board of Directors 60 Subsidiaries and Associates 71 FINANCIAL STATEMENTS 74 Consolidated Financial Statements 154 Material Events 160 Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION 8 | FASA 2014 Annual Report COMPANY DETAILS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 9 | FASA 2014 Annual Report 9 LEGAL NAME Farmacias Ahumada S.A. DOING BUSINESS AS FASA S.A. CHILEAN TAX ID INTRODUCTION Company Details Letter from the Chairman 93,767,000-1 THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Publicly Held Corporation TYPE OF ENTITY INCORPORATION Resolution Nº 309-S issued by the Superintendency of Insurance Companies, Corporations and Stock Exchanges on November 29, 1977, and published in the Official Gazette on January 16, 1978, approved the Company and its bylaws as evidenced in the public instrument dated November 28, 1977, legalized by the Santiago Public OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People Notary Mr. Álvaro Bianchi Rosas. COMPANY REGISTRATION The Company was registered on page 310 number 167 of the Santiago Commercial Registry in 1978. LEGAL ADDRESS PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Miraflores 383, floor 6, Santiago. TELEPHONE FAX 56-2-2222 1122 56-2-2661 9410 WEBSITE www.fasa.cl DATE OF SECURITIES REGISTRATION October 15, 1997 SVS REGISTRATION NUMBER 629 TICKER SYMBOL FASA INDEPENDENT AUDITORS KPMG Auditores Consultores Limitada INVESTOR RELATIONS CONTACT [email protected] 10 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility LETTER FROM THE CHAIRMAN Farmacias Ahumada became part of Walgreens Boots Alliance, a world leader in health and wellbeing. 11 | FASA 2014 Annual Report 11 Dear FASA shareholders: With great pleasure I present the annual report for Farmacias As of December 31, 2014, we had 1,480 stores after adding 180 new Ahumada (“FASA” or “the Company”). This report details our locations during 2014, an increase of 13,8%, mainly through the performance in 2014, a year marking a major milestone in the history acquisition of Farmacias ABC in Mexico. Thus, we ended 2014 with of our organization. Farmacias Ahumada was acquired by Alliance 1,023 stores in Mexico, 442 in Chile and 15 in Brazil. Boots, currently Walgreens Boots Alliance, following the strategic INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People partnership between Alliance Boots and Walgreen Co., the largest Consolidated revenues for the year ended December 31, 2014, totaled drugstore chain in the USA. Ch$ 942,014,333,000, in comparison with Ch$ 845,134,550.000 for the previous year, an increase of 11.5% or Ch$ 96,879,783,000. We are very supportive of the integration between Walgreens Boots Alliance and our Company and are sure that the process will be With 70.1% of our pharmacies and 71.3% of our customers outside smooth, since both organizations share a commitment to improve Chile, 58.2% of consolidated revenues for the year came from foreign the health of the local communities that we serve and to help our operations. customers and patients look and feel better. The year 2015 will provide us with many challenges and opportunities. Some of the most important developments for FASA in 2014 include: However, we still believe in our ability to remain market leaders. With a new owner, we will continue working with the same care and Our Mexican subsidiary, Farmacias Benavides S.A.B. de C.V., acquired dedication for which we are known in order to generate value for our 99.99% of Farmacias ABC México S.A. de C.V. in June. This acquisition customers, shareholders and employees. completed our regional expansion plans for the Mexican market that started a few years ago. Finally, I want to thank our shareholders, employees, suppliers and, above all, our valuable customers for their trust and support. Alliance Boots acquired 99.39% of the Company in August through a takeover bid. After a second bid in December, which finished in January 2015, 99.41% of shareholders accepted the offer. Furthermore, Alliance Boots acquired 96.55% of Farmacias Benavides PERFORMANCE Consolidated Indicators Investment and Financing S.A.B. de C.V. in Mexico following a takeover bid in December. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates December 31, thereby creating the new company Walgreens Boots FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Finally, Walgreen Co. finalized its merger with Alliance Boots on Alliance, which is indirectly the new majority shareholder of the Company. As a result of these transactions, Farmacias Ahumada became part of Walgreens Boots Alliance, a world leader in health and wellbeing. Juan Guerra Chairman Throughout 2014 we have maintained our spirit of growth and continuous improvement with an important focus on strengthening our business after an ambitious expansion process. The market challenges us to be more productive and competitive, to reduce costs, and—most importantly for our customers—to offer a wider range of quality products. Farmacias Ahumada S.A. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility THE COMPANY 14 | FASA 2014 Annual Report HISTORY 1999 Falabella S.A.C.I. became a shareholder of FASA— AIG became a shareholder acquiring a 20% stake in the Company—and of FASA acquiring a 10% Latin Health Care Fund, stake, although FASA a US Investment Fund, was still a privately held acquired a 7.7% stake. company. On December Both transactions were 4, 1997, shares in Farmacias Ahumada were performed through a capital increase carried out offered on the Santiago Stock Exchange through a on the Santiago Stock Exchange, which capital increase increased FASA's capital by of approximately US$21 US$49 million. million, which raised the number of shareholders from 11 to 256. 1997 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People 1992 1969 The first store in the Farmacias Ahumada chain was opened. National expansion in Chile began by opening the first pharmacy in the Fifth Region. 2001 A 15% stake in Boticas FASA in Peru was acquired bringing the total holding to 100% of this company, and a further 17% was acquired in CNG Chile. PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 1977 "Farmacias Ahumada S.A." is formed as a privately held corporation. 1996 Boticas FASA S.A. was launched, which started to develop a chain of pharmacies in Peru. 1998 2000 FASA acquired 50% of The subsidiary Compañía Nutrición Administradora General (CNG), de Beneficios which markets GNC Farmacéuticos, ABF S.A. products. FASA and was formed, to provide AIG Capital acquired medicine to institutions, 77% of Drogamed, businesses and Brazil. insurance companies. 2002 FASA took control of the Mexican company Far-Ben S.A. de C.V. (Farmacias Benavides) on December 23, through subscribing to a capital increase in Far-Ben for US$45 million. FASA acquired the remainder of the shares in Compañía Nutrición General, to bring its total holding to 100% of this subsidiary. 15 | FASA 2014 Annual Report 2007 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility 2004 Placement of two series of electronic bearer bonds (Series C and D) for UF2.2 million. FASA increased its stake in Farmacias Benavides S.A.B. de C.V. on April 10 by 2.901%, to bring its total holding to 71.076% of this company. FASA sealed a strategic partnership with the Euroamérica Group on June 28, to create the company Inmobiliaria Avantuen in which Inmobiliaria FASA S.A. owns 49% while Euroamérica owns 51%. The partnership aims to develop shopping centers, strip centers and commercial shops, where our chain will have an important presence. 2009 FASA sold its entire stake in the associate Pharma Genexx to Inversiones Opko Limitada on October 2. On December 13, the entire stake in the associate Inmobiliaria Avantuen S.A. was sold to Compañía de Seguros Corpvida S.A. OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 2005 Farmacias Benavides incorporated 26 pharmacies from Farmacias El Fénix S.A. de C.V., in which Farmacias Benavides held a 50% stake. 2008 2013 2011 FASA acquired a further 24.55% stake in Farmacias Benavides S.A.B. de C.V. in January, to bring its total holding to 95.62% of this subsidiary. Series E and F Bonds were placed on May 15 and 19 for UF4 million, in order to refinance its Series C and D Bonds and purchase 24.55% of Farmacias Benavides S.A.B. de C.V. 2010 Grupo Casa Saba acquired 98.7% of the Company through a takeover bid. 2012 FASA continued to expand its chain of pharmacies and strengthen the development of product lines such as Nativa, FarmaRebajas, GNC and Guapa. The latter is marketed in Chile and Mexico. FASA sold its Peruvian subsidiaries, Farmacias Peruanas S.A. and Droguería La Victoria S.A., in January. FASA acquired 99.9% of the Brazilian subsidiary Casa Saba Brasil Holdings Ltda. in August. 2014 Alliance Boots acquired 99.39% of the Company on August 11. Farmacias Benavides acquired Farmacias ABC in June. On December 31, Walgreens Boots Alliance became the new indirect controller of the Company. 16 | FASA 2014 Annual Report WALGREENS BOOTS ALLIANCE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The Walgreens Boots Alliance was created through the merger of Walgreens and Alliance Boots in December 2014. 17 | FASA 2014 Annual Report It is with great pride that we welcome our new controller, Walgreens INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Boots Alliance. The company, which is a publicly held corporation incorporated under the laws of the State of Delaware, owns various businesses that manufacture, sell and distribute pharmaceutical products. Walgreens operates 8,206 drugstores in 50 states in the United States, providing consumer goods and services, pharmaceuticals, photography, health and wellbeing products. Boots has been in business for over 160 years, with stores in various locations across Great Britain offering health, personal care and cosmetics products. The Boots loyalty program has 17.8 million regular users. Its scope reaches beyond the shores of Great Britain and includes countries such as Norway, Lithuania, the Netherlands and Thailand. The Walgreens Boots Alliance was created through the combination of Walgreens and Alliance Boots in December 2014. This transaction brings together iconic global brands and a heritage of trusted healthcare services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. Its purpose is to help customers across the world lead healthier and happier lives. The Company, with a presence in more than 25 countries, employs GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates over 370,000 people and is the largest retail pharmacy, health and FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Its wholesale network has 340 distribution centers that deliver to over daily living destination in the USA and Europe. It boasts over 12,800 stores in 11 countries. 180,000 pharmacies, doctors, health centers and hospitals each year in 19 countries. It is the largest purchaser of prescription drugs and many other health and wellbeing products. The company’s size and expertise will help us to expand the supply, and address the rising cost of, prescription drugs. The creation of Walgreens Boots Alliance provides an opportunity to further accelerate the development of a fully integrated, global platform for the future to provide innovative ways to address health and wellness challenges. Our company is well positioned to expand customer offerings in existing markets and become the health and wellbeing partner of choice in emerging markets. 18 | FASA 2014 Annual Report REGIONAL PRESENCE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 1,537 TOTAL SALES (USD MILLIONS) 19 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing MEXICO CHILE BRAZIL GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates ANNUAL SALES (USD THOUSANDS) ANNUAL SALES (USD THOUSANDS) ANNUAL SALES (USD THOUSANDS) FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 892,490 643,049 1,392 20 | FASA 2014 Annual Report MEXICO: FARMACIAS BENAVIDES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12,097 1,023 162 21 230,825 185 111,314 8,076 Annual sales (MX$ millions) Number of pharmacies Openings in the period Closures in the period Sales area (M2) Number of cities covered Customers served (thousands) Employees Farmacias Benavides was acquired by FASA in late 2002, when it had 523 stores. The plan to open new stores continued in 2014, going from 882 pharmacies in 2013 to 1,023 in 2014, an increase of 14.0%. This resulted in an increase in our sales floor area of 24,065 m2, or 10% more than 2013, ending the year with a total of 230,825 m2. These openings required a total investment of MX$ 65.7 million. An important development in 2014 was the acquisition of the Farmacias ABC chain, with 138 branches. This brought total coverage to 22 states and 185 cities, bringing us closer to customers in Jalisco, Baja California, Sonora, Mexico State and the Federal District. 21 | FASA 2014 Annual Report ACTIVITIES AND PROJECTS We have continued to strengthen projects launched in previous years, such as Home Services and Clinics, we are also developing two new projects: Smart Benefits Card and Great People - Platinum Card. Smart Benefits Card. INTRODUCTION Company Details Letter from the Chairman A loyalty program to benefit our customers by accumulating points THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility personalized discounts for our customers. OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People By the end of 2014, both loyalty programs had over 3 million members. for each purchase at our stores, which can be redeemed for any item in our stores at a later date. The cards can also be used to provide Great People - Platinum Card. A sales card for the general public that provides exclusive promotions on medicines from laboratories registered with the "Great People" program. It also provides other benefits, such as life insurance and ambulance services. PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility NUMBER OF STORES 1023 2014 882 2013 2012 2011 2010 772 746 723 SALES FLOOR AREA AVERAGE TICKET (Thousands of m2) (Mexican pesos) 230.8 2014 2013 2012 206.8 184.9 109 2014 100 2013 94 2012 2011 179.4 2011 2010 177.1 2010 87 78 22 | FASA 2014 Annual Report CHILE: FARMACIAS AHUMADA INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility 394,137 442 46 8 63,389 102 46,680 3,640 OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Annual sales (Ch$ millions) Number of pharmacies Openings in the period Closures in the period Sales area (M2) Number of cities covered Customers served (thousands) Employees The main business of Farmacias Ahumada is marketing pharmaceutical products through its pharmacy network. In addition, it sells natural products, nutritional supplements, beauty products, hygiene and personal care products and convenience items. In December 2014 we operated 442 stores in 102 cities across Chile with coverage from Arica to Punta Arenas. We had a total sales area of 63,389 m2, allowing us to serve over 46 million customers, with our business concentrated in central Chile. During 2014, we opened 46 new stores and closed 8. Sales revenue totaled Ch$ 394,137 million, an increase of 8.1% over 2013. By year end, the Company employed 3,640 people, of which 3,416 worked in pharmacies (including the Special Prescription Laboratory), 264 at head office and subsidiaries and 69 at the Distribution Center. 23 | FASA 2014 Annual Report ACTIVITIES AND PROJECTS As part of the Company's expansion plans, around Ch$ 4,727 million in investments were made during the year, primarily for store openings and remodeling as well as several technology projects. We inaugurated a record number of new stores in 2014 with 46 INTRODUCTION Company Details Letter from the Chairman openings under our different retail formats: Farmacias Ahumada, THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility care and other general goods. The third format is a new discount NATIVA, FarmaRebajas and GNC. NATIVA is a perfume shop without gondola shelving that offers beauty products, baby products, personal drugstore targeting a broader population segment. Finally, our Chilean operations include a franchise of the GNC brand, which has allowed us to develop full size stores that sell only nutrition products and nutritional supplements. This year new projects were completed that bring us even closer to our customers and their varied needs, always striving to improve quality and service. OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility NUMBER OF STORES 442 2014 404 2013 2012 2011 2010 368 356 343 2014 2013 SALES FLOOR AREA AVERAGE TICKET (Thousands of m2) (Chilean pesos) 63.4 61.7 8,065 2014 7,195 2013 2012 59.8 2012 2011 58.5 2011 2010 57.7 2010 6,390 6,066 5,815 24 | FASA 2014 Annual Report BUSINESS UNITS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 25 | FASA 2014 Annual Report FASA has developed a successful business model, which has been universally applied and adjusted to each country as needed. This model includes attractive retail formats that bring customers closer, and offers a wide range of medicines and health, hygiene and INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility personal care products. We have become an attractive choice, and provide comprehensive solutions that meet consumer needs. We have supplemented this model by continuously introducing new services that add value to our existing product offering. We have also introduced and developed our own brands and various exclusive brands, in order to ensure profitability and differentiation. 26 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Pharmacy Beauty and Personal Care GNC and Natural Products 27 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report General Goods Baby Photography 28 | FASA 2014 Annual Report CREATION AND DEVELOPMENT OF OWNED AND LICENSED BRANDS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The goal is to provide our customers in Latin America with quality brands that improve their health and wellbeing at the best price. 29 | FASA 2014 Annual Report Over 150 A key strategy to improving profitability and the contribution of our business model is the development of our owned and licensed brands. We are constantly creating and seeking new brands in categories that include OTC, RX, beauty, personal care and baby, by specialized suppliers evaluating market trends and identifying real value propositions for our customers. These products gain reputation and thereby generate INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People differentiation. A team of professionals searches for new products, analyzes the opportunities in various markets and selects manufacturing companies that compete in quality and cost with the large multinationals, thus meeting our customers’ requirements. The goal is to provide our customers in Latin America with quality brands that improve their health and wellbeing at the best price. We have developed a network of over 150 global specialized suppliers using a process that certifies good manufacturing practices Important exclusive brands include "GNC" (market leader in vitamin and quality control. and mineral supplements), "Neoalledryl" (antihistamines), "Vigorex" (genito-urinary products), "Dolostat" (anti-inflammatories) "CareSens We benefit from economies of scale due to our strong presence N" (Korean glucose meter), "Prudence" and "Trojan" (market leaders in Latin America. We are currently supplied by manufacturers from in condoms in Brazil and the USA), "Lierac" (French luxury dermo- different parts of the world, such as Mexico, Chile, Argentina, USA, cosmetics, recognized for anti-aging and body treatments) "ROC" Korea, China, England, Canada, etc. And our customers benefit at (dermo-cosmetics, expert in anti-aging and anti-cellulite products); PERFORMANCE Consolidated Indicators Investment and Financing our pharmacies by finding the best value proposition at competitive "Phyto" (market leader in haircare and dermo-cosmetics in France); prices compared to global and local brands. "Nuk" (market leader in baby accessories); "Lee Stafford" (leading GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Options, our own global brand, reported increased sales during 2014. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility British cosmetic haircare brand). This brand includes baby products such as diapers, accessories, wet During 2014 Farmacias Ahumada exclusively imported two prestigious wipes, etc., and beauty products like makeup, creams and cosmetic makeup brands: "Rimmel", which is the top brand in England, and accessories. "Wet n Wild", which is an excellent value brand with a strong presence in the USA. The other foundation for this strategy is to provide licensed or exclusive brands, which are reputable and high quality brands within Another important project during this year was the launch of their categories and have already established a substantial market Creightons. This brand focuses on hair and body care with excellent presence. quality products, aromas and attractive packaging. 30 | FASA 2014 Annual Report OWNED AND LICENSED BRANDS CONSUMER Personal care products with exquisite fragrances. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates German baby product brand, dedicated to finding solutions for parents to contribute to the development of their children. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Accessories, textiles and fragrance products based on the Flintstones for boys and girls. 31 | FASA 2014 Annual Report French luxury dermo-cosmetic brand to combat skin aging. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The London make-up brand always at the forefront of trends. Wide variety of personal care products. FRESCURA NATURAL PARA TU PIEL English brand of personal care products such as soaps, creams and hair products. Innovative English brand of professional quality haircare products. A make-up brand imported directly from Los Angeles, USA, putting the latest fashion trends within everyone's reach. 32 | FASA 2014 Annual Report OWNED AND LICENSED BRANDS PHARMACEUTICAL A complete range of nutritional supplements. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Recognized brand of Brazilian condoms, which ranks second in the Chilean and Brazilian markets. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility A range of antiinflammatory-analgesics (Ibuprofen), in various formats for family care. 33 | FASA 2014 Annual Report A brand that unites the best properties of honey and propolis and strengthens the body's defense system. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People A range of bio-equivalent antihistamines that are manufactured locally to high standards and proven effectiveness. Korean blood glucose monitoring devices, globally certified as accurate and reliable. PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Family of analgesics and antipyretics (Paracetamol bio-equivalents) developed for fever and cold relief. A high-tech pregnancy test that is easy to use and very sensitive, to ensure a reliable result. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Antiseptic and germicide, effective against mild mouth and pharynx infections and manufactured according to international standards. Vitamin C brand manufactured to GMP standards, aimed at reducing influenza in adults and children. 34 | FASA 2014 Annual Report CORPORATE SOCIAL RESPONSIBILITY INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Thanks to the change voluntarily contributed by our customers, we raised Ch$ 148 million, which enabled the foundation to provide zero-cost care throughout the country. 35 | FASA 2014 Annual Report CHILE We have formed an alliance with Fundación Arturo Lopez Perez—a INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility charitable comprehensive cancer clinic—to support the prevention, early detection, diagnosis and treatment of cancer in low-income segments of the population. The campaign "Your Change is Valuable" was born from this alliance. Through customer donations of their change at checkout, we raised Ch$ 148 million in 2014, helping provide zero-cost care throughout the country. During 2014, 1,900 mammograms were performed, benefiting the following locations: Valparaíso, Rancagua, Talca, La Serena, Coquimbo, Paipote, Copiapó, Osorno, Valdivia, Cerrillos, Temuco and Los Ángeles. We also partially or totally financed OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing treatments for qualifying low-income patients. MEXICO Farmacias Benavides has a strong commitment to associations that support important causes, and we have developed several social responsibility programs involving our employees, suppliers and customers. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates These programs include the "Rounding Program", which supports causes aimed at health and related areas. Thanks to contributions from our customers, we raised MX$ 369,000, which were donated to FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Fundación Ale, Casa Azul, Un Solo San Pedro and INCan. Medicine donations were sent to Casa Mi Ángel, Cáritas de Monterrey and DIF Municipal Durango with the aim of getting our medicines to the communities that need them most. We also donated more than a thousand articles to "DonaMedicamentos.org", who supplied this aid to the victims of Hurricane Odile, in southern Baja California. Another of our support programs is Carrera Benavides. The race was a huge success, raising enough funds to finance 20 reconstructive surgeries, provided through Fundación Alma, for breast cancer survivors. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility OWNERSHIP AND MANAGEMENT 38 | FASA 2014 Annual Report SHAREHOLDERS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The Company's structure enabled us to successfully face the challenges in 2014. 39 | FASA 2014 Annual Report CONTROLLER OWNERSHIP AND CONTROL SHARES The Company is controlled by Alliance Boots Chile SpA, which is a As of December 31, 2014, the total number of nominative, single- simplified corporation incorporated in Chile. Through Alliance Boots series common shares, with no par value, subscribed and paid is Latin America Limited, this company is 100% owned by and indirectly 1,500,000,000. controlled by Alliance Boots GmbH, a private limited liability company INTRODUCTION Company Details Letter from the Chairman incorporated in Switzerland, which in turn is controlled by Walgreens At the extraordinary shareholders' meeting held on May 17, 2013, Boots Alliance Inc., a Delaware (USA) corporation. shareholders approved a proposal to increase capital by Ch$ 180,000,000,000 through a rights issue of 670,000,000 new shares. Shareholders also agreed to authorize the board to calculate the final THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility placement price for these shares in accordance with Article 23 of the Corporate Regulations, and to select the markets and methods for this placement. Subsequently, at the extraordinary shareholders' meeting held on November 8, 2013, shareholders approved a proposal to extend only once the deadline of 180 days for the board to calculate the final placement price. As of December 31, 2014, there have been no new agreements on this matter. As of December 31, 2014, 82 shareholders are registered in the Company's shareholder registry. (*) FASA SHAREHOLDER REGISTRY AS OF 12/31/2014 CHILEAN TAX ID SHARES AS OF 12/31/2014 % PERCENTAGE 76378831-8 1,490,833,059 99.39% BANCO DE CHILE ON BEHALF OF NON-RESIDENT THIRD PARTIES 97004000-5 4,474,685 0.30% LARRAIN VIAL S A CORREDORA DE BOLSA 80537000-9 546,739 0.04% 4461742-0 452,130 0.03% INDIVIDUAL/COMPANY NAME ALLIANCE BOOTS CHILE SPA WALKER ARANGUA JUAN RICARDO BANCHILE C DE B S A 96571220-8 428,775 0.03% SANTANDER S A C DE B 96683200-2 394,759 0.03% CONSORCIO C DE B S A 96772490-4 300,829 0.02% 84177300-4 239,894 0.02% 48069498-8 216,190 0.01% BTG PACTUAL CHILE S A C DE B BELLINI CARL UNDURRAGA ABBOTT CLAUDIO BOLSA DE COMERCIO DE SANTIAGO BOLSA DE VALORES CAVAGNARO SANTA MARIA ELSA XIMENA 12 majority shareholders Other shareholders TOTAL 4429528-8 174,790 0.01% 90249000-0 147,060 0.01% 5279991-0 142,050 0.01% 1,498,350,960 99.89% 1,649,040 0.11% 1,500,000,000 100.00% (*) As reported by the Superintendency of Securities and Insurance (SVS) in Official Ruling Number 3852 dated February 20, 2015, and considering additional information available and reported in the extraordinary shareholders' meeting held on February 24, 2015, that approved the voluntary delisting of FASA shares in the Securities Registry maintained by the SVS and the Chilean stock exchanges, the total number of FASA shareholders on February 13, 2015, ranged between 184 and 194, including those shareholders whose shares were held in custody by the corresponding authorized entities. 40 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility BOARD OF DIRECTORS OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility According to its bylaws, Farmacias Ahumada S.A. is managed by a board of directors composed of seven members, who are elected for three-year periods and may be re-elected. 41 | FASA 2014 Annual Report THE BOARD OF DIRECTORS IS AS FOLLOWS (*): INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Juan José Ricardo Guerra Chairman Italian passport YA2715221 Certified Public Accountant Appointment date: August 11, 2014 Marcello Ferrari Director Italian passport YA5385795 Management Engineer Appointment date: August 11, 2014 Dean Thompson (**) Director British passport 508088944 Bachelor of Science Appointment date: October 29, 2014 Resignation date: February 25, 2015 Marc Dench Director British passport 306063491 Certified Public Accountant Appointment date: August 11, 2014 Michele Antonio Ingravallo Director Italian passport YA5415229 Professor of Science, Mathematics and Technology Appointment date: August 11, 2014 (**) Mr. Dean Thompson is replaced by: Elizabeth Fagan Director British passport 706184798 Biochemist Appointment date: February 25, 2015 THE BOARD OF DIRECTORS WAS AS FOLLOWS UNTIL AUGUST 11, 2014: Manuel Saba Ades Chairman Mexican passport G07598123 Businessman Re-election date: April 30, 2014 Alberto Isaac Saba Ades Director Mexican passport G06189417 Businessman Re-election date: April 30, 2014 Joaquín López Dóriga López Ostolaza Director Mexican passport 07320002903 Bachelor of Economics Re-election date: April 30, 2014 Pedro Alejandro Sadurni Gómez Vice Chairman Mexican passport G01964606 Certified Public Accountant Re-election date: April 30, 2014 Marco Vera Olvera Director US passport 422308926 Bachelor of Economics Re-election date: April 30, 2014 Stephen Martin Clifford Director US passport 467475742 Bachelor of Economics Appointment date: April 30, 2014 Julián Silva Brisset Director Chilean ID: Foreigner Business Administration Appointment date: April 30, 2014 * As of December 31, the Company has 5 directors, and the appointment of 2 directors is pending. ( ) 42 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People CORPORATE MANAGEMENT ORGANIZATIONAL STRUCTURE BOARD OF DIRECTORS DEAN THOMPSON Executive Director PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MARCELO WEISSELBERGER A Chief Executive Officer FASA Chile JOSÉ LUIS ROJAS T. Chief Executive Officer FASA Mexico JUAN ALONSO GARCÍA H. Chief Executive Officer FASA Brasil Distrilife GÜNTHER GOECKE F. Corporate Finance and Administration Director PATRICIO LIRA K. Corporate Logistics and Systems Director MARIO PERALES J. Corporate Legal Director BENIGNO SEGOVIA M. Corporate Human Resources Director 43 | FASA 2014 Annual Report KEY EXECUTIVES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility DEAN THOMPSON Executive Director Bachelor of Science British passport 508088944 Appointment date: December 2014 Employed by FASA since: December 2014 GÜNTHER GOECKE F. Corporate Finance and Administration Director Certified Public Accountant Chilean ID: 8.767.035-K Appointment date: April 2011 Employed by FASA since: July 2003 PATRICIO LIRA K. Corporate Logistics and Systems Director Industrial Engineer Chilean ID: 8.494.420-3 Appointment date: May 2006 Employed by FASA since: November 1999 MARIO PERALES J. Corporate Legal Director Doctor of Law Mexican passport G04803808 Appointment date: May 2011 Employed by FASA since: April 2003 BENIGNO SEGOVIA M. Corporate Human Resources Director Bachelor of Computer Systems, MBA Mexican passport G07969321 Appointment date: November 2011 Employed by FASA since: February 2003 COMPENSATION OF KEY EXECUTIVES BONUS PLANS During 2014, the fixed gross compensation paid to FASA has an annual variable bonus based on key Company executives was Ch$ 2,451,828,747 and meeting targets set by senior management, to variable compensation totaled Ch$ 829,699,334. encourage and retain our executives. Likewise, for 2013, fixed gross compensation was Ch$ 2,259,464,290 and variable compensation totaled Ch$ 565,312,338. This includes the compensation paid to executives who have left the Company. TERMINATION BENEFITS DISTRIBUTION OF HUMAN RESOURCES As of December 31, 2014, the personnel at FASA and its related companies was distributed as follows: During 2014, Ch$ 86,477,734 was paid in termination benefits based on years of service. CORPORATE MANAGEMENT FASA CHILE FASA BRAZIL FASA MEXICO TOTAL Executives 5 7 1 8 21 Head Office and Distribution Center 0 326 15 603 944 Pharmacies and Prescription Centers 0 3,416 42 7,733 11,191 Total 5 3,749 58 8,344 12,156 44 | FASA 2014 Annual Report REGIONAL MANAGEMENT CHILE SENIOR MANAGEMENT INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MARCELO WEISSELBERGER ARAUJO Chief Executive Officer Business Engineer 10.032.623-K Chilean Appointment date: November 1, 2008 MIGUEL FARAH NEMTALA Operations and Real Estate Development Manager Pharmaceutical Chemist 8.481.178-5 Bolivian Appointment date: April 1, 2008 GERARDO SILVA REYNOSO Financial Control Manager MARCO CORTÁZAR GARCÍA Information Systems Director Certified Public Accountant 23.535.639-2 Mexican Appointment date: November 1, 2010 Systems Engineer COGM600508116 Mexican Appointment date: September 1, 2011 MEXICO SENIOR MANAGEMENT ANTONIO VERGARA ALCARAZ Commercial Director Bachelor of Economics VEAA590426AIA Mexican Appointment date: June 1, 2011 ÁLVARO BRITO PONS Pharmaceutical and Institutional Sales (ABF) Division Manager Business Engineer 11.242.857-7 Chilean Appointment date: August 1, 2010 JOSÉ ROJAS TOLEDO Chief Executive Officer Certified Public Accountant Passport: G07522442 Mexican Appointment date: November 1, 2011 AÍDA MARCELA VALDEZ FAZ Finance and Administration Director Bachelor of Economics VAFA750717S95 Mexican Appointment date: December 1, 2014 ALEJANDRO VILCHES BARROS Consumer and Marketing Division Manager Industrial Engineer 9.968.272-8 Chilean Appointment date: December 1, 2010 EDUARDO FERNÁNDEZ PADILLA Real Estate Development Director Bachelor in International Trade FEPE7504219Y7 Mexican Appointment date: November 5, 2012 PEDRO ELIZONDO PÉREZ Efficient Logistics Center Director Industrial and Systems Engineer EIPP750724GJ9 Mexican Appointment date: September 1, 2011 JAIME PALMA GUTIÉRREZ Information Systems Manager Civil Engineer 8.940.800-8 Chilean Appointment date: April 1, 2009 MANUEL GARCÍA GARCÍA Northern Sales Director Preparatory Diploma GAGM580427LP2 Mexican Appointment date: May 1, 2013 SEBASTIÁN GOYCOOLEA PRADO Logistics Manager Civil Engineer 8.394.491-9 Chilean Appointment date: June 1, 2013 MARCO GARCÍA HERNÁNDEZ Central Sales Director Certified Public Accountant GAHM6006263A3 Mexican Appointment date: May 1, 2013 BRAZIL SENIOR MANAGEMENT JUAN ALONSO GARCÍA HUITRÓN Chief Executive Officer Bachelor of Business Administration Passport: G033652010 Mexican Appointment date: October 8, 2012 45 | FASA 2014 Annual Report CORPORATE STRUCTURE FARMACIAS AHUMADA S.A. INTRODUCTION Company Details Letter from the Chairman 100% FASA Chile S.A. 100% FASA Investment Ltda. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility 100% Farmacias Ahumada Internacional S.A. 100% Exportadora Regional del Norte S.A. de C.V. OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 100% Laboratorios MDK S.A. 100% ABF, Administradora de Beneficios Farmacéuticos S.A. 95.6% Farmacias Benavides S.A.B. de C.V. 100% Compañia de Nutrición General S.A. 100% Inversiones Internacionales Inverfar S.A. 100% Droguería, Distribuidora y Logística DLI S.A. 100% Distrilife Distribuidora Atacadista de Suplementos Alimenticios Ltda. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 100% Administradora FASA S.A. 100% Comercializadora y Distribuidora BF S.A. 100% Comercial Farmacéutica S.A. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 100% Inmobiliaria Gestión Punto Retail S.A. This corporate structure is a simplified diagram, giving the percentages of each company owned by FASA, not the direct percentages between them. 49.0% Inmobiliaria Avantuen S.A. 49.0% Inmobiliaria Faster S.A. 46 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility TRAINING OUR PEOPLE Farmacias Ahumada is concerned for the continued development of During the second half of the year we presented a training program its employees. During 2014 we provided over 37,000 hours of training, developed specifically for the Special Prescription Laboratory team, involving 2,555 employees throughout Chile, using classroom lessons designed to encourage all to achieve a common goal, while sharing and e-learning. information and knowledge. During the first half of the year we launched an e-learning course Finally, entitled "Code of Ethics", which was directed to all staff at the Head administrative staff at the Head Office, due to the organizational Office, the Special Prescription Laboratory and the Distribution Center. changes experienced during the last year. They participated in the Likewise, we presented the course "Policies of Fair Competition", course "Positive Psychology Applied to Work", which impacts work at directed principally to staff in sales departments. Both courses were a personal, group and corporate level, and encouraged reflection on designed to strengthen our commitment to ethical conduct, based how work can be a source of growth and wellbeing. Furthermore, 70 on professionalism, moral integrity, loyalty and respect for individuals. scholarships were awarded to top-performing staff within this same a training program was developed specifically for target group to fund English classes and provide them with tools to In addition, we continued with the specialization program for store staff working with dermatology products, exclusive brands and GNC, strengthening their expertise in these matters, and focused on continuously improving our services. In addition, we provided training days for auxiliary pharmacy staff, encouraging career development for these employees. better understand this language. 47 | FASA 2014 Annual Report FASA 2014 CONVENTION "MAKE IT HAPPEN" The first FASA Convention "Make It Happen" was held at the Termas de Puyehue Hotel near Osorno on March 20-22. Here we specially recognized the best performing pharmacists and sales staff. This experience was very enriching for the lucky participants. They also heard presentations from our key executives on our corporate INTRODUCTION Company Details Letter from the Chairman strategy for 2014. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility interact with our executives, pharmacists and sales staff, helping The event also featured a commercial gallery, where suppliers could them to understand their products and clarify any doubts. It was also an opportunity for participants to engage in professional and leisure activities and be rewarded for their hard work. We reinforced teamwork and fostered enthusiasm and creativity among all participants, reminding them that targets can always be reached, and fulfillment depends on each individual’s hard work and OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility commitment to “Make it Happen”. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility PERFORMANCE 50 | FASA 2014 Annual Report CONSOLIDATED INDICATORS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates NUMBER OF EMPLOYEES (Number of employees in thousands) 12.2 2014 11.8 2013 10.4 2012 9.4 2011 10.2 2010 FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility CONSOLIDATED SALES (Thousands of Chilean pesos) 942.0 2014 2013 2012 845.1 765.3 2011 744.8 2010 735.1 51 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates NUMBER OF STORES 1,480 2014 1,300 2013 AVERAGE TICKET (Thousands of m2) (Chilean pesos) 295.8 2014 268.9 2013 1,140 2012 SALES FLOOR AREA 2012 244.7 2012 1,102 2011 237.9 2011 2010 1,066 2010 234.8 2010 INVESTMENTS PROFIT AFTER TAX (Thousands of Chilean pesos) 5,526 2013 2011 FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 5,962 2014 4,868 4,570 4,216 EBITDA (Thousands of Chilean pesos) (Thousands of Chilean pesos) 11.5 2014 17.2 2013 2012 6.9 7.2 2011 2010 5.4 -11.9 2014 15.8 2013 23.4 2012 2011 2010 9.1 -3.0 30.8 2014 2013 38.5 2012 36 35.1 2011 2010 23.9 52 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INVESTMENT AND FINANCING During 2014, investment reached Ch$ 11,545 and 158 million customers visited our pharmacies in Mexico and Chile. 53 | FASA 2014 Annual Report INVESTMENTS DEBT PROFILE INVESTMENT POLICY BONDS ISSUED IN CHILE FASA's investment program is optimized and aligned to meet the Farmacias Ahumada S.A. currently has two series of bonds growth plans for each country, and is designed to fulfill our overall in Chile, placed on May 15 and 19, 2008. The Series E Bonds expansion and continuous improvement plans. were registered under number 531 on April 16, 2008, in the SVS Securities Registry, for UF4 million, at a nominal interest rate of INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility For these purposes, management has sufficient authority to 4.25% per annum, repayable in 8 years with a 3-year grace period, make business-related investments, as well as any other directly and which may be totally or partially prepaid any business day complementary investment, provided they are aligned with the plans after May 15, 2009. approved by the board and the returns sought by our shareholders. MAJOR INVESTMENTS PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 2008, in the SVS Securities Registry, for UF4 million, at a nominal interest rate of 4.75% per annum, repayable in 21 years with a During 2014, investments totaled Ch$ 11,545 million, a decrease of 2-year grace period, and which may be totally or partially prepaid 32% over the previous year. any business day after May 15, 2013. Both series were classified Major investments include: • Opening 71 new stores, 46 in Chile and 25 in Mexico, reaffirming OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People The Series F Bonds were registered under number 532 on April 16, our commitment to grow our current market share. • Investments in various technology projects at a local and a corporate level. FINANCING FINANCING POLICY FASA's financing policy consists of funding its short and long-term operational investments by effectively managing working capital and generating its own resources (EBITDA). Long-term investments are those whose objective is to increase our stake in any subsidiary or to purchase a new company. To finance these, FASA evaluates the various instruments available on the financial market including bank borrowings, public bonds, etc., selecting the one that best suits the nature of the investment and our cash flow needs. 54 | FASA 2014 Annual Report as category BBB by ICR Compañía Clasificadora de Riesgo Ltda. RISK ASSOCIATED WITH THE GROWING IMPORTANCE OF INSTITUTIONAL CUSTOMERS IN THE HEALTH CARE INDUSTRY FASA must remain within maximum net indebtedness levels FASA customers include institutions, such as hospitals and health on a quarterly basis, as established in the bond contracts, insurance providers (Isapres). The agreements negotiated by Isapres and measured using its consolidated statements of financial with certain pharmacy chains produce an important flow of customers. position, which have already been adjusted to comply with IFRS. The potential amendment or termination of these agreements could Furthermore, the financial clauses stipulate that we cannot divest affect FASA. Moreover, hospitals or other institutional customers essential assets, such as the brands Farmacias Ahumada and that change their medicine suppliers or purchase them direct from FASA and must maintain control over Farmacias Benavides S.A.B. laboratories could potentially impact the financial performance of the de C.V. Company. To mitigate this risk and protect FASA's presence in this as category A- (stable) by the Rating Agency Humphreys Ltda., as category BBB+ by Feller Rate Clasificadora de Riesgo Ltda. and INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People sector, we have strengthened our subsidiary ABF, Administradora de Series E and F were placed on the Santiago Stock Exchange on Beneficios Farmacéuticos S.A. May 15 and 19, 2008. On May 15, 2008, UF1,800,000 were placed from the E Series at a rate of 4.21% with a spread of 106 basis points. Moreover, UF2,000,000 were placed from the F Series RISK ASSOCIATED WITH INTERNATIONAL EXPANSION AND GROWTH at a rate of 4.50% with a spread of 95 basis points. On May 19, 2008, an additional UF200,000 were placed from the F Series The at a rate of 4.50% with a spread of 100 basis points. Demand program targeting markets in Mexico and Brazil, which is now in for both series was high, generating historical Company spread a consolidation phase. This has enabled us to gain the experience ranges. The market's broad interest was reflected in the diversity necessary to decrease the risks of international expansion, while of investors who took part in the transaction, which included laying the foundations for growth in these countries. Additionally, it AFP's, insurance companies, mutual funds, investment funds, will enable us to enter other countries in Latin America in the future. banks, stock brokers, portfolio managers and individuals. The result of this process predominantly depends on the ability of Company has developed an international expansion our management to adapt our business model to the particular conditions of our target markets. PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MARKET RISK FACTORS COUNTRY SPECIFIC POLITICAL, REGULATORY AND ECONOMIC RISKS The main risks to the Company are: The Company is exposed to regulatory changes that we cannot RISK OF INCREASING COMPETITION OR THE EMERGENCE OF ALTERNATIVE CHANNELS control. Any policy changes in pharmacy regulations that allow medicine sales through other stores, such as supermarkets, could affect the Company's revenues. Another regulatory change which Given the characteristics of our markets, new chains could emerge could affect FASA is the preference given to generic drugs, as these or an existing chain may locally or regionally expand. This is have lower margins. Therefore, FASA partly mitigates this risk by compounded by the possibility that alternative channels to distribute incorporating new sales formats that emphasize other products pharmaceutical products may open up, which could reduce our types, not just medications, and introducing our own brands and market share or place greater pressure on margins. However, this risk exclusive brands. is partly mitigated by the different store formats currently used by the Company across various countries, as well as our strong brand RISK OF CONCENTRATION OF SUPPLIERS positioning in each one. There is a market risk due to the concentration of distributors and wholesalers in Mexico. To mitigate this risk FASA centralizes its product purchases directly from suppliers or distributors and then manages distribution logistics through distribution centers. 55 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People RISK RATING INSURANCE As of December 31, 2014, the risk rating of Farmacias Ahumada S.A. We have established an insurance program for FASA and its was: subsidiaries that covers a wide range of risks, including inventory, HUMPHREYS ICR * Shares First Class Level 4 First Class Level 4 First Class Level 4 Outlook Positive Stable Stable Bonds BBB+ A- BBB In Chile and abroad, FASA and its subsidiaries own various registered Outlook Positive Favorable Positive trademarks under which we sell some of our products. In addition, we * September 2014 PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility fires, funds remittances, robbery, civil liability, equipment and losses FELLER RATE COMPANY BUSINESS SUMMARY inflicted by stoppages. TRADEMARKS AND PATENTS market products under license from well-known international brands. The Company has license agreements for trademarks that have been registered for use in Peru with the business that bought our CUSTOMERS operations there. Over 158 million customers visited our pharmacies in Mexico and Chile during 2014. Our customer portfolio also includes institutional customers, such as insurance companies, health insurance providers (Isapres) and businesses that provide medication benefits to their REGULATORY FRAMEWORK members or employees through our subsidiary ABF. The Company is regulated in Chile by Law 18,045 on the Securities CONTRACTS Market and Law 18,046 on Corporations, and must comply with special regulations contained in the Sanitary Code, in Decree 466 issued by Most of our contracts relate to the lease of sales outlets for pharmacies the Ministry of Health dated 1984 regarding the regulations covering and general services. pharmacies, drugstores, pharmaceutical warehouses, first aid facilities and authorized deposits, and Decree 3 issued by the Ministry of Health SUPPLIERS dated 2011 that approves the National Control System regulations governing pharmaceutical products for human use. We have developed relationships with all the medical production laboratories in each country, and with other domestic and foreign product suppliers. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility GENERAL INFORMATION 58 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility REGARDING SHAREHOLDERS AND THE BOARD OF DIRECTORS We now have 1,480 stores, because being close to our customers is our priority. 59 | FASA 2014 Annual Report CHILEAN STOCK MARKET INFORMATION (*) Publically traded FASA share transactions are as follows: PERIOD UNITS First quarter 2013 Second quarter 2013 INTRODUCTION Company Details Letter from the Chairman Third quarter 2013 THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Second quarter 2014 OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Fourth quarter 2013 First quarter 2014 Third quarter 2014 AMOUNT (Ch$) AVERAGE PRICE (Ch$) 59,923 40,666,300 680.45 2,040,254 1,632,145,372 443.51 54,523 49,803,663 831.75 200,437 19,309,129 96.66 4,374,202 476,803,719 109.00 6,558,673 1,287,251,189 154.27 1,491,806,543 356,682,393,012 236.62 579,854 137,120,868 236.65 Fourth quarter 2014 (*) Information regarding transactions on the Santiago Stock Market, the Chilean Electronic Stock Market and Valparaíso Stock Ex- change. DIVIDENDS PAID The last three dividends paid by the Company were as follows: Payment Date Year Type CH$/SHARE (HISTORICAL) NUMBER OF SHARES May 30, 2012 2011 Final 17.5456 150,000,000 May 30, 2013 2012 Final 46.85893 150,000,000 May 30, 2014 2013 Final 3.16388 1,500,000,000 DIVIDEND POLICY BOARD COMPENSATION The Company's general dividend distribution policy for 2014 is to During 2014, the board was not compensated for its services, distribute at least 30% of profit for the year, which is the minimum according to the second transitory article of the bylaws approved at dividend established by law and the Company bylaws, notwithstanding the extraordinary shareholders' meeting dated May 17, 2013. The vice any interim dividends authorized by the board payable out of profit chairman of the board, Pedro Sadurni, received compensation as an for the year. executive of Ch$ 334,475,170. SUMMARY OF COMMENTS AND PROPOSALS FROM SHAREHOLDERS BOARD EXPENSES No comments or proposals have been received regarding corporate During 2014, the Board of Directors of Farmacias Ahumada S.A. did business between January 1 and December 31, 2014 from not incur any significant expenses. shareholders that own or represent over 10% of issued shares with voting rights. 60 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES CHILE - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates ABF, ADMINISTRADORA DE BENEFICIOS FARMACÉUTICOS S.A. ADMINISTRADORA FASA S.A. COMERCIAL FARMACÉUTICA S.A. Type of Entity: Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Chile) Privately Held Corporation (Chile) Chilean Tax ID: Chilean Tax ID: Chilean Tax ID: 96.863.980-3 76.031.544-3 76.213.595-7 Address: Address: Address: Miraflores 383, floor 6, Santiago, Chile. Miraflores 383, floor 6, Santiago, Chile. Miraflores 383, floor 6, Santiago, Chile. Telephone - Fax: Telephone - Fax: Telephone - Fax: 26313835 – 26313834 26313620 – 26613410 26313620 – 26613410 Subscribed and Paid Capital as of Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: 12.31.2014: ThCh$1.803.644 ThCh$20,000 ThCh$1,000 % Direct and Indirect Interest % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: as of 12.31.2014: 100% 100% 100% % Investment over Parent Assets: % Investment over Parent Assets: % Investment over Parent Assets: 1.75% 0.40% -0.07% Corporate Purpose: Corporate Purpose: Corporate Purpose: Organization, administration and Establishing private investment funds whose Purchase, sale, import, export, distribution development of health systems, particularly units are not offered to the public and are and supply of all types of medicines, systems related to the sale, marketing, managed at the risk of the private fund personal hygiene and care products and distribution and consumption of medicines. contributors. others, the provision of pharmaceutical Board: Board: premises, transportation, storage and Juan José Ricardo Guerra (Chairman), Directors: Juan José Ricardo Guerra distribution of goods, marketing of real Marcelo Weisselberger Araujo (Chairman), Marc Dench, Marcelo estate and others. and Günther Goecke Figueroa. Weisselberger Araujo Chief Executive Officer: and Günther Goecke Figueroa. One Board: Marcelo Weisselberger Araujo vacancy. Juan José Ricardo Guerra (Chairman), Alternate Directors: Five vacancies. Marcelo Weisselberger Araujo and Günther Chief Executive Officer: Goecke Figueroa. Mauricio Schwartzman Telias. Chief Executive Officer: services, operating chains of commercial FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Marcelo Weisselberger Araujo 61 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report COMERCIALIZADORA Y DISTRIBUIDORA BF S.A. COMPAÑÍA DE NUTRICIÓN GENERAL S.A. Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Chile) Chilean Tax ID: Chilean Tax ID: 76.213.594-9 96.792.260-9 Address: Address: Miraflores 383, floor 6, Santiago, Chile. Miraflores 383, floor 6, Santiago, Chile. Telephone - Fax: Telephone - Fax: 26313620 – 26613410 26313400 – 26313490 Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: ThCh$1,000 ThCh$1,107,253 % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: 100% 100% % Investment over Parent Assets: % Investment over Parent Assets: -0.40% 0.06% Corporate Purpose: Corporate Purpose: Purchase, sale, import, export, distribution Production, preparation, import, export, and supply of all types of personal hygiene purchase, sale, distribution and in general and care products, cosmetics, perfumes marketing in any form of all types of and pharmaceutical products, and others, pharmaceutical, dietary, alimentary, the provision of pharmaceutical services, homeopathic and organic products. operating chains of commercial premises, transportation, storage and distribution of Board: goods, marketing of real estate and others. Juan José Ricardo Guerra (Chairman), Marcelo Weisselberger Araujo and Günther Board: Goecke Figueroa. Juan José Ricardo Guerra (Chairman), Chief Executive Officer: Marcelo Weisselberger Araujo and Günther Marcelo Weisselberger Araujo. Goecke Figueroa. Chief Executive Officer: Marcelo Weisselberger Araujo 62 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES CHILE - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility DROGUERÍA, DISTRIBUIDORA Y LOGÍSTICA DLI S.A. FASA CHILE S.A. FASA INVESTMENT LIMITADA Type of Entity: Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Chile) Limited Liability Company (Chile) Chilean Tax ID: Chilean Tax ID: Chilean Tax ID: 96.860.090-7 96.809.530-7 96.969.830-7 Address: Address: Address: Avenida Los Vientos 19.867, Ciudad de Los Miraflores 383, floor 6, Santiago, Chile. Miraflores 383, floor 6, Santiago, Chile. Valles, Pudahuel, Santiago, Chile. Telephone - Fax: Telephone - Fax: Telephone - Fax: 26313620 – 26613410 26313620 – 26613410 23355400 – 23555452 Subscribed and Paid Capital as of Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: 12.31.2014: ThCh$2,016,794 ThCh$81,291,829 ThCh$1,731,307 % Direct and Indirect Interest % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: as of 12.31.2014: 100% 100% 100% % Investment over Parent Assets: % Investment over Parent Assets: % Investment over Parent Assets: 8.31% 50.66% 0.93% Corporate Purpose: Corporate Purpose: Corporate Purpose: Purchase, sale, import, export, distribution Investing in tangible and intangible, Production, purchase, sale, distribution and and supply of all types of medicines, domestic and foreign real estate and in general, marketing of pharmaceutical, personal hygiene and care products and personal property. cosmetic and toiletries products, and others, the provision of pharmaceutical providing storage, distribution, supplies and services, operating chains of commercial Board: other services, for itself or on behalf of third premises, transportation, storage and Juan José Ricardo Guerra (Chairman), parties. distribution of such goods, and the Marcelo Weisselberger Araujo and Günther purchase, sale, lease and administration of Goecke Figueroa. real estate property. Chief Executive Officer: Board: Marcelo Weisselberger Araujo. Juan José Ricardo Guerra (Chairman), Marcelo Weisselberger Araujo and Günther Board: Goecke Figueroa. Juan José Ricardo Guerra (Chairman), Chief Executive Officer: Marcelo Weisselberger Araujo and Günther Marcelo Weisselberger Araujo. Goecke Figueroa. Chief Executive Officer: Marcelo Weisselberger Araujo. 63 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report INMOBILIARIA GESTIÓN PUNTO RETAIL S.A. INVERSIONES INTERNACIONALES INVERFAR S.A. Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Chile) Chilean Tax ID: Chilean Tax ID: 99.562.480-K 99.506.180-5 Address: Address: Miraflores 383, floor 6, Santiago, Chile. Miraflores 383, floor 6, Santiago, Chile. Telephone - Fax: Telephone - Fax: 26313650 – 26613410 26313650 – 26613410 Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: ThCh$1,089 ThCh$5,031,009 % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: 100% 100% % Investment over Parent Assets: % Investment over Parent Assets: 5.84% -2.03% Corporate Purpose: Corporate Purpose: Purchase, sale, construction, urbanization, Investing in tangible and intangible, restructuring and exploitation in general of domestic and foreign real estate and real estate property, all types of real estate personal property. development projects, and real estate consultancy. Board: Juan José Ricardo Guerra (Chairman), Marc Board: Dench, Marcelo Weisselberger Araujo Juan José Ricardo Guerra (Chairman), and Günther Goecke Figueroa. Marcelo Weisselberger Araujo and Günther Chief Executive Officer: Goecke Figueroa. Günther Goecke Figueroa. Chief Executive Officer: Marcelo Weisselberger Araujo. 64 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES CHILE - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility LABORATORIOS MDK S.A. FARMACIAS AHUMADA INTERNACIONAL S.A. Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Uruguay) Chilean Tax ID: Subscribed and Paid Capital as of 79.663.290-9 12.31.2014: ThCh$400,272 Address: % Direct and Indirect Interest Miraflores 383, floor 6, Santiago, Chile. as of 12.31.2014: Telephone - Fax: 100% 26313440 – 26313490 % Investment over Parent Assets: -0.01% Subscribed and Paid Capital as of 12.31.2014: Corporate Purpose: ThCh$1,824,779 Investments in securities, bonds, % Direct and Indirect Interest shares, debentures, letters, analogous as of 12.31.2014: documents, imports, exports, commissions, 100% representations, mandates, and financial % Investment over Parent Assets: transactions. 1.38% Board: Corporate Purpose: Production, development, registration, import, export, purchase, sale, storage, transport and distribution of all types of pharmaceutical products, and the representation of domestic and foreign products in Chile and abroad, for itself or on behalf of third parties. Board: Juan José Ricardo Guerra (Chairman), Marcelo Weisselberger Araujo and Günther Goecke Figueroa. Chief Executive Officer: Marcelo Weisselberger Araujo. Manon Lecueder de San Vicente (Chairman). 65 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES CHILE - ASSOCIATES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INMOBILIARIA AVANTUEN S.A. INMOBILIARIA FASTER S.A. Type of Entity: Type of Entity: Privately Held Corporation (Chile) Privately Held Corporation (Chile) Chilean Tax ID: Chilean Tax ID: 76.912.090-4 76.009.174-K Address: Address: Avenida Santa María 6350 floor 1, Vitacura. Avenida Santa María 6350 floor 1, Vitacura. Telephone - Fax: Telephone - Fax: 2750 8400 - 2750 8401 2750 8400 - 2750 8401 Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: ThCh$3,202,126 ThCh$1,086 % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: 49.0% 49.0% % Investment over Parent Assets: % Investment over Parent Assets: 0.75% 0.44% Corporate Purpose: Corporate Purpose: Purchase, sale, construction, urbanization Purchase, sale, construction, urbanization of real estate, development of real estate of real estate, development of real estate projects, marketing, operating and leasing projects, marketing, operating and leasing real estate, for itself or on behalf of a third real estate, for itself or on behalf of a third party, real estate consultancy services, party, real estate consultancy services, including real estate brokerage. including real estate brokerage. Board: Board: Directors: Eduardo Valenzuela Sepúlveda Directors: Marcelo Weisselberger Araujo (Chairman), Henry Comber Sigall, Fernando (Chairman), Günther Goecke Figueroa, Escrich Juleff, Marcelo Weisselberger Araujo, Miguel Farah Nemtala, Henry Comber Günther Goecke Figueroa and Miguel Farah Sigall, Eduardo Valenzuela Sepúlveda and Nemtala. Fernando Escrich Juleff. Alternate Directors: Alternate Directors: Jaime Artigas Celis, Juan Patricio Lira Kappes, Álvaro Brito Pons, Juan de Dios Vergara Montes, José Miguel Infante de Dios Vergara Montes, Jaime Artigas Celis Lira, Patricio Lira Kappes and Álvaro Brito and José Miguel Infante Lira. Pons. Chief Executive Officer: Chief Executive Officer: Carlos Cortés González. Carlos Cortés González. 66 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES MEXICO - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility FARMACIAS BENAVIDES, S.A.B. DE C.V. BENAVIDES DE REYNOSA, S.A. DE C.V. FARMACIAS ABC DE MÉXICO, S.A. DE C.V. Type of Entity: Type of Entity: Type of Entity: Publicly Held Corporation (Mexico) Privately Held Corporation (Mexico) Privately Held Corporation (Mexico) Address: Address: Address: Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Colonia Colonia Colonia Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, México, C.P. 64750 México, C.P. 64750 México, C.P. 64750 Telephone: Telephone: Telephone: (52) 8150-7700 (52) 8150-7700 (52) 8150-7700 Subscribed and Paid Capital as of Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: 12.31.2014: ThCh$27,025,360 ThCh$1,145,328 ThCh$13,036,107 % Direct and Indirect Interest % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: as of 12.31.2014: 95.6% 100% 95.62% % Investment over Parent Assets: % Investment over Parent Assets: % Investment over Parent Assets: 6.66% 0.28% 2.10% Corporate Purpose: Corporate Purpose: Corporate Purpose: Purchase, sale, use, production, storage, Import and export all products, and Purchase, sale, use, production, storage, operation, distribution, commission, marketing of all commercial articles, operation, distribution, commission, consignment and representation of all types especially related to medicines and consignment and representation of all types of commercial articles, particularly related to pharmacies. of commercial articles, particularly related to medicines, pharmacies, perfumery, medicines, pharmacies, perfumery, etc. Board: photography, gifts, toys, magazines, cafe Board: José Luis Rojas Toledo (Chairman), Juan and restaurant, as well as real estate. Directors: José Luis Rojas Toledo José Ricardo Guerra and Mario Perales (Chairman), Juan José Ricardo Guerra and Juárez. Board: Mario Perales Juárez. Chief Executive Officer: José Luis Rojas Toledo (Chairman), Mario Independent Directors: Ernesto Milmo José Luis Rojas Toledo. Perales Juárez and Juan José Ricardo Rangel, Víctor Sergio García Tapia and Guerra. Mauricio Iván Montes Sepúlveda. Chief Executive Officer: Chief Executive Officer: José Luis Rojas Toledo. José Luis Rojas Toledo. 67 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report SERVICIOS LOGÍSTICOS BENAVIDES, S.A. DE C.V. SERVICIOS OPERACIONALES BENAVIDES, S.A. DE C.V. EXPORTADORA REGIONAL DEL NORTE DE MÉXICO, S.A. DE C.V. Type of Entity: Type of Entity: Type of Entity: Privately Held Corporation (Mexico) Privately Held Corporation (Mexico) Privately Held Corporation (Mexico) Address: Address: Address: Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Colonia Colonia Colonia Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, México, C.P. 64750 México, C.P. 64750 México, C.P. 64750 Telephone: Telephone: Telephone: (52) 8150-7700 (52) 8150-7700 (52) 8150-7700 Subscribed and Paid Capital as of Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: 12.31.2014: ThCh$2,061 ThCh$2,200 ThCh$3,689 % Direct and Indirect Interest % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: as of 12.31.2014: 95.62% 100% 100% % Investment over Parent Assets: % investment over parent assets: % Investment over Parent Assets: -0.01% 0% 0% Corporate Purpose: Corporate Purpose: Corporate Purpose: Purchase, sale, use, production, storage, Purchase, sale, use, production, storage, Production, purchase, sale, import, export, operation, distribution, commission, operation, distribution, commission, distribution and supply of all medicines, consignment and representation of all types consignment and representation of all types raw materials and others, storage and of commercial articles, particularly related of commercial articles, particularly related distribution of these goods, for itself or on to medicines, pharmacies, perfumery, to medicines, pharmacies, perfumery, behalf of third parties. photography, gifts, toys, magazines, cafe photography, gifts, toys, magazines, cafe and restaurant, as well as real estate. and restaurant, as well as real estate. Board: Board: José Ricardo Guerra and Mario Perales José Luis Rojas Toledo (Chairman), Juan José Luis Rojas Toledo (Chairman), Juan Juárez. José Ricardo Guerra and Mario Perales José Ricardo Guerra and Mario Perales Chief Executive Officer: Juárez. Juárez. José Luis Rojas Toledo. Chief Executive Officer: Chief Executive Officer: José Luis Rojas Toledo. José Luis Rojas Toledo. Board: José Luis Rojas Toledo (Chairman), Juan 68 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES MEXICO - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility COMERCIALIZADORA Y SERVICIOS BENAVIDES, S.A. DE C.V. SERVICIOS EJECUTIVOS BENAVIDES, S.A. DE C.V. SERVICIOS GENERALES BENAVIDES, S.A. DE C.V. Type of Entity: Type of Entity: Type of Entity: Privately Held Corporation (Mexico) Privately Held Corporation (Mexico) Privately Held Corporation (Mexico) Address: Address: Address: Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Avenida Fundadores 935, Interior 301, Colonia Colonia Colonia Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, Valle del Mirador, Monterrey, Nuevo León, México, C.P. 64750 México, C.P. 64750 México, C.P. 64750 Telephone: Telephone: Telephone: (52) 8150-7700 (52) 8150-7700 (52) 8150-7700 Subscribed and Paid Capital as of Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: 12.31.2014: ThCh$1,845 Ch$1,845 Ch$1,845 % Direct and Indirect Interest % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: as of 12.31.2014: 100% 100% 100% % investment over parent assets: % Investment over Parent Assets: % Investment over Parent Assets: 0% 0% 0% Corporate Purpose: Corporate Purpose: Corporate Purpose: Purchase, sale, use, production, storage, Purchase, sale, use, production, storage, Purchase, sale, use, production, storage, operation, distribution, commission, operation, distribution, commission, operation, distribution, commission, consignment and representation of all types consignment and representation of all types consignment and representation of all types of commercial articles, particularly related of commercial articles, particularly related of commercial articles, particularly related to medicines, pharmacies, perfumery, to medicines, pharmacies, perfumery, to medicines, pharmacies, perfumery, photography, gifts, toys, magazines, cafe photography, gifts, toys, magazines, cafe photography, gifts, toys, magazines, cafe and restaurant, as well as real estate. and restaurant, as well as real estate. and restaurant, as well as real estate. Board: Board: Board: José Luis Rojas Toledo (Chairman), Juan José Luis Rojas Toledo (Chairman), Juan José Luis Rojas Toledo (Chairman), Juan José Ricardo Guerra and Mario Perales José Ricardo Guerra and Mario Perales José Ricardo Guerra and Mario Perales Juárez. Juárez. Juárez. Chief Executive Officer: Chief Executive Officer: Chief Executive Officer: José Luis Rojas Toledo. José Luis Rojas Toledo. José Luis Rojas Toledo. 69 | FASA 2014 Annual Report SUBSIDIARIES AND ASSOCIATES BRAZIL - SUBSIDIARIES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility CASA SABA BRASIL HOLDINGS LTDA. DISTRILIFE DISTRIBUIDORA ATACADISTA DE SUPLEMENTOS ALIMENTICIOS LTDA. Type of Entity: Type of Entity: Limited Company (Brazil) Limited Company (Brazil) Address: Address: Avenida das Américas, 2000 – loja 05 – Avenida das Américas 3484, Bloco 5, sala Barra da Tijuca – RJ – CEP: 22640-101, Rio 204, Barra da Tijuca, Rio de Janeiro, Brasil, de Janeiro, Brasil. CEP 22640-102 Telephone - Fax: Telephone – Fax: (55)213-4313-922 (55) 21-3328-8774 Subscribed and Paid Capital as of Subscribed and Paid Capital as of 12.31.2014: 12.31.2014: ThCh$69,384,135 ThCh$410,082 % Direct and Indirect Interest % Direct and Indirect Interest as of 12.31.2014: as of 12.31.2014: 100% 100% % Investment over Parent Assets: % Investment over Parent Assets: 17% -2.37% Corporate Purpose: Corporate Purpose: Participate in other companies as partner, Marketing of wholesale food products shareholder or through units, in Brazil or in general, food complements and abroad. supplements, cosmetics and perfumery products, marketing, distribution and import Directors/Managers: of merchandise in general and retailing Juan Alonso García Huitrón. general or specialized food products. Chief Executive Officer: N/A Manager: Juan Alonso García Huitrón. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility FINANCIAL STATEMENTS 72 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report 73 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility | FASA 2014 Annual Report 74 | FASA 2014 Annual Report CONSOLIDATED CLASSIFIED STATEMENT OF FINANCIAL POSITION AS OF DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) ASSETS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People NOTE 12/31/2014 ThCh$ 6 44,199,408 12/31/2013 ThCh$ CURRENT ASSETS Cash and Cash Equivalents 30,653,040 Other Financial Assets, Current 7 3,118,173 411 Other Non-Financial Assets, Current 8 3,283,487 4,741,344 Net Trade and Other Receivables, Current 7 35,048,477 30,280,617 Related Party Receivables, Current 7-10 156,988 5,216,012 Inventories 11 169,906,972 150,101,658 Current Tax Assets 18 TOTAL CURRENT ASSETS 20,698,848 16,831,213 276,412,353 237,824,295 NON-CURRENT ASSETS Other Financial Assets, Non-Current 7 655,529 1,447,180 Other Non-Financial Assets, Non-Current 8 6,174,268 4,620,474 7-10 - 49,530,977 Related Party Receivables, Non-Current Investments Accounted for Using the Equity Method 12 1,545,281 1,326,006 PERFORMANCE Consolidated Indicators Investment and Financing Intangible Assets Other than Goodwill 13 65,720,059 58,644,181 Goodwill 15 13,246,489 12,934,697 Property, Plant and Equipment, Net 14 79,171,968 89,135,739 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Deferred Tax Assets 17 16,934,783 10,418,562 TOTAL NON-CURRENT ASSETS 183,448,377 228,057,816 TOTAL ASSETS 459,860,730 465,882,111 FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. 75 | FASA 2014 Annual Report CONSOLIDATED CLASSIFIED STATEMENT OF FINANCIAL POSITION AS OF DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) LIABILITIES INTRODUCTION Company Details Letter from the Chairman NOTE 12/31/2014 ThCh$ 12/31/2013 ThCh$ CURRENT LIABILITIES Other Financial Liabilities, Current 7-19 28,325,726 19,622,084 THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Trade and Other Payables, Current 7-20 279,236,260 234,928,138 Related Party Payables, Current OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People NON-CURRENT LIABILITIES PERFORMANCE Consolidated Indicators Investment and Financing Total Non-Current Liabilities GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates NET EQUITY FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 7-10 529,603 8,799,359 Other Provisions, Current 21 2,477,736 2,132,879 Current Tax Liabilities 18 4,356,877 5,014,537 Other Non-Financial Liabilities, Current TOTAL CURRENT LIABILITIES Other Financial Liabilities, Non-Current 7-19 Other Non-Financial Liabilities, Non-Current 248,480 769,066 315,174,682 271,266,063 58,526,212 72,162,257 602,302 601,582 7-10 - 34,571,771 Deferred Tax Liabilities 17 3,658,933 2,403,699 Non-Current Employee Benefits Provisions 22 Related Party Payables, Non-Current TOTAL LIABILITIES Issued Capital 5,277,404 115,016,713 385,137,577 386,282,776 59,274,176 59,274,176 Retained Earnings (Accumulated Deficit) 35,495,322 44,594,540 Other Reserves (25,114,813) (29,287,912) Equity Attributable to Owners of the Parent Company 69,654,685 74,580,804 5,068,468 5,018,531 74,723,153 79,599,335 459,860,730 465,882,111 Non-Controlling Interests TOTAL EQUITY TOTAL EQUITY AND LIABILITIES The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. 23 7,175,448 69,962,895 76 | FASA 2014 Annual Report CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME, BY NATURE FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) NOTE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People Revenue 2013 ThCh$ 940,638,509 843,901,012 1,375,824 1,233,538 5 942,014,333 845,134,550 11 (701,619,358) (629,924,047) 5 (86,562,034) (72,659,134) 13-14 (12,557,421) (10,484,136) Other income, by nature TOTAL OPERATING INCOME Raw materials and consumables Employee benefit expenses Depreciation and amortization 2014 ThCh$ Impairment losses recognized in profit or loss 14 (632,972) (554,360) Other expenses, by nature 5 (123,076,068) (104,002,936) Other gains (losses) 5 (20,935,707) (4,403,502) 3,072,379 5,894,473 5 (6,587,090) (6,921,087) Finance income Finance costs 12,545 522,913 166,104 2,235,195 Loss on indexation adjustments (3,550,700) (2,862,435) PERFORMANCE Consolidated Indicators Investment and Financing PROFIT (LOSS) BEFORE TAXES (10,255,989) 21,975,494 (1,442,612) (5,659,275) GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates PROFIT (LOSS) FROM CONTINUED OPERATIONS (11,698,601) 16,316,219 - - (11,698,601) 16,316,219 (11,877,713) 15,819,396 179,112 496,823 (11,698,601) 16,316,219 (7.92) 10.55 FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Share of income from investments in associates 12 Exchange differences Income tax benefit 17 PROFIT (LOSS) FROM DISCONTINUED OPERATIONS PROFIT (LOSS) Profit (Loss) Attributable to Owners of the Parent Company Profit (Loss) Attributable to Non-Controlling Interests PROFIT (LOSS) EARNINGS PER SHARE Basic earnings per share (common shares) (Ch$/Share) 25 Diluted earnings per share (diluted shares) (Ch$/Share) 25 PROFIT (LOSS) The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. (7.92) 10.55 (11,698,601) 16,316,219 77 | FASA 2014 Annual Report CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME, BY NATURE FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) NOTE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 2014 ThCh$ 2013 ThCh$ Cash Flow Hedge (*) 23 1,051,274 539,326 Pension Plan Reserves (*) 23 (744,301) 700,103 Translation Adjustments (*) 23 4,288,293 7,762,168 TOTAL OTHER INCOME AND EXPENSES CHARGED OR CREDITED TO NET EQUITY 23 4,595,266 9,001,597 (7,103,335) 25,317,816 (7,389,401) 24,379,144 286,066 938,672 (7,103,335) 25,317,816 (4.93) 16.25 0.19 0.63 TOTAL COMPREHENSIVE INCOME (LOSS) Comprehensive income (loss) attributable to owners of the parent company Comprehensive income (loss) attributable to non-controlling interests TOTAL COMPREHENSIVE INCOME (LOSS) Basic earnings per share attributable to owners of the parent company Basic earnings per share attributable to non-controlling interests (*) These entries will be reclassified to the Consolidated Statement of Comprehensive Income by Nature when they are settled. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. 78 | FASA 2014 Annual Report CONSOLIDATED STATEMENT OF CHANGES IN NET EQUITY FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Issued Capital OPENING BALANCE AS OF JANUARY 1, 2013 Translation Reserves 59,274,176 (21,212,783) Equity Attributable Retained to Owners Earnings of the Non-ConOther Total Other (Accumulated Parent trolling Reserves Reserves Deficit) Company Interests Pension Plan Reserves Hedge Reserves 657,640 (711,963) (16,580,554) (37,847,660) 33,520,963 54,947,479 4,573,254 59,520,733 Profit (loss) - - - 669,437 Other comprehensive income (loss) - 7,350,985 539,326 - Dividends - CLOSING BALANCE AS OF DECEMBER 31, 2013 - 59,274,176 (13,861,798) 1,196,966 Issued Capital OPENING BALANCE AS OF JANUARY 1, 2014 - Translation Reserves 59,274,176 (13,861,798) 1,196,966 - - 15,819,396 15,819,396 - 8,559,748 - - 8,559,748 441,849 9,001,597 - (4,745,819) (4,745,819) (493,395) (5,239,214) Equity Attributable Retained to Owners Earnings of the Non-ConOther Total Other (Accumulated Parent trolling Reserves Reserves Deficit) Company Interests Total Equity (42,526) (16,580,554) (29,287,912) 44,594,540 74,580,804 5,018,531 79,599,335 Profit (loss) - - - - - Other comprehensive income (loss) - 4,134,977 1,051,274 (697,939) - 4,488,312 Increase (decrease) for transfers and other changes - - - - (315,213) (315,213) CLOSING BALANCE AS OF DECEMBER 31, 2014 496,823 16,316,219 (42,526) (16,580,554) (29,287,912) 44,594,540 74,580,804 5,018,531 79,599,335 Pension Plan Reserves Hedge Reserves Total Equity - (11,877,713) (11,877,713) - 4,488,312 2,778,495 2,463,282 179,112 (11,698,601) 106,954 4,595,266 (236,129) 2,227,153 59,274,176 (9,726,821) 2,248,240 (740,465) (16,895,767) (25,114,813) 35,495,322 69,654,685 5,068,468 74,723,153 The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. 79 | FASA 2014 Annual Report CONSOLIDATED CASH FLOW STATEMENT FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) DIRECT CASH FLOW STATEMENT INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility NOTE 12/31/2014 ThCh$ 12/31/2013 ThCh$ 986,860,696 870,265,983 (830,939,944) (737,178,542) CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES PROCEEDS FROM OPERATING ACTIVITIES Proceeds from the sale of goods and provision of services Payments Payments to suppliers for goods and services Payments to and on behalf of employees (88,733,114) (73,889,314) Loan interest payments (4,097,666) (4,930,809) Income taxes refunded (paid) (11,444,481) (21,655,079) Other cash inflows (outflows) (843,232) (162,913) 50,802,259 32,449,326 - (4,012,349) NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES Loans to related companies Proceeds from the sale of property, plant and equipment - 143,722 (10,429,918) (14,690,277) Purchases of intangible assets (1,920,770) (2,054,702) Other cash inflows (outflows) - - (12,350,688) (20,613,606) 26,696,782 52,927,420 Purchases of property, plant, and equipment NET CASH FLOWS USED IN INVESTING ACTIVITIES CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES Proceeds from short-term loans Total loan proceeds 26,696,782 52,927,420 Loan repayments (37,330,061) (60,957,661) Finance lease payments Dividends paid NET CASH FLOWS USED IN FINANCING ACTIVITIES NET INCREASE IN CASH AND CASH EQUIVALENTS BEFORE EFFECT OF EXCHANGE RATE CHANGES Effect of exchange rate changes on cash and cash equivalents INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD The accompanying notes 1 to 32 are an integral part of these consolidated financial statements. 6 (595,817) (595,205) (14,203,132) (148,095) (25,432,228) (8,773,541) 13,019,343 3,062,179 527,025 1,034,988 13,546,368 4,097,167 30,653,040 26,555,873 44,199,408 30,653,040 80 | FASA 2014 Annual Report CONTENTS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 72 Independent Auditors' Report 74 Consolidated Financial Statements 82 NOTE 1 Corporate Information 83 NOTE 2 Summary of Significant Accounting Policies 94 NOTE 3 New Accounting Pronouncements 96 NOTE 4 Accounting Changes and Reclassifications 96 NOTE 5 Income and Expenses 97 NOTE 6 Cash and Cash Equivalents 98 NOTE 7 Financial Instruments 102 NOTE 8 Other Non-Financial Assets 102 NOTE 9 Risk Management 108 NOTE 10 Related Parties 112 NOTE 11 Inventories 113 NOTE 12 Investments in Related Companies 115 NOTE 13 Intangible Assets Other than Goodwill 117 NOTE 14 Property, Plant and Equipment 119 NOTE 15 Goodwill 120 NOTE 16 Finance Lease Disclosures (by Asset Class and Leaseholder) and Operating Lease Disclosures 122 NOTE 17 Deferred Taxes 124 NOTE 18 Current Tax Assets and Liabilities 125 NOTE 19 Interest-Bearing Obligations 130 NOTE 20 Trade and Other Payables, Current 131 NOTE 21 Provisions 132 NOTE 22 Non-Current Employee Benefits Provisions 134 NOTE 23 Equity 136 NOTE 24 Contingencies and Commitments 148 NOTE 25 Earnings per Share 148 NOTE 26 Share-Based Payment Policies 148 NOTE 27 Business Combinations 148 NOTE 28 Segment Reporting 151 NOTE 29 Local and Foreign Currencies 153 NOTE 30 Events After the Reporting Period 153 NOTE 31 Environment 153 NOTE 32 Financial Statement Approval INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 82 | FASA 2014 Annual Report NOTES TO THE FINANCIAL STATEMENTS AS OF DECEMBER 31, 2014 AND 2013 (IN THOUSANDS OF CHILEAN PESOS) NOTE 1 CORPORATE INFORMATION A. COMPANY INFORMATION INTRODUCTION Company Details Letter from the Chairman Farmacias Ahumada S.A. (hereinafter FASA, the Company or the Farmacias Ahumada S.A. has been operating in Chile since 1977 and Group), Chilean Tax ID 93,767,000-1, is the holding company for had 442 stores as of December 31, 2014. the group of businesses included in these Consolidated Financial THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Statements. The Company has been operating in Mexico since 2002, through Farmacias Benavides S.A.B. de C.V. and as of December 31, 2014, it had Farmacias Ahumada S.A. is a publicly held corporation incorporated 1,023 stores, of which 133 were added this year with the acquisition of under the laws of the Republic of Chile. It is registered in the Farmacias ABC de México, S.A. de C.V. Securities Registry held by the Chilean Superintendency of Securities and Insurance under number 629. Its shares are traded on the Chilean The Company has been operating in Brazil since the end of 2012, stock market. through Distrilife Distribuidora Atacadista de Suplementos Alimenticios Ltda., as the only distributor of the GNC product line. As of December The Company's head office is located at Miraflores 383, piso 6, 31, 2014, it had 15 stores in Brazil. Santiago, Chile. As of December 31, 2014, FASA operated over 1,480 stores with a total Farmacias Ahumada S.A. is owned by Alliance Boots Chile SpA sales floor surface of 295,812 m2. (99.39%), an indirect subsidiary of Walgreens Boots Alliance, Inc., a corporation constituted under the laws of Delaware whose corporate The extensive range of products that FASA markets includes the purpose is to invest in other companies. sale of medicines, personal hygiene and care products, beauty, baby products, pharmaceutical services, photographic supplies and At an extraordinary board meeting held on December 13, 2014, the printing services and collection services, etc. board approved a re-organization and merger plan between FASA, GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility its subsidiaries FASA Chile S.A. ("FASA Chile") and FASA Investment As of December 31, 2014, the Company employed 12,156 people as Limitada ("FASA Investment"), and Alliance Boots Chile SpA ("Alliance follows: Boots Chile"), which owns over 99% of the shares of FASA. The main objective was to reduce regulatory, legal and administrative costs • Pharmacies: 11,191 associated with the current corporate structure, and re-organize • Head Office and Distribution Centers: 954 these companies in the most efficient manner, always respecting the • Key Executives: 11 rights and interests of FASA minority shareholders. The Company employed an average of 11,520 people during the year B. DESCRIPTION OF OPERATIONS AND MAIN ACTIVITIES Farmacias Ahumada S.A. is the largest chain of pharmacies in Latin America, with stores in Mexico, Chile and Brazil. ended December 31, 2014. 83 | FASA 2014 Annual Report NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INTRODUCTION Company Details Letter from the Chairman 2.1. INFORMATION ON GOING CONCERN The operational continuity of the Company does not indicate any Consolidated Financial Statements as of December 31, 2013 uncertainty with respect to going concern and there are no intentions THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates to substantially reduce the scale of operations. The consolidated financial statements of Farmacias Ahumada S.A. as of December 31, 2013 and for the year then ended have been prepared 2.2. BASIS OF PREPARATION AND PRESENTATION OF THE CONSOLIDATED FINANCIAL STATEMENTS in accordance with International Financial Reporting Standards (IFRS) Consolidated Financial Statements as of December 31, 2014 The Consolidated Financial Statements and their corresponding issued by the International Accounting Standard Board (IASB). notes are shown comparatively for the years ended December 31, 2014 and 2013. The consolidated financial statements as of December 31, 2014, and for the year then ended have been prepared in accordance The Consolidated Financial Statements are presented in thousands of with International Financial Reporting Standards (IFRS), issued by the Chilean pesos (unless otherwise mentioned), which is the functional International Accounting Standards Board (IASB), and instructions currency of the Parent Company. issued by the Chilean Superintendency of Securities and Insurance (SVS). They were approved by the board on March 25, 2015. 2.3. PERIOD COVERED BY THE CONSOLIDATED FINANCIAL STATEMENTS Where discrepancies exist between IFRS and instructions from the SVS, the latter shall predominate. As of December 31, 2014, the only The Company presents its Statement of Financial Position as of instruction from the SVS that contravenes IFRS refers to accounting December 31, 2014 and 2013, its Statement of Income and of for the effects of deferred taxes established in Official Ruling 856 Comprehensive Income for the years ended December 31, 2014 and dated October 17, 2014. 2013, and its Statements of Changes in Net Equity and Cash Flow for the years ended December 31, 2014 and 2013. This ruling issues an obligatory exception to the framework for the FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility preparation and disclosure of financial information that the regulator The Company has prepared consolidated financial statements, which has defined as the International Financial Reporting Standards (IFRS). include the assets, liabilities, income and cash flows of the parent This ruling instructs companies that: "The differences in deferred tax company and the subsidiaries that are detailed in table below. assets and liabilities directly due to the increase in corporate income tax rates introduced by Law 20,780 should be accounted for in equity in that year." Consequently, this changes the framework for the preparation and disclosure of financial information applied up to the previous year end, as IFRS should be adopted comprehensively and explicitly without reserve. 84 | FASA 2014 Annual Report OWNERSHIP INTEREST INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility CHILEAN TAX ID COMPANY NAME 12/31/2014 Direct Indirect 79.663.290-9 Laboratorios MDK S.A. 0.0000 96.809.530-7 FASA Chile S.A. 96.863.980-3 ABF, Administradora Beneficios Farmacéuticos S.A. 96.860.090-7 Droguería, Distribuidora y Logística DLI S.A. 96.969.830-7 FASA Investment Ltda. 96.792.260-9 Compañía de Nutrición General S.A. 100.0000 12/31/2013 Total Total 100.0000 100.0000 99.9993 0.0007 100.0000 100.0000 0.0000 100.0000 100.0000 100.0000 0.0000 100.0000 100.0000 100.0000 99.9997 0.0003 100.0000 100.0000 0.0000 100.0000 100.0000 100.0000 99.506.180-5 Inversiones Internacionales Inverfar S.A. 0.0000 100.0000 100.0000 100.0000 99.562.480-K Inmobiliaria Gestión Punto Retail S.A. 0.0000 100.0000 100.0000 100.0000 76.031.544-3 Administradora FASA S.A. 0.0000 100.0000 100.0000 100.0000 76.091.951-9 Fondo de Inversión Privado Retail Chile 0.0000 0.0000 0.0000 0.0000 Foreign Farmacias Ahumada Internacional S.A. (Uruguay) 0.0000 100.0000 100.0000 100.0000 Foreign Farmacias Benavides S.A.B. de C.V. (México) 0.0000 95.6242 95.6242 95.6242 Foreign Benavides de Reynosa S.A. de C.V. (México) 0.0000 95.6242 95.6242 95.6242 Foreign Servicios Operacionales Benavides S.A. de C.V. (México) 0.0000 95.6242 95.6242 95.6242 Foreign Servicios Logísticos Benavides S.A. de C.V. (México) 0.0000 95.6242 95.6242 95.6242 Foreign Exportadora Regional del Norte de (México) S.A. de C.V. 0.1000 99.9000 100.0000 100.0000 76.141.833-5 Inversiones Retail Chile Limitada 0.0000 0.0000 0.0000 0.0000 76.213.595-7 Comercial Farmacéutica S.A. 0.0000 100.0000 100.0000 100.0000 76.213.594-9 Comercializadora y Distribuidora BF S.A. 0.0000 100.0000 100.0000 100.0000 Foreign Servicios Ejecutivos Benavides S.A. de C.V. 0.0000 99.9000 99.9000 99.9000 Foreign Comercializadora y Servicios Benavides S.A. de C.V. 0.0000 99.9000 99.9000 99.9000 Foreign Servicios Generales Benavides S.A. de C.V. 0.0000 99.9000 99.9000 99.9000 Foreign Casa Saba Brasil Holdings Ltda. 0.0000 99.9000 99.9000 99.9000 Foreign Distrilife Distribuidora Atacadista de Suplementos Alimenticios Ltda. 0.0000 100.0000 100.0000 100.0000 Foreign Farmacias ABC de México, S.A. de C.V. 0.0000 95.6242 95.6242 0.0000 This consolidation includes the Private Investment Fund Retail Chile The subsidiary Farmacias Benavides S.A.B. de C.V. is a Mexican and its subsidiary Inversiones Retail Chile Ltda. as they are considered corporation that trades its shares on the Mexican Stock Exchange. special purpose entities, whose exclusive business purpose is to invest in credits (invoices) or rights that third parties may hold against On June 3, 2014 all the shares of Farmacias ABC de México, S.A. de Farmacias Ahumada S.A. and its subsidiaries. The Fund acquires C.V. were acquired for MX$170,000,000 by Farmacias Benavides, suppliers credits before they fall due and subsequently collects them S.A.B. de C.V. and its subsidiary Servicios Operacionales Benavides, S.A. from Farmacias Ahumada S.A. or its subsidiaries. de C.V. leaving these companies with 99.99% and 0.01%, respectively. On June 25, 2014, these securities were transferred, as the agreed The financial statements of subsidiaries have been prepared for the contractual terms and conditions had been fulfilled for the purchase same periods reported above, using consistent accounting policies. of these shares. Revenue and expenses and gains and losses on transactions between FASA and its subsidiaries, including unrealized results arising on On March 11, 2014, Droguería y Distribuidora FASA S.A., changed its transactions within the group, have been eliminated on consolidation. legal name to Droguería, Distribuidora y Logística DLI S.A. 85 | FASA 2014 Annual Report On March 11, 2014, Inmobiliaria FASA S.A. changed its legal name to Inmobiliaria Gestión Punto Retail S.A. i. Trade and other receivables and Related party receivables: These are recognized initially at their fair value (nominal value including implicit interest) and subsequently at their amortized cost using On August 29, 2013, Laboratorios FASA S.A. changed its legal name to the effective interest rate method, less any impairment provisions. Laboratorios MDK S.A. ii. ii) Investments held to maturity: Investments that the Company INTRODUCTION Company Details Letter from the Chairman On January 17, 2013, the Brazilian company Casa Saba Brasil Holdings has the intention and ability to hold to maturity are recognized at Ltda., which was a subsidiary of Inversiones Internacionales Inverfar amortized cost. S.A., signed a purchase agreement with conditions precedent, where it agreed to sell all its shares in its subsidiary CSB Drogarias S.A. iii. Financial assets at fair value through profit and loss have been to Nice Rj Participacoes S.A., which is a subsidiary of the Brazilian designated as such when they were initially recognized. They are company Profarma Distribuidora de Productos Farmacéuticos S.A. valued in the consolidated statement of financial position at their THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Subsequently, on September 25, 2013, they signed various agreements fair value and changes in their value are recognized directly in that confirmed that the conditions precedent had been fulfilled, and profit or loss when they occur. OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People 2.4. IFRS COMPLIANCE AND ADOPTION PERFORMANCE Consolidated Indicators Investment and Financing that the sale price was agreed at R$11,743,307 (US$5,365,500). iv. Investments available for sale: These are financial assets that are This sale released the Company from operating a chain of pharmacies specifically designated as available for sale or those that are not in Brazil mostly in the State of Rio of Janeiro, enabling it to focus its included within the three previous categories. They are almost efforts in Brazil on operating its GNC franchise. entirely financial investments in capital. The acquisition and sale of financial assets are recognized using the transaction date. b. Cash and other cash equivalents The Company, its subsidiaries and associates have applied all the mandatory standards and interpretations as of December 31, 2014. This account includes cash in hand, time deposits and other short- The consolidated financial statements present fairly the financial term investments originally maturing in three months or less that can situation, the financial performance and the cash flows of the be quickly liquidated. Company. c. Financial liabilities except derivatives The information contained in these consolidated financial statements is the responsibility of the Company's board, who declare that Financial liabilities are generally recognized as their cash proceeds, GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates they fully comply with the principles and criteria described in the net of transaction costs. In subsequent periods these obligations are International Financial Reporting Standards (IFRS) issued by the valued at amortized cost, using the effective interest rate method. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 2.5. FINANCIAL INSTRUMENTS International Accounting Standards Board (IASB). The fair value of borrowings is calculated separately for debt at a fixed rate of interest or "fixed debt", and debt at a variable rate of interest or "variable debt". This information is used to recognize them in the a. Financial investments except derivatives consolidated statement of financial position and in other fair value disclosures. Fixed debt accrues interest at a rate that was fixed either The Company classifies its financial investments, whether permanent explicitly or implicitly at the initial transaction date for the remainder or temporary, excluding investments accounted for using the equity of its term. Variable debt carries a variable interest rate, where each method and those held for sale, into four categories: interest payment is calculated at the start of each interest period based on a benchmark interest rate. The debt is valued by discounting future cash flows and repayments using the agreed interest rates. 86 | FASA 2014 Annual Report d. Derivative instruments and hedging transactions e. Impairment of financial assets The Company's hedging transactions are fundamentally contracts to At each reporting date the Company evaluates whether there is any cover interest rate, exchange rate and inflation risks. Their purpose evidence of impairment of a financial asset or group of financial is to eliminate or significantly reduce the risks in the underlying assets. transactions being hedged. If the impairment decreases in a subsequent financial period, and the INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Hedge contracts are recognized initially at their fair value on the date decrease can be objectively related to an event that occurred after the contract was agreed, and subsequently at their fair value as of an impairment provision was initially recognized, then the previous the reporting date. Any gains or losses resulting from measurement impairment provision can be reversed. at fair value are recognized in the consolidated statement of comprehensive income by nature as gains or losses in fair value on Any subsequent reversal of an impairment provision is recognized in financial instruments, unless the derivative instrument is designated profit or loss to the extent that the asset's carrying amount does not as a hedging instrument. exceed its fair value at the date of the reversal. A derivative financial instrument is designated as a hedging instrument 2.6. INVENTORIES for accounting purposes if, on the transaction date, the Company assigns the hedging instrument to an underlying transaction, and Inventories are valued at cost or net realizable value, whichever is specifies its risk management objectives and its hedging strategy. The lower. Cost is calculated using the weighted average cost method. Group also evaluates at the outset and on a continual basis whether the derivatives used in hedge transactions are highly effective in The cost of finished goods includes the raw materials, direct labor, offsetting changes in the fair value or the cash flows of hedged items. other direct costs and general production expenses based on a normal operating capacity, but does not include interest. A hedge is considered highly effective when changes in the fair value, or underlying cash flows attributable to the risk hedged, are offset by Net realizable value is the estimated selling price in the ordinary changes in the fair value or cash flows of the hedge instrument, with course of business, less any applicable variable costs of sale. an effectiveness in the range of 80% - 125%. Various concepts are used to calculate the obsolete inventory The effective portion of the change in the fair value of hedge provision. The most important factor is an evaluation of every inventory instruments is initially recognized in Hedge Reserves in a separate item with no or only one sale during the last eight months, except component of equity. The gain or loss on the ineffective portion is seasonal products. Additionally, the remaining time to expiration is recognized immediately in the consolidated statement of income by considered, and the associated seasonal nature. This concludes that nature. The accumulated amounts in equity are reclassified to profit or these inventories cannot be sold in normal conditions. loss in the same period that the respective risk exposure appears in the FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility consolidated statement of income by nature. When a hedge ceases to comply with the hedge accounting criteria, any accumulated gain or loss in equity remains there, and is recognized when the expected transaction is finally recognized in the consolidated statement of income by nature. When an expected transaction is no longer likely to occur, the accumulated gain or loss in equity is recognized immediately in the consolidated statement of income by nature. 87 | FASA 2014 Annual Report 2.7. TRADE AND OTHER RECEIVABLES • The actuarial hypotheses used to calculate obligations to employees - Note 22. Trade and other receivables do not explicitly accrue interest and are recognized at amortized cost. 2.9. INTANGIBLE ASSETS The Company evaluates the granting of credit to customers using a. Purchased goodwill historical parameters, their financial situation and commercial INTRODUCTION Company Details Letter from the Chairman reports. The evaluation of large businesses is approved by the Credit Purchased goodwill generated on consolidation represents the Committee. difference between the acquisition cost and FASA's share in the fair value of the assets and liabilities, including identifiable contingent Impairment provisions are estimated by applying different percentages liabilities, of a subsidiary at the acquisition date. to aged debt ranges, through to a 100% provision against debts over THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 300 days past due, except for those cases where partial impairment Acquired assets and liabilities are valued on a provisional basis as of is expected based on an individual analysis in accordance with policy. the date the Company takes control. These valuations are reviewed The analysis of aged receivables by ranges is based on a historical within a maximum period of one year from the acquisition date. analysis of the recovery of accounts receivable from customers. Until the final fair value of acquired assets and liabilities is known, the difference between the purchase price and the book value of the The consolidated allowance for doubtful accounts as of December acquired company is registered on a provisional basis as purchased 31, 2014 and 2013, was ThCh$2,540,907 and ThCh$2,088,438, goodwill. respectively. If the final value of purchased goodwill is reported in the financial 2.8. ESTIMATION POLICY the previous year used for comparison purposes must be restated to The consolidated financial statements have been prepared using incorporate the final value of the acquired assets and liabilities and the estimates and assumptions based on the best available information final purchased goodwill as of the acquisition date. at the reporting date. Purchased goodwill is recognized in the same functional currency as Consolidated financial statements prepared according to IFRS are the respective investment. required to use estimates and judgments that affect assets, liabilities and cash flows. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates statements of the year after acquisition, the financial statements for Purchased goodwill is not amortized, but at each reporting date the respective investment is evaluated for evidence of impairment that These estimates have been aligned with the professional judgment might reduce its recoverable value to below its book value, which policies used by Alliance Boots to calculate provisions, which do not would trigger an impairment provision. differ from current standards. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility b. Trademarks Therefore, actual outcomes in subsequent periods may differ from these estimates. The Company has recognized specific independently acquired trademarks The principal estimates refer to: as assets and others acquired under business combinations, all of which have been valued by independent experts. These trademarks carry the reasonable expectation of generating • Goodwill valuations - Note 2.9. future financial gains. The cost of these assets can be reliably • Intangible asset valuations - Note 2.9. measured. Their useful life is indefinite, though they can be impaired • Asset useful lives - Note 2.9. if their recoverable value falls. • Asset impairment provisions - Note 2.11. • Fair value calculations - Note 2.5 d. • Obsolescent inventory provisions - Note 2.6. • Allowances for doubtful accounts - Note 2.7. 88 | FASA 2014 Annual Report These trademarks are detailed in Note 13 Intangible Assets other than 2.10. PROPERTY, PLANT AND EQUIPMENT: Goodwill. Property, plant and equipment is valued at acquisition cost, net of c. Definition of finite or indefinite useful life corresponding accumulated depreciation and any impairment. The historical cost includes all expenses directly attributable to the • Finite useful life is where the number of productive units or other acquisition and implementation of the asset. similar time-based indicators define the time that the Company INTRODUCTION Company Details Letter from the Chairman can make use of the intangible or fixed asset, or the period that The cost of any subsequent components are added to the initial the intangible asset will generate financial gains for the Company. value of the asset or are recognized as a separate assets, only when The assets that the Company classifies as having a finite useful life it is probable that these costs will increase productivity, capacity or are as follows: efficiency, or extend the asset's useful life, and the cost of those components can be reliably determined. The value of removed THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing - Patents and registered trademarks components is expensed for accounting purposes. All repairs and - Lease rights maintenance are expensed in same financial year that they occur. - Software Asset depreciation is calculated using the straight-line method over • Indefinite useful life is where an analysis of all the relevant factors estimated useful lives. does not identify a foreseeable limit to the period that the asset will generate net cash inflows for the Company. The assets that the Company classifies as having an indefinite useful life are as follows: - Goodwill Life or Rate for Buildings - Trademarks Life or Rate for Plant and Equip- MINIMUM LIFE OR RATE MAXIMUM LIFE OR RATE YEARS YEARS 20 100 ment 4 10 As of December 31, 2014 and 2013, there was no evidence that the Life or Rate for IT Equipment 4 7 trademarks classified with an indefinite useful life have been impaired. Life or Rate for Motor Vehicles 5 10 d. Amortization The residual value and the useful lives of assets are reviewed, and GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Amortization is recognized in profit or loss on a straight line basis adjusted if necessary, as of each reporting date. over the estimated useful life of intangible assets from the date they become available for use, except for goodwill and trademarks. The When the book value of an asset is greater than its estimated useful lives for the current period and the comparative period are as recoverable amount, its book value is reduced to its recoverable follows: amount. Useful life for software 3 to 7 years Gains and losses on the sale of property, plant and equipment are Useful life for lease rights As lease contract calculated by comparing the proceeds to the book value, and are Patents and registered trademarks 5 to 10 years recorded in the statement of income. The cost may also include gains or losses on qualifying cash flow hedges for acquisitions of property, plant and equipment in foreign currency, transferred from net equity. 2.11. IMPAIRMENT OF NON-FINANCIAL ASSETS The Company evaluates whether there is any indication of impairment in property, plant and equipment as of each reporting date. When 89 | FASA 2014 Annual Report such indications are found, the Company estimates the recoverable 2.13. INVESTMENTS IN SUBSIDIARIES value of the asset to determine the impairment provision. Subsidiaries are those entities, including structured entities, which The recoverable value of property, plant and equipment is calculated FASA controls. FASA controls an entity when it is exposed to, or has by discounting future cash flows at the required rate of return. the right to receive, variable returns based on its participation, and has the power to influence these returns. Generally control requires INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Intangible assets with an indefinite useful life are tested for impairment participation in more than half the voting rights. When evaluating annually, or more frequently when there are indications that they are whether the Group controls another entity, the existence and effect impaired. of potential voting rights that are exercisable or convertible are considered. A subsidiary is consolidated from the date on which When the book value of an investment exceeds the present value control is transferred to the Group and is excluded from consolidation of future cash flows discounted at the required rate of return, an on the date on which it ceases to be controlled. The accounting impairment provision is recognized and is expensed to the statement treatment for the acquisition of subsidiaries by the Group is detailed of income. in Note 2.22. The Company has established that any impairment provision for an 2.14. INTEREST-BEARING LOANS asset or asset group may be reversed in the future, when the present value of future cash flows is greater than the net book value on the Current and non-current financial liabilities are initially recognized evaluation date. at fair value, which is their placement value discounting all directly associated transaction costs, and are subsequently valued at In the case of other assets, the recoverable value is the estimated amortized cost using the effective rate method. disposal value of those assets. 2.15. LEASES When the estimate of the recoverable amount for an asset increases, and impairment provisions have been recognized in previous years, a. Operating leases these are reversed net of depreciation, while the value of the asset is increased and the gain taken to the statement of income. When the Company is the lessee and the contract qualifies as an operating lease, all payments are expensed. 2.12. INVESTMENTS IN ASSOCIATES ACCOUNTED FOR USING THE EQUITY METHOD At the end of the operating lease contract period, any contract penalties or compensations required by the lessor are expensed in the Associates are those entities over which the Group has significant financial period when the contract ended. Leasehold improvements influence. to buildings are depreciated over the estimated useful lives of the improvements, or the remaining leasing contract term, whichever is FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Investments in associates are accounted for under the equity method less. and are initially recognized at cost. The Group's share of the earnings or losses after the acquisition of an associate are recognized in Leasehold improvements to buildings are depreciated over the profit or loss, and their participation in all other movements after the estimated useful lives of the improvements using normal policies for acquisition are recognized in reserves. The accumulated movements assigning useful lives, or the remaining lease contract term, whichever after the acquisition are taken to the book value of the investment. is less. When the Group's share of the losses of an associate is equal or greater than its investment, including any other unsecured accounts receivable, no additional losses are recognized, unless the Group has incurred obligations or made payments on behalf of the associate. Unrealized gains and losses on transactions between the Group and its associates are eliminated in proportion to the Group's ownership interest. 90 | FASA 2014 Annual Report b. Finance leases rate, mortality and future wage increases, all determined on the basis of actuarial calculations. Leases of personal or real estate property that transfer substantially all the risks and benefits of ownership are classified as finance leases. The initial transition asset or liability is recognized only if a new Finance leases are capitalized at the beginning of the lease at the fair defined benefit plan is established. Past service arising from the value of the leased property, or the present value of minimum lease new plan is amortized over the remaining working life of employ- payments, whichever is less. ees that will receive those benefits. As of December 31, 2014, the Group had not established new benefit plans. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing The corresponding lease obligations, net of finance costs, are included in other financial liabilities. Interest in the finance cost is In accordance with accounting standards, the actuarial gains and expensed during the period of the lease in such a way as to obtain a losses that exceed plan assets by more than 10% and defined ben- constant periodic rate of interest on the liability's remaining balance efit obligations (before deducting the plan assets) by more than for each year. Assets acquired under finance leases are depreciated 10% can be expensed by the Group using either of two different under the general rules that apply to property, plant and equipment. methods: (i) they can be amortized to profit or loss during the remaining working lives of the employees who will receive those 2.16. PROVISIONS benefits, or (ii) they can be applied systematically to produce a faster recognition in profit or loss. Provisions are recognized when the Company has a present obligation, as a result of a past event, whose settlement is likely to (ii) Termination benefits: require a future disbursement which can be reliably measured. Termination benefits are recognized as an expense when the a. Onerous contracts Group is demonstrably committed to a detailed formal plan either to terminate the employment relationship before the normal Provisions for onerous contracts are recognized for the unavoidable retirement date, or to provide termination benefits as a result of costs to fulfill the contract, i.e., the costs to comply with all the an offer to encourage the employee to voluntarily retire, without contract terms and any compensation or penalties arising from any any possibility of avoiding payment. If the Group makes an offer breach. to encourage voluntary retirement, the termination benefits will be valued taking into account the number of acceptances. If the b. Employee benefits benefits are payable more than 12 months after the reporting period, they are discounted to present value. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility (i) Defined benefit plans: (iii) Short-term benefits: The Group recognizes the employment obligations on the defined benefits of seniority premiums and pension plans. Costs are Short-term benefit obligations to employees are valued without expensed as employees provide their services, and actuarial cal- discounting them and are expensed as the services are rendered. culations are applied to the present value of these employment The amount of direct short-term cumulative and non-cumulative obligations. The calculation of the items to be amortized and the benefits are provisioned. net cost for the period on defined benefit obligations uses the "projected unit credit method". The seniority premium is awarded when staff who have over fifteen years' service leave, and is calculated using the number of years worked. The seniority premium is awarded to employees regardless of the reason for their departure. Pension plan provisions use assumptions such as continuing to 60 years old and 15 years of service, discount rate and interest 91 | FASA 2014 Annual Report 2.18. INCOME TAXES (iv) Profit sharing: The Group recognizes a provision for contractual obligations, or The tax expense for the year includes current and deferred taxes. when there is a precedent that has created a constructive obli- Tax is expensed, except when it relates to items recognized in other gation. comprehensive income, or directly in net equity. In this case, the corresponding tax is also recognized in other comprehensive income The interest rates and actuarial assumptions used to calculate the or directly in net equity, respectively. present values of the obligation referred to in point (i) consider INTRODUCTION Company Details Letter from the Chairman the use of nominal rates, due to the Group's non-inflationary eco- Differences between the book value of assets and liabilities and nomic environment. The most important financial assumptions their tax base generates deferred tax assets or liabilities, which are are as follows. calculated using the expected local tax rates when those assets and liabilities will be realized. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing FINANCIAL ASSUMPTIONS 2014 2013 Discount rate 7.00% 6.75% Rate of salary increase 4.20% 4.50% Rate of minimum wage increase 3.50% 3.50% Post-retirement interest rate 7.00% 6.75% Rate of return 7.00% 6.75% FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility considered probable that there will be sufficient future taxable profits to recover the temporary differences and apply the tax credits. The Company does not recognize deferred tax on temporary differences in investments in subsidiaries and associates since it controls the date on which these will be reversed, and they are c. Other provisions unlikely to be reversed in the foreseeable future. Other provisions include employee benefits due to the restructuring Any deferred tax on items that are recognized directly in net equity plan approved by the board that includes the following concepts: will also be recognized directly in net equity. • Termination benefits As of each reporting date, deferred tax assets and liabilities are • Executive retention plan on change of control reviewed in order to ensure that they remain valid, and if necessary • Royalties and profit sharing corrected. 2.17. DIVIDENDS GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Deferred tax assets and tax credits are recognized only when it is On September 29, 2014, the Tax Reform Act became law. This new law defines the default tax regime applicable to the Company and Company bylaws and Chilean Corporate Law establish that unless the default corporate income tax rates phased in between 2014 and another agreement is adopted unanimously at the respective meeting 2018, but allows companies to choose between either the Attributed by all current shareholders, publicly traded companies must annually Income Regime or the Semi-Integrated Regime, where different tax distribute as a dividend in cash to their shareholders, in proportion rates apply from 2017 onwards. to their shares or in the proportion established in the bylaws should there be preferential shares, at least 30% of profit each year, except The Attributed Income Regime applies to individual entrepreneurs, when accumulated losses from previous years must be absorbed. individual companies with limited liability, communities and partnerships when the latter are formed exclusively by individuals that Interim and final dividends are recognized against “net equity” at the are domiciled and resident in Chile; and the Semi-Integrated Regime time they are approved by the board for the former, and at a general applies to the remainder of taxpayers, such as public and private shareholders’ meeting for the latter. corporations, simplified corporations or partnerships not formed exclusively by individuals that are domiciled and resident in Chile. The default tax regime for the Company shall be the Semi-Integrated Regime with effect from January 1, 2017. 92 | FASA 2014 Annual Report In addition, the Company can choose to change the regime during 2.21. CAPITALIZATION OF INTEREST the last three months of 2016, by approval at an extraordinary shareholders' meeting, with a quorum of at least two-thirds of the Interest that is directly attributable to the acquisition, construction or issued shares with voting rights. It shall become effective by presenting production of assets is capitalized to form part of the cost of such a signed declaration to this effect by the Company, accompanied assets. Other interest costs are expensed. by the meeting minutes signed by the Company and legalized as a public instrument. The Company shall remain in the corresponding 2.22. BUSINESS COMBINATIONS taxation regime for at least five consecutive years. After this period INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility has elapsed, the regime can be changed, but cannot be altered for at The Group uses the acquisition method to account for business least another five consecutive years. combinations, except for business combinations with entities under common control as described below. The payment for the acquisition 2.19. REVENUE RECOGNITION of a subsidiary matches the fair value of the transferred assets, the liabilities incurred by the previous owners and the participation in the a. Commercial products equity issued by the Group. This payment includes the fair value of any assets or liabilities that arise from a contingency. The identifiable Revenue is recognized by Farmacias Ahumada S.A. when the financial assets, liabilities and contingencies acquired in a business combination benefits arising from its main activities are received, which represents are valued initially at their fair value on the acquisition date. the physical delivery of inventory when sold, and services rendered during the period, until the reporting date. Revenue is shown net of The costs associated with the acquisition are expensed in the period taxes, price discounts and other deductions that directly affect the in which they are incurred. selling price. The excess of the consideration paid over the fair value of identifiable Revenue is recognized when the rights and obligations of the goods net assets acquired is recognized as goodwill. If the consideration have been substantially transferred to the buyer, in accordance with paid is less than the fair value of the net assets of the subsidiary IAS 18 "Revenue". acquired, for acquisitions in very favorable conditions, the difference is recognized directly in the statement of income. b. Interest Business combinations with entities under common control use the The Company recognizes interest income from their investments and "predecessor accounting" method recognizing the excess/shortfall other sources as it accrues. in the consideration paid over the pre-existing book value of the acquired entity, and charging this to other reserves. 2.20. EARNINGS (LOSSES) PER SHARE This method requires the incorporation of all assets and liabilities at Basic earnings per share are calculated as profit (loss) for the period their pre-combination book values with no regard to their fair value, attributable to common shareholders divided by the weighted average recognizing the excess/shortfall in the consideration paid over the number of issued common shares during that period, excluding the pre-existing book value of the acquired entity, and charging this to average number of shares held by the Parent Company, if applicable other reserves. at any time and the shares that form part of the Executive Bonus Plan - Note 25. 93 | FASA 2014 Annual Report 2.23. TRANSLATION OF BALANCES IN FOREIGN CURRENCY 2. Operating activities: Those activities that form the main source of the Company’s revenue, and other activities that are not considered financing or investing. Transactions in currencies other than the functional currency of each company are recognized at the prevailing exchange rates at the time of 3. Investing activities: Those activities involving the acquisition, sale the transaction. During the period, the differences that arise between or disposal by other means of non-current assets and other in- the exchange rate used at initial recognition and that used on the vestments not included in cash and cash equivalents. date of collection, payment or closure are recognized as exchange INTRODUCTION Company Details Letter from the Chairman differences in the consolidated statement of comprehensive income. size and composition of net shareholders’ equity and financial liaExchange differences arising from the translation of assets and liabilities in units denominated in indexed currencies are expensed, THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates under indexation adjustments. DETAIL 2014 Ch$ 2013 Ch$ US dollar 606.75 524.61 41.23 40.12 228.43 224.00 24,627.10 23,309.56 Mexican peso Brazilian real UF (a Chilean peso based indexed currency) 2.24. CLASSIFICATION OF BALANCES AS CURRENT AND NON-CURRENT Balances in the statement of financial position are classified by maturity, namely current are those due within twelve months and non-current are those due over a longer period. 2.25. CASH FLOW STATEMENT The cash flow statement reports cash movements during the year using the direct method. The following expressions are used in these FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 4. Financing activities: Those activities that produce changes in the consolidated cash flow statements: 1. Cash flows: Inflows and outflows of cash or other equivalents including time deposits with an original term of three months or less that are highly liquid and with a low risk of variation in value. bilities. 94 | FASA 2014 Annual Report NOTE 3 NEW ACCOUNTING PRONOUNCEMENTS NEW IFRS AND INTERPRETATIONS FROM THE INTERPRETATIONS COMMITTEE The following standards, interpretations and amendments are mandatory for the first time for annual periods beginning on January 1, 2014: STANDARDS AND INTERPRETATIONS INTRODUCTION Company Details Letter from the Chairman IFRIC 21 "Levies" AMENDMENTS AND IMPROVEMENTS THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MANDATORY FOR ANNUAL PERIODS BEGINNING January 1, 2014 MANDATORY FOR ANNUAL PERIODS BEGINNING IAS 32 " Financial Instruments: Presentation” January 1, 2014 IAS 27 "Separate Financial Statements" and IFRS 10 "Consolidated Financial Statements" and IFRS 12 "Disclosure of Interests in Other Entities" January 1, 2014 IAS 36 “Impairment of Assets” January 1, 2014 IAS 39 "Financial Instruments: Recognition and Measurement" January 1, 2014 The adoption of these standards, amendments and interpretations do not have a significant impact on the consolidated financial statements of the Company. STANDARDS, INTERPRETATIONS AND AMENDMENTS ISSUED, BUT NOT YET MANDATORY FOR ANNUAL PERIODS BEGINNING ON JANUARY 1, 2014, AND WHICH HAVE NOT BEEN ADOPTED EARLY. MANDATORY FOR ANNUAL PERIODS BEGINNING IFRS 9 "Financial Instruments" January 1, 2018 IFRS 14 "Regulatory Deferral Accounts" January 1, 2016 IFRS 15 "Revenue from Contracts with Customers" January 1, 2017 AMENDMENTS AND IMPROVEMENTS IAS 19 "Employee Benefits" MANDATORY FOR ANNUAL PERIODS BEGINNING July 1, 2014 IFRS 11 "Joint Arrangements" January 1, 2016 IAS 16 "Property, Plant and Equipment" and IAS 38 "Intangible Assets" January 1, 2016 IAS 16 "Property, Plant and Equipment" and IAS 41 "Intangible Assets" January 1, 2016 IAS 27 "Separate Financial Statements" January 1, 2016 IFRS 10 "Consolidated Financial Statements" and IAS 28 "Investments in Associates and Joint Ventures". January 1, 2016 IAS 1 "Presentation of Financial Statements" January 1, 2016 95 | FASA 2014 Annual Report IMPROVEMENTS TO INTERNATIONAL FINANCIAL REPORTING STANDARDS (2012) ISSUED IN DECEMBER 2013. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MANDATORY FOR ANNUAL PERIODS BEGINNING IFRS 2 "Share-based Payment" July 1, 2014 IFRS 3 "Business Combinations" July 1, 2014 IFRS 8 "Operating Segments" July 1, 2014 IFRS 13 "Fair Value Measurement" July 1, 2014 IAS 16 "Property, Plant and Equipment" July 1, 2014 IAS 24 "Related Party Disclosures" July 1, 2014 IMPROVEMENTS TO INTERNATIONAL FINANCIAL REPORTING STANDARDS (2013) ISSUED IN DECEMBER 2013. MANDATORY FOR ANNUAL PERIODS BEGINNING IFRS 1 "First-time Adoption of International Financial Reporting Standards" July 1, 2014 IFRS 3 "Business Combinations" July 1, 2014 IFRS 13 "Fair Value Measurement" July 1, 2014 IAS 40 "Investment Property" July 1, 2014 IMPROVEMENTS TO INTERNATIONAL FINANCIAL REPORTING STANDARDS (2014) ISSUED IN SEPTEMBER 2014. MANDATORY FOR ANNUAL PERIODS BEGINNING IFRS 5 "Non-Current Assets held for Sale and Discontinued Operations". January 1, 2016 IFRS 7 "Financial Instruments: Disclosures" January 1, 2016 IAS 19 "Employee Benefits" January 1, 2016 IAS 34 "Interim Financial Reporting" January 1, 2016 The Company’s Management believes that the adoption of these standards, amendments and interpretations will have no significant impact on the Company’s consolidated financial statements when they are first applied. NOTE 4 Accounting changes and reclassifications 96 | FASA 2014 Annual Report NOTE 4 ACCOUNTING CHANGES AND RECLASSIFICATIONS D. OTHER NON-OPERATING GAINS (LOSSES) As of December 31, 2014 there have been no accounting changes 2014 ThCh$ from the previous year. OTHER NON-OPERATING EXPENSES INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 2013 ThCh$ (21,358,442) (4,572,448) (48,822) - (238,809) (18,126) NOTE 5 INCOME AND EXPENSES Loss on the sale of property, plant and equipment Income and expenses were as follows: Compensation paid to third parties A. REVENUE Bank charges (658,958) (344,010) Fines (134,920) (144,889) - (2,269,564) 2014 ThCh$ 2013 ThCh$ Goods sold 830,303,667 759,782,494 Services rendered 110,334,842 84,118,518 Interest income from private investment fund (Retail Chile) TOTAL OPERATING INCOME 1,375,824 1,233,538 942,014,333 845,134,550 Sale of Brazilian company Irrecoverable withholding taxes (1,283,227) - Amortization of share placement costs (1,114,399) - Legal contingencies (2,439,583) - Robberies (323,155) (249,674) Employment liabilities for employer substitution (247,039) - (11,496,926) - (3,372,604) (1,546,185) 422,735 168,946 Impairment of non-operating receivables B. EMPLOYEE BENEFIT EXPENSES Other 2014 ThCh$ 2013 ThCh$ OTHER NON-OPERATING GAINS Wages and salaries (67,862,135) (57,991,731) Profit on the sale of property, plant and equipment - 106,930 Short-term benefits (7,762,435) (6,678,950) Tax refunds 34,772 1,277 (10,937,464) (7,988,453) Insurance claims 67,115 - - 20,426 Other personnel expenses TOTAL (86,562,034) (72,659,134) Property sales Other income TOTAL C. FINANCE COSTS 2014 ThCh$ 2013 ThCh$ Interest expense on bank loans (3,212,901) (3,211,655) Interest expense on other financial instruments (3,374,189) (3,709,432) (6,587,090) (6,921,087) TOTAL 320,848 40,313 (20,935,707) (4,403,502) 97 | FASA 2014 Annual Report E. OTHER EXPENSES, BY NATURE 6.1. INFORMATION ON CASH AND CASH EQUIVALENTS BY CURRENCY 2014 ThCh$ 2013 ThCh$ Materials and consumables (3,212,107) (2,579,977) General repairs and maintenance (7,332,625) (6,188,086) Currency Utilities (10,263,375) (8,785,251) Leases and common costs (51,882,456) (44,805,218) Cash and cash equivalents (ThCh$) (7,784,812) CASH AND CASH EQUIVALENTS Currency INTRODUCTION Company Details Letter from the Chairman Transport (9,185,866) Computing and communications (3,384,993) (2,791,041) Security (3,100,527) (2,525,240) THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Commissions (7,387,416) (5,409,030) Currency (5,079,966) (4,575,890) Cash and cash equivalents (ThCh$) OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Consulting and professional services Marketing expenses (10,253,925) (10,239,167) Travel expenses (1,334,294) (1,196,588) Insurance costs (1,264,089) (1,116,892) (648,534) (676,599) Inventory costs (3,091,905) (2,917,252) Other expenses (5,653,990) (2,411,893) Costs of taxes and municipal business licenses TOTAL Cash and cash equivalents (ThCh$) TOTAL CASH AND CASH EQUIVALENTS NOTE 6 CASH AND CASH EQUIVALENTS This account is detailed as follows: CASH AND CASH EQUIVALENT CATEGORIES CASH AND CASH EQUIVALENTS 12/31/2014 ThCh$ 12/31/2013 ThCh$ 44,199,408 30,653,040 5,592,213 4,801,298 Bank balances 13,849,400 12,144,724 Time deposits and other short-term investments 24,757,795 13,707,018 Cash in hand In the consolidated statement of cash flows, these include cash in hand, time deposits and other short-term investments originally maturing in three months or less. Accounting overdrafts are excluded, as these are external resources and are reclassified as current liabilities. 12/31/2013 ThCh$ Chilean Peso Chilean Peso 12,265,431 US Dollar 115,356 Other Currencies 11,434,634 US Dollar 25,906 Other Currencies 31,818,621 19,192,500 44,199,408 30,653,040 As of December 31, 2014 and 2013, the Company has no restrictions on its cash and cash equivalents. (123,076,068) (104,002,936) 12/31/2014 ThCh$ 98 | FASA 2014 Annual Report NOTE 7 FINANCIAL INSTRUMENTS As of December 31, 2014 and 2013 financial instruments were as follows: 12/31/2014 ThCh$ INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2013 ThCh$ CASH AND CASH EQUIVALENTS 44,199,408 30,653,040 Foreign currency hedges, current 3,118,173 411 OTHER FINANCIAL ASSETS, CURRENT Trade receivables net, current Other receivables net, current 3,118,173 411 28,207,545 23,226,922 6,840,932 7,053,695 35,048,477 30,280,617 Other financial assets, non-current 655,529 1,447,180 OTHER FINANCIAL ASSETS, NON-CURRENT 655,529 1,447,180 Related party receivables, current 156,988 5,216,012 TRADE AND OTHER RECEIVABLES NET, CURRENT Related party receivables, non-current - 49,530,977 156,988 54,746,989 15,674,623 7,591,168 6,450 - Other financial liabilities for bonds, current 12,644,653 12,030,916 OTHER FINANCIAL LIABILITIES, CURRENT 28,325,726 19,622,084 9,936,075 15,408,817 RELATED PARTY RECEIVABLES Bank borrowings and finance leases, current Other financial liabilities, current Bank borrowings and finance leases, non-current Liabilities for foreign currency derivatives, non-current 655,529 258,638 Other financial liabilities for bonds, non-current 47,934,608 56,494,802 OTHER FINANCIAL LIABILITIES, NON-CURRENT 58,526,212 72,162,257 Related party payables, current Related party payables, non-current RELATED PARTY PAYABLES 529,603 8,799,359 - 34,571,771 529,603 43,371,130 Trade and other payables, current 279,236,260 234,928,138 TRADE AND OTHER PAYABLES, CURRENT 279,236,260 234,928,138 99 | FASA 2014 Annual Report 7.1. TRADE AND OTHER RECEIVABLES a.- As of December 31, 2014 and 2013, current trade receivables were as follows: Gross Value ThCh$ CONCEPT INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Trade receivables 12/31/2013 Allowance for Doubtful Accounts ThCh$ Allowance for Doubtful Accounts ThCh$ Net Value ThCh$ 30,540,737 (2,333,192) Notes receivable Gross Value ThCh$ 28,207,545 Net Value ThCh$ 25,128,843 (1,901,921) 23,226,922 292,227 (207,715) 84,512 264,940 (186,517) 78,423 6,756,420 - 6,756,420 6,975,272 - 6,975,272 37,589,384 (2,540,907) 35,048,477 32,369,055 (2,088,438) 30,280,617 Miscellaneous receivables (1) TOTAL 12/31/2014 (1) These are mainly advances to suppliers. b.- Trade receivables net of the allowance for doubtful accounts, containing not yet due and aged past due balances, were as follows: 12/31/2014 CUSTOMER TYPE Agreements Laboratories and distributors Total ThCh$ Not Yet Due ThCh$ 1-30 Days ThCh$ 31-60 Days ThCh$ 22,814,966 16,052,131 3,600,604 61-90 Days ThCh$ 735,680 237,114 91-120 Days ThCh$ 121-150 Days ThCh$ 151-180 Days ThCh$ 133,566 159,442 129,845 181-210 Days ThCh$ 53,544 211-250 Days ThCh$ 70,718 Over 250 Days ThCh$ 1,642,322 5,311,804 4,768,421 336,926 96,518 52,024 5,575 3,691 8,045 2,448 1,382 36,774 397,243 191,994 68,591 35,866 12,067 12,843 1,957 15,580 18,590 11,694 28,061 2,016,724 1,453,814 118,598 35,016 1,163 3,066 2,404 3,483 584 133 398,463 SUB TOTAL 30,540,737 22,466,360 4,124,719 903,080 302,368 155,050 167,494 156,953 75,166 83,927 2,105,620 Allowance for doubtful accounts (2,333,192) - (17,531) (29,265) (21,953) (33,103) (58,931) (38,439) (44,316) (2,089,654) TOTAL 28,207,545 22,466,360 4,124,719 885,549 273,103 133,097 134,391 98,022 36,727 Not Yet Due ThCh$ 31-60 Days ThCh$ 61-90 Days ThCh$ 91-120 Days ThCh$ Leases Other businesses - 39,611 15,966 211-250 Days ThCh$ Over 250 Days ThCh$ 12/31/2013 CUSTOMER TYPE Agreements Laboratories and distributors Leases Other businesses Total ThCh$ 1-30 Days ThCh$ 18,653,993 11,085,065 121-150 Days ThCh$ 151-180 Days ThCh$ 181-210 Days ThCh$ 4,508,017 788,008 242,272 124,218 83,252 105,937 78,454 23,389 1,615,381 5,470,013 4,941,217 428,675 29,146 16,273 2,686 571 93 245 1,858 49,249 288,152 140,095 69,332 24,732 14,143 5,583 2,860 5,047 4,088 9,876 12,396 716,685 464,330 1,007 48,229 183,894 17,347 1,683 - - - 195 SUB TOTAL 25,128,843 16,630,707 5,189,918 859,233 274,371 132,487 86,683 111,077 82,982 36,130 1,725,255 Allowance for doubtful accounts (1,901,921) - (16,905) (26,371) (19,206) (17,811) (44,009) (51,114) (21,928) (1,704,577) TOTAL 23,226,922 16,630,707 5,189,918 842,328 248,000 113,281 68,872 67,068 31,868 14,202 - 20,678 100 | FASA 2014 Annual Report c.- Movements in the allowance for doubtful accounts was as follows: MOVEMENTS 12/31/2014 ThCh$ Initial balance (2,088,438) (1,685,809) Acquisitions through business combinations (246,855) - Increase for impairment, recognized in profit or loss (426,870) (519,166) 241,125 160,274 Impaired financial assets written off INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 12/31/2013 ThCh$ Increase (decrease) due to exchange rate changes TOTAL (19,869) (43,737) (2,540,907) (2,088,438) 7.2. AS OF DECEMBER 31, 2014 AND 2013, HEDGING CONTRACTS WERE AS FOLLOWS. 12/31/2014 ASSET Swaps - cash flow hedges Forward Swap TOTAL Less non-current portion: Swaps - cash flow hedges Swap CURRENT PORTION 12/31/2013 LIABILITY 3,078,339 ASSET - LIABILITY 1,188,542 - 39,834 6,450 411 - 655,529 655,529 258,638 258,638 3,773,702 661,979 1,447,591 258,638 - - - - - - 1,188,542 - 655,529 655,529 258,638 258,638 655,529 655,529 1,447,180 258,638 3,118,173 6,450 411 - Derivative instruments are classified as current assets or liabilities. The fair value of a hedging instrument is classified as a non-current asset or liability if the hedged item matures over 12 months later, and as a current asset or liability if the hedged item matures in less than 12 months. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Hedging instruments are described in detail in Note 9 letter f. 101 | FASA 2014 Annual Report 7.3. INDEBTEDNESS CALCULATION In accordance with the bond contracts and their amendments on indebtedness ratio is defined as the ratio of net financial debt to net March 16, 2010, Farmacias Ahumada S.A. is committed to keeping equity. For 2014 and 2013 these values are 1.49 and 1.41, respectively. its consolidated indebtedness ratio under the values set for each INTRODUCTION Company Details Letter from the Chairman year from 2009 to 2029, which is when the obligation expires, as As of December 31, 2014 and 2013, the calculation and fulfilment of reported in its quarterly interim and annual financial statements. This this covenant was as follows: COVENANT CALCULATION 12/31/2014 ThCh$ 12/31/2013 ThCh$ Interest-bearing loans, current 15,674,623 7,591,168 Other financial liabilities, current 12,644,653 12,030,916 9,936,075 15,408,817 THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Interest-bearing loans, non-current Other financial liabilities, non-current 47,934,608 56,494,802 TOTAL PUBLIC FINANCIAL DEBT 86,189,959 91,525,703 Cash and cash equivalents (44,199,408) (30,653,040) (3,118,173) (411) TOTAL PUBLIC FINANCIAL DEBT, NET 38,872,378 60,872,252 OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People TOTAL NET EQUITY 74,723,153 79,599,335 9,726,821 13,861,798 PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Other financial assets, current ADJUSTMENTS INCLUDED, ACCORDING TO THE COVENANT Effect on equity of foreign subsidiaries Effect of investment fund 358,640 192,498 - 4,745,819 Loan to purchase shares - 3,067,409 Impairment adjustments 1,652,341 1,019,369 Dividends provisioned TOTAL EFFECTS 11,737,802 22,886,893 86,460,955 102,486,228 INDEBTEDNESS RATIO (TOTAL NET DEBT / ADJUSTED EQUITY) 0.45 0.59 INDEBTEDNESS RATIO - MAXIMUM VALUE 1.49 1.41 COMPLIANCE YES YES TOTAL NET EQUITY - ADJUSTED 102 | FASA 2014 Annual Report NOTE 8 OTHER NON-FINANCIAL ASSETS Other non-financial assets were as follows: 8.1. OTHER NON-FINANCIAL ASSETS, CURRENT 12/31/2014 ThCh$ INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Prepaid rent Prepaid insurance premiums 12/31/2013 ThCh$ 1,416,377 1,086,092 453,195 532,561 - 722,612 Share placement expenses Municipal business licenses - 92,723 197,715 145,144 345,838 572,725 9,758 29,094 Miscellaneous consumables 479,310 200,970 Pre-operating expenses 291,056 230,537 90,238 1,128,886 3,283,487 4,741,344 Licenses Consultancy Computer maintenance services Other non-financial assets TOTAL 8.2. OTHER NON-FINANCIAL ASSETS, NON-CURRENT 12/31/2014 ThCh$ Lease guarantees 4,987,865 3,897,225 67,673 64,217 Miscellaneous guarantees Other non-financial assets TOTAL 12/31/2013 ThCh$ 1,118,730 659,032 6,174,268 4,620,474 NOTE 9 RISK MANAGEMENT The Company is exposed to certain risks that are managed using Depending on the Company's expectations and the debt structure systems to identify, measure and monitor them as well as limit their objectives, the Company enters hedge contracts to mitigate these concentration. risks. A. INTEREST RATE RISK Financial debt by interest rate was as follows: Variations in interest rates modify the fair value of those assets and liabilities that accrue interest at a fixed rate, and the future cash flows relating to assets and liabilities with a variable interest rate. Fixed nominal interest Variable interest The objective of managing the interest rate risk is to achieve a balance Fixed real interest in the debt structure that minimizes the cost of debt over the long- TOTAL term. 12/31/2014 12/31/2013 27.20% 22.71% 2.51% 2.63% 70.29% 74.66% 100% 100% 103 | FASA 2014 Annual Report B. EXCHANGE RATE RISK In addition, there is an exchange rate risk in the recognition of investments in foreign subsidiaries, where variations in their equity The Company has an adequate match of currencies in terms of costs following translation to the presentation currency directly affects the and revenues, with about 60% of revenues and costs generated in Company's net equity. foreign currency, mainly Mexican pesos. However, 84% of its financial obligations are denominated in UF and 15% in Chilean pesos, so a The Group's exposure to foreign currency risk was as follows: significant appreciation of the Chilean peso against the Mexican peso can affect its ability to meet its financial obligations. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing DECEMBER 31, 2014 Trade receivables Trade payables FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility THOUSANDS OF BRAZILIAN REALS THOUSANDS OF US DOLLARS THOUSANDS OF MEXICAN PESOS THOUSANDS OF BRAZILIAN REALS THOUSANDS OF US DOLLARS 238,817 1,695 - 220,918 2,195 - (2,857,076) (8,267) - (3,638,634) (3,716) - Receivables Grupo Casa Saba S.A.B de C.V. - - - - - 59,405 Payables Grupo Casa Saba S.A.B de C.V. - - - (152,744) - (26,486) CUMULATIVE EXPOSURE IN THE STATEMENT OF FINANCIAL POSITION (3,399,817) (2,021) - (2,788,902) (6,072) 32,919 Equity and profit (loss) for the subsidiaries in Mexico and Brazil at each reporting date were as follows: DECEMBER 31, 2014 Thousands of Mexican pesos Thousands of Brazilian reals DECEMBER 31, 2013 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates DECEMBER 31, 2013 THOUSANDS OF MEXICAN PESOS Thousands of Mexican pesos Thousands of Brazilian reals EQUITY PROFIT (LOSS) 2,802,760 101,200 29,509 24,631 EQUITY PROFIT (LOSS) 2,856,957 289,890 4,587 (19,090) 104 | FASA 2014 Annual Report C. LIQUIDITY RISK Liquidity risk relates to the Company's ability to respond to operating Farmacias Ahumada S.A. prefers long-term financing, in order to cash requirements under normal and exceptional conditions, and match its financial structure to the liquidity of its assets, and with over various time horizons. maturity dates that are compatible with cash flows. As of December 31, 2014 and 2013, significant debts valued at over 10% of bank loans and which accrue interest were as follows: INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MATURITY Creditor Name Creditor Country Up to 90 Days ThCh$ 90 days to 1 Year ThCh$ Total Current as of 12/31/2014 ThCh$ 1 to 2 Years ThCh$ 2 to 3 Years ThCh$ 3 to 4 Years ThCh$ 4 to 5 Years ThCh$ Over 5 Years ThCh$ Total NonCurrent as of 12/31/2014 ThCh$ Banco CorpBanca Chile - 5,214,038 5,214,038 - - - - - - Banco Santander Chile 1,450,433 1,255,751 2,706,184 2,478,233 2,456,259 - - - 4,934,492 1 to 2 Years ThCh$ 2 to 3 Years ThCh$ 3 to 4 Years ThCh$ 4 to 5 Years ThCh$ Over 5 Years ThCh$ Total NonCurrent as of 12/31/2014 ThCh$ - - - - - - MATURITY Creditor Name Banco de Chile Creditor Country Up to 90 Days ThCh$ 90 days to 1 Year ThCh$ Total Current as of 12/31/2014 ThCh$ Chile - 1,018,560 1,018,560 Banco de Chile Chile - 1,216,500 1,216,500 - - - - - - Banco Santander Chile - 1,423,946 1,423,946 - - - - - - Banco Santander Chile - 223,995 223,995 - 2,482,000 2,482,000 2,443,280 - 7,407,280 Banco Estado Chile - 464,736 464,736 400,000 400,000 400,000 391,997 - 1,591,997 Issuing Company Country Guaranteed (Yes/No) Other current and non-current bond liabilities Book Value, Current Series Nominal Amount Placed UF 12/31/2014 ThCh$ 12/31/2014 ThCh$ Book Value, Non-Current 12/31/2014 ThCh$ 12/31/2014 ThCh$ Maturity Date E 1,800,000 8,951,097 8,522,337 4,264,225 12,194,591 5/15/2016 Chile NO F 2,200,000 3,693,556 3,508,579 43,670,383 44,300,211 5/15/2029 Chile NO Total 4,000,000 12,644,653 12,030,916 47,934,608 56,494,802 105 | FASA 2014 Annual Report As part of its comprehensive risk management framework, the iii. Risks associated with international expansion and growth Company has developed liquidity management policies aimed at ensuring the timely fulfilment of its obligations, in accordance with The Company has developed an international expansion pro- the scale and risk of its operations, both in normal and exceptional gram targeting Mexico and Brazil, which is now in a consolida- conditions. In exceptional circumstances cash flows can substantially tion phase. This has enabled us to gain the experience necessary differ from expectations, due to unexpected changes in general to decrease the risks of international expansion, while laying the market conditions or other particular situations. foundations for growth in these countries. Additionally, it will enable us to enter other countries in Latin America in the future. The INTRODUCTION Company Details Letter from the Chairman Therefore, the liquidity management policies define how the risk result of this process predominantly depends on the ability of our is managed, the roles and responsibilities of management, the management to adapt our business model to the particular con- internal limits to mismatches with cash flow, the sources of risk, the ditions of our target markets. contingency plans and internal control mechanisms. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates iv. Country-specific political, regulatory and financial risks In the event that there is a consolidated shortage of cash, the Company has various short- and long-term financing alternatives, The Company is exposed to regulatory changes that we cannot among which are available lines of credit with banks and access to control. Any policy changes in pharmacy regulations that allow debt capital markets. medicine sales through other stores, such as supermarkets, could affect the Company's revenues. Another regulatory change which D. OPERATIONAL RISK (UNAUDITED) could affect FASA is the preference given to generic drugs, as these have lower margins. Therefore, FASA partly mitigates this The main risks to the Company are: risk by incorporating new sales formats that emphasize other products types, not just medications, and introducing our own i. Risk of increasing competition or the emergence of alternative brands and exclusive brands. channels. v. Risk of concentration of suppliers Given the characteristics of FASA's markets, new pharmacy chains may emerge or an existing chain may expand regionally, nationally There is a market risk due to the concentration of distributors and or internationally. Furthermore, alternative channels may emerge wholesalers in Mexico. To mitigate this risk FASA centralizes its to distribute pharmaceutical products. Either of these could re- product purchases directly from suppliers or distributors and then duce market shares or place pressure on margins. However, this manages distribution logistics through distribution centers. risk is partly mitigated by the different store formats currently used by the Company across various countries, as well as our strong E. CREDIT RISK brand positioning in each one. Company sales are 95% cash and 5% on credit. Therefore, this is an FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility ii. Risk associated with the growing importance of institutional customers in the health care industry FASA customers include institutions, such as hospitals and health insurance providers (Isapres). The agreements negotiated by Isapres with certain pharmacy chains produce an important flow of customers. The potential amendment or termination of these agreements could affect FASA. Moreover, hospitals or other institutional customers that change their medicine suppliers or purchase them direct from laboratories could potentially impact the financial performance of the Company. To mitigate this risk and protect FASA's presence in this sector, we have strengthened our subsidiary ABF, Administradora de Beneficios Farmacéuticos S.A. atomized risk and diversified across various countries. 106 | FASA 2014 Annual Report F. ESTIMATE OF FAIR VALUE OF DERIVATIVE INSTRUMENTS Level 3: This method measures fair value using valuation techniques which do not use observable market data for those Financial instruments that have been accounted for at fair value in assets and liabilities. the statement of financial position as of December 31, 2014, have been valued in accordance with IAS 39. The valuation methods The Company classifies its valuation methods within these three applied to financial instruments are classified according to a hier- levels, taking into account the nature and characteristics of the in- archy, as follows: struments held in its portfolio. The current valuation process uses internal techniques and observable market parameters to perform INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Level 1: This method measures fair value using market prices these valuations, mainly the present value method. (unadjusted) on active markets for those assets and liabilities. Level 2: This method measures fair value using observable price The percentage of financial instruments measured at fair value as data not included in Level 1 for those assets and liabilities, either a proportion of the total value were as follows: as direct prices or indirectly derived from prices. BOOK VALUE Classification Fair value through profit and loss Hedges Group 12/31/2014 ThCh$ Note Other financial assets, current 7 Other financial assets, non-current 7 Other financial liabilities, current 7 Other financial liabilities, non-current 7 Other financial assets, current 7 VALUATION METHOD (%) 12/31/2013 ThCh$ Level I Level II Level III Amortized cost 39,834 411 100% - - - 655,529 258,638 100% - - - 6,450 - 100% - - - 655,529 258,638 100% - - - 3,078,339 1,188,542 - 100% - - 107 | FASA 2014 Annual Report Instruments that have been classified as level II are mainly hedge fair value of instruments maturing in less than a year does not contracts, either forwards or cross currency swaps, which have differ significantly from the book value. This approach has been been valued by discounting future contractual cash flows for both applied to balances held in trade and other receivables, cash and the asset and liability component of each instrument. This meth- cash equivalents, trade and other payables, and the current por- od is known as "Mark to Market". The structure of interest rates tion of bank loans and bonds payable. used to calculate the present value of future cash flows uses the INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Company's functional currency and is inferred from instrument The fair value of the non-current portion of debt instruments rec- transactions in relevant markets. ognized at amortized cost, including bonds and bank loans, has been calculated as the amount required to pre-pay this debt less In addition, the fair value has been estimated for information pur- the current portion. poses for those instruments recognized at amortized cost. The As of December 31, 2014 and 2013, hedging instruments were as follows: HEDGE CONTRACTS AS OF DECEMBER 31, 2014 ASSETS / LIABILITIES Position purchase / sale ThCh$ EFFECT ON PROFIT OR LOSS Contract type Contract value ThCh$ Banco de Chile Swap 41,012,090 2015 Purchase Other financial assets, current 3,078,339 695,267 2,383.072 Banco de Chile Forward 823,650 2015 Purchase Other financial assets, current 11,856 11,856 - Banco Santander Forward 13,261,320 2015 Purchase Other financial assets, current 27,978 27,978 - Banco Santander Swap 8,690,100 2017 Sale Other financial assets, non-current 655,529 655,529 - Banco Santander Swap 9,486,564 2017 Purchase Other financial liabilities, non-current 655,529 (655,529) - Banco CorpBanca Forward 972,963 2015 Purchase Other financial liabilities, current 6,450 (6,450) - Entity Maturity HEDGE CONTRACTS AS OF DECEMBER 31, 2013 Entity Banco Santander Contract type Forward Contract value ThCh$ 101,271 Maturity Name Value ThCh$ ASSETS / LIABILITIES Position purchase / sale ThCh$ Name Realized ThCh$ Unrealized ThCh$ EFFECT ON PROFIT OR LOSS Value ThCh$ Realized ThCh$ Unrealized ThCh$ 2014 Purchase Other financial assets, current 411 411 - 2015 Purchase Other financial assets, non-current 1,188,542 (1,404,795) 1,644,957 Banco de Chile Swap 45,162,273 Banco Santander Swap 8,690,100 2014 Sale Other financial assets, non-current 258,638 258,638 - Banco Santander Swap 8,979,037 2017 Purchase Other financial liabilities, non-current 258,638 (258,638) - 108 | FASA 2014 Annual Report NOTE 10 RELATED PARTIES All transactions with related parties over ThCh$20,000 are disclosed. Furthermore, all transactions directly or indirectly involving a Company director are disclosed. 10.1. KEY PERSONNEL COMPENSATION Key personnel are those people who are responsible for directly or indirectly planning, directing and controlling the Company, including any INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing member of the board or the equivalent governing body at the Company, regardless of whether they are also an executive officer. 12/31/2014 ThCh$ 12/31/2013 ThCh$ Management compensation 728,167 649,601 Key personnel compensation 30,315 27,076 282,770 244,381 1,041,252 921,058 Key personnel compensation, short-term benefits Total key personnel compensation 10.2. BALANCES WITH RELATED PARTIES The Company believes that the nature of related party relationships were only as follows: • Associates • Common shareholders • Other related parties • Key personnel The timing and conditions of balances and transactions with related parties were as follows: • Related party receivables and payables are mainly for buying and selling inventory, and current account movements. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates • The classification of related party receivables and payables into short and long-term is based on the budgeted cash flow for these parties. • Transactions with related entities carry the same terms and conditions as those offered to third parties and are recognized in their current FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility account. As of December 31, 2014 and 2013, related party receivables and payables are unsecured, and there are no allowances for doubtful accounts for them. 109 | FASA 2014 Annual Report a. Related party receivables, current Chilean Tax ID INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Company name Country Relationship Description Term Currency Foreign Casa Saba S.A. de C.V. Mexico Common parent Inventory sale 60 days MX$ - 436,834 Foreign Farmacias ABC de México, S.A. de C.V. Mexico Common parent Inventory sale 60 days MX$ - 4,154,201 Foreign Casa Saba S.A. de C.V. Mexico Common parent Employer substitution 30 days MX$ - 624,977 76.009.174-K Inmobiliaria Faster S.A. Chile Associate Current account Ch$ 156,988 - 156,988 5,216,012 TOTAL 12/31/2014 ThCh$ 12/31/2013 ThCh$ b. Related party receivables, non-current Chilean Tax ID Company name Country Relationship Description Term Currency Foreign Grupo Casa Saba S.A.B de C.V. Mexico Owner Current account Ch$ - 18,366,456 Foreign Grupo Casa Saba S.A.B de C.V. Mexico Owner Current account US$ - 31,164,521 - 49,530,977 TOTAL 12/31/2014 ThCh$ 12/31/2013 ThCh$ c. Related party payables, current Chilean Tax ID Company name Country Relationship Description Term Currency 12/31/2014 ThCh$ 12/31/2013 ThCh$ Foreign Casa Saba S.A.de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 6,589,577 Foreign Farmacias ABC de México, S.A. de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 471,854 Foreign Centennial, S.A. de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 623,506 Foreign Publicaciones Citem, S.A. de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 30,542 Foreign Daltem Provee Norte, S.A. de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 202,681 Foreign Transportes Marproa, S.A. de C.V. Mexico Common parent Inventory purchase 60 days MX$ - 270,229 Other Chile Minority shareholders Dividends Ch$ 98,981 134,809 Inmobiliaria Avantuen S.A. Chile Associate Current account Ch$ 430,622 476,161 529,603 8,799,359 76.912.090-4 TOTAL 110 | FASA 2014 Annual Report d. Related party payables, non-current Chilean Tax ID INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Company name Country Relationship Description Term Currency 12/31/2014 ThCh$ Foreign Grupo Casa Saba S.A.B de C.V. Mexico Owner Company purchase 42 months US$ - 13,895,014 Foreign Casa Saba S.A.B de C.V. Mexico Common parent Property purchase 42 months MX$ - 6,128,092 Foreign Controladora Casa Saba S.A.B de C.V. Mexico Owner Dividends Ch$ - 14,102,959 Foreign Grupo Casa Saba S.A.B de C.V. Mexico Owner Current account Ch$ TOTAL 12/31/2013 ThCh$ - 445,706 - 34,571,771 The transactions and outstanding balances with other related group parties are disclosed within the consolidated financial statements. Transactions and outstanding balances between the Company and its subsidiaries are eliminated on consolidation and have no effect on the consolidated financial statements and thus are excluded from this note. Only the balances for Farmacias ABC de México S.A. de C.V. as of December 31, 2013, have been included, since as of December 31, 2014 it had become a subsidiary and had been consolidated. 111 | FASA 2014 Annual Report Transactions with related parties. 2014 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Company Name Grupo Casa Saba S.A.B de C.V. Casa Saba S.A.B de C.V. Centennial S.A. De C.V. Publicaciones Citem S.A. de C.V. Daltem Provee Norte S.A. Transportes Marproa S.A. de C.V. Transportes Marproa S.A. de C.V. Casa Saba S.A.B de C.V. Farmacias ABC de México, S.A. de C.V. Grupo Casa Saba S.A.B de C.V. Inmobiliaria Avantuén S.A. Euroamérica Seguros de Vida S.A. Inmobiliaria Faster S.A. Distribuidora y Comercial Imexporta Ltda. Grupo Casa Saba S.A.B de C.V. Casa Saba S.A.B de C.V. Distribuidora y Comercial Imexporta Ltda. Inmobiliaria Faster S.A. Inmobiliaria Avantuén S.A. 2013 Effect on Profit or Loss ThCh$ Amount ThCh$ Effect on Profit or Loss ThCh$ Amount ThCh$ Country Relationship Description Mexico Mexico Mexico Owner Common parent Common parent Interest Inventory purchase Inventory purchase 1,738,733 27,205,980 528,078 1,738,733 (26,136,389) (441,521) 2,874,934 70,520,949 537,046 2,874,934 (69,780,643) (498,732) Mexico Common parent Inventory purchase 412 (388) 132,944 - Mexico Common parent Inventory purchase 307,680 (297,389) 836,248 (831,516) Mexico Common parent 19,670 - 840,802 (766,978) Mexico Mexico Common parent Common parent Inventory purchase Transport service purchase Inventory sale 888,604 616,451 (794,100) 448,721 2,690,849 2,690,849 Mexico Common parent Inventory sale - - 8,285,534 8,285,534 Mexico Owner Current account - - 325,557 - Chile Associate Current account 45,538 45,538 285,136 - Chile Chile Other related parties Associate Rental paid Current account 48,765 156,973 (48,765) - 31,186 244,261 (31,186) - Chile Other related parties Mexico Mexico 6,172 5,186 83,065 (47,360) Owner Common parent Logistical service collections Company purchase ABC Warehouse sale 7,571,477 6,803,180 - - - Chile Chile Other related parties Associate Inventory purchase Current account 100,986 156,973 (84,862) - - - Chile Associate Current account 45,538 45,538 - - 112 | FASA 2014 Annual Report 10.3. PRICING FOR TRANSACTIONS WITH RELATED PARTIES As of December 31, 2014 and 2013, the main categories of inventory were as follows: Sales and purchases between related entities were performed using FINISHED GOODS 12/31/2014 ThCh$ 12/31/2013 ThCh$ by the board. Transactions between related entities do not accrue TOTAL 169,436,172 150,118,304 interest or inflation indexing, with the exception of current accounts Food, beverages and tobacco 6,347,358 5,464,783 which carry market interest rates. Drugs and pharmaceuticals 116,780,115 106,600,633 Cosmetic and personal hygiene products 42,498,441 32,817,823 3,810,258 5,235,065 2014 ThCh$ 2013 ThCh$ 701,619,358 629,924,047 701,619,358 629,924,047 normal market prices, terms and conditions, and were duly approved INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility NOTE 11 INVENTORIES Diverse consumer goods As of December 31, 2014 and 2013, inventories were as follows: INVENTORIES 12/31/2014 ThCh$ 12/31/2013 ThCh$ TOTAL TOTAL 169,906,972 150,101,658 492,938 598,511 Cost of inventories expensed during the period 169,436,172 150,118,304 Goods in transit 767,629 6,588 Other inventories 413,535 286,806 (1,203,302) (908,551) Raw materials Finished goods Obsolete inventory provision 11.1. REVERSALS IN IMPAIRMENT As of December 31, 2014: • There have been no reversals of impairment provisions from The movement in the obsolescence provision was as follows: previous years, that would reduce the cost of inventories expensed during the period. 12/31/2014 ThCh$ 12/31/2013 ThCh$ Initial balance (908,551) (806,133) Inventory impairment (298,114) (112,001) 3,363 9,583 (1,203,302) (908,551) Translation effect TOTAL In the period covered by these financial statements impairment recognized in previous years has not been reversed. • No circumstances have been detected to trigger the reversal of an impairment provision. • The book value of inventories have not been pledged as security on borrowing. 113 | FASA 2014 Annual Report NOTE 12 INVESTMENTS IN RELATED COMPANIES A. AS OF DECEMBER 31, 2014 AND 2013, THE MOVEMENT IN INVESTMENTS IN SUBSIDIARIES AND ASSOCIATES WAS AS FOLLOWS: There have been no movements in investments in subsidiaries and INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates associates during the years ended December 31, 2014 and 2013. B. ADDITIONAL DISCLOSURES ON INVESTMENTS IN ASSOCIATES Summary financial information on associates as of the reporting dates was as follows: 12/31/2013 Associate name Inmobiliaria Avantuen S.A. Inmobiliaria Avantuen S.A. Cost of investment in associate in thousands of pesos 1,546,390 1,546,390 Associate's country of incorporation Chile Chile Functional currency Chilean peso Chilean peso Associate's main business Management, development and services for real estate projects and property leasing Management, development and services for real estate projects and property leasing 49% 49% Interest in the associate 12/31/2014 ASSETS ThCh$ Current for associates LIABILITIES ThCh$ 3,075,134 2,012,375 Non-current for associates 2,094,050 - TOTAL 5,169,184 2,012,375 12/31/2013 ASSETS ThCh$ Current for associates Non-current for associates TOTAL PROFIT (LOSS) FOR ASSOCIATES Revenue for associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2014 Operating expenses for associates Profit (loss) for associates Investments in associates • Inmobiliaria Avantuen S.A. • Inmobiliaria Faster S.A. 6,680,348 LIABILITIES ThCh$ Associate's country of incorporation 12/31/2013 Inmobiliaria Faster S.A. Inmobiliaria Faster S.A. 490 490 Chile Chile Functional currency Chilean peso Chilean peso Associate's main business Real estate Real estate development development 6,129,075 2,158,034 - 8,838,382 6,129,075 12/31/2014 ThCh$ Cost of investment in associate in thousands of pesos 12/31/2014 12/31/2013 ThCh$ 587,716 1,467,997 (562,114) (400,830) 25,602 1,067,167 Interest in the associate Investments in associates accounted for using the equity method, opening balance Changes in investments in associates 49% 49% 12/31/2014 ThCh$ 12/31/2013 ThCh$ 1,326,006 803,093 12,545 522,913 Share of income (loss) from investments in associates 206,730 - Share in prior period items 219,275 522,913 Changes in investments in associates, total 1,545,281 1,326,006 Investments in associates accounted for using the equity method, closing balance 1,545,281 1,326,006 114 | FASA 2014 Annual Report Reconciliation of revenue from associates C. SIGNIFICANT SUBSIDIARIES The Company has revenue from the following associates: The Company's significant subsidiaries were as follows: • Inmobiliaria Avantuen S.A. • FASA Investment Ltda. • Inmobiliaria Faster S.A. • FASA Chile S.A. 12/31/2014 ThCh$ INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Share of income (loss) from investments in associates 12/31/2013 ThCh$ 12,545 522,913 DECEMBER 31, 2014 Chilean Tax ID Coun- Functional try Currency Subsidiary Participation 100% 100% 96.969.830-7 Chile Chilean peso FASA Investment Ltda. 96.809.530-7 Chile Chilean peso FASA Chile S.A. TOTAL Current Assets ThCh$ NonCurrent Assets ThCh$ Current Liabilities ThCh$ 209,826,859 144,808,947 173,010,169 130,400,995 40,262,826 133,125,137 340,227,854 185,071,773 306,135,306 NonCurrent Liabilities ThCh$ Revenue ThCh$ 32,610,530 547,877,472 13,898,584 Profit (Loss) ThCh$ (40,781) 396,641,740 476,584 46,509,114 944,519,212 435,803 NonCurrent Liabilities ThCh$ Profit (Loss) ThCh$ DECEMBER 31, 2013 Current Assets ThCh$ NonCurrent Assets ThCh$ Current Liabilities ThCh$ 137,170,448 Coun- Functional try Currency Subsidiary Participation 96.969.830-7 Chile Chilean peso FASA Investment Ltda. 100% 198,602,010 132,075,361 96.809.530-7 Chile Chilean peso FASA Chile S.A. 100% 132,337,202 37,648,579 134,381,454 Chilean Tax ID TOTAL Revenue ThCh$ 47,451,311 474,266,004 11,953,551 330,939,212 169,723,940 271,551,902 59,404,862 369,159,793 19,060,747 3,777,692 843,425,797 22,838,439 115 | FASA 2014 Annual Report NOTE 13 INTANGIBLE ASSETS OTHER THAN GOODWILL Intangible assets were as follows: 12/31/2014 ThCh$ INTANGIBLE ASSETS IDENTIFIABLE INTANGIBLE ASSETS, NET Development costs, net INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing (1) Trademarks, patents and registered trademarks, net (2) Lease rights, net Software, net IDENTIFIABLE INTANGIBLE ASSETS, GROSS Development costs, gross (1) Trademarks, patents and registered trademarks, gross (2) Lease rights, gross 58,644,181 1,865,376 917,400 55,745,135 53,985,994 6,842,113 2,180,460 1,267,435 1,560,327 84,095,983 72,511,543 1,865,376 917,400 59,458,652 54,523,248 10,289,247 5,063,965 12,482,708 12,006,930 ACCUMULATED AMORTIZATION AND IMPAIRMENT PROVISIONS, INTANGIBLE ASSETS, TOTAL 18,375,924 13,867,362 Accumulated amortization and impairment provisions, trademarks, patents and registered trademarks (2) 3,713,517 537,254 Accumulated amortization and impairment provisions, lease rights 3,447,134 2,883,505 11,215,273 10,446,603 Accumulated amortization and impairment provisions, software (1) These are capitalized IT projects under development. When complete, they will be transferred to property, plant and equipment. (2) The most significant acquired trademarks are: DETAIL 12/31/2014 ThCh$ 12/31/2013 ThCh$ Trademark Farmacias Ahumada 1,036,944 1,036,944 Trademark Farmacias Benavides 53,887,625 52,436,854 820,566 512,196 55,745,135 53,985,994 TOTAL PATENTS AND REGISTERED TRADEMARKS There is no evidence of impairment for these trademarks as of the reporting date. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 65,720,059 Software, gross Patents and registered trademarks GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 12/31/2013 ThCh$ 116 | FASA 2014 Annual Report The movements in intangible assets during the years ended December 31, 2014 and 2013 were as follows: MOVEMENTS DURING THE YEAR ENDED 12/31/2014 Opening balance as of January 1, 2014 Additions INTRODUCTION Company Details Letter from the Chairman Software, Net Identifiable Intangible Assets, Net 917,400 53,985,994 2,180,460 1,560,327 58,644,181 1,285,501 501,168 - 134,101 1,920,770 114,792 - 5,021,425 220,563 5,356,780 (43,513) - (754,843) (28,077) (826,433) Amortization Increase (decrease) due to exchange rate changes OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People Opening balance as of January 1, 2013 FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Lease Rights, Net Additions under business combinations CLOSING BALANCE AS OF DECEMBER 31, 2014 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Trademarks, Patents and Registered Trademarks, Net Retirements THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility PERFORMANCE Consolidated Indicators Investment and Financing Development Costs, Net Other increases (decreases) Total changes - (190,055) (567,216) (751,957) (1,509,228) 14,359 1,448,028 962,287 15,814 2,440,488 (423,163) - - 116,664 (306,499) 947,976 1,759,141 4,661,653 (292,892) 7,075,878 1,865,376 55,745,135 6,842,113 1,267,435 65,720,059 Development Costs, Net Trademarks, Patents and Registered Trademarks, Net Lease Rights, Net 740,727 49,646,093 1,067,269 Additions 271,732 829,258 Retirements (18,215) - MOVEMENTS DURING THE YEAR ENDED 12/31/2013 Amortization Increase (decrease) due to exchange rate changes Other increases (decreases) Total changes CLOSING BALANCE AS OF DECEMBER 31, 2013 Software, Net Identifiable Intangible Assets, Net 1,054,510 52,508,599 635,238 318,475 2,054,703 (9,626) (10,002) (37,843) - (398,864) (112,468) (179,051) (690,383) 12,482 3,909,507 600,047 376,395 4,898,431 (89,326) - - - (89,326) 176,673 4,339,901 1,113,191 505,817 6,135,582 917,400 53,985,994 2,180,460 1,560,327 58,644,181 117 | FASA 2014 Annual Report NOTE 14 PROPERTY, PLANT AND EQUIPMENT As of December 31, 2014 and 2013, the net and gross value of items of property, plant and equipment were as follows: PROPERTY, PLANT AND EQUIPMENT BY CATEGORY 12/31/2014 ThCh$ Property, plant and equipment, net Land, net INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Buildings, net Plant and equipment, net IT equipment, net Motor vehicles, net Leasehold improvements, net Property, plant and equipment, gross Land, gross 79,171,968 89,135,739 5,576,055 10,511,176 8,644,492 9,870,912 19,730,285 22,547,382 4,419,999 5,735,595 47,278 30,256 40,753,859 40,440,418 239,715,661 251,096,317 5,576,055 10,511,176 10,330,544 11,302,182 Plant and equipment, gross 84,027,120 85,136,635 IT equipment, gross 39,090,194 49,725,772 522,632 497,412 100,169,116 93,923,140 160,543,693 161,960,578 1,686,052 1,431,270 Accumulated depreciation and impairment, plant and equipment 64,296,835 62,589,253 Accumulated depreciation and impairment, IT equipment 34,670,195 43,990,177 475,354 467,156 59,415,257 53,482,722 Buildings, gross Motor vehicles, gross Leasehold improvements, gross Total accumulated depreciation and impairment, property, plant and equipment Accumulated depreciation and impairment, buildings Accumulated depreciation and impairment, vehicles Accumulated depreciation and impairment, leasehold improvements Property, plant and equipment is valued at depreciated historical cost. Land is valued at historical cost. Historical cost includes all expenses FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2013 ThCh$ directly attributable to the acquisition of the asset. REAPPRAISED ASSET Book Value Before Reappraisal Thch$ Reappraisal Adjustment Thch$ New Value Thch$ 14.1 REVALUATION OF PROPERTY, PLANT AND EQUIPMENT Land, Chilean Distribution Center 875,016 1,312,626 2,187,642 As of the transition date to IFRS, the Company applied the attributed Buildings, Chilean Distribution Center 6,745,514 1,514,869 8,260,383 Land, Mexico 1,779,897 (1,187,495) 592,402 cost exemption allowed under IFRS 1. The Chilean Distribution Center and certain plots owned by its Mexican subsidiary Farmacias Benavides S.A.B. de C.V. were revalued by independent experts. The reappraisal used the following variables: replacement value of the assets, commercial value, comparative market value and depreciation. The effects of this revaluation was as follows: As of December 31, 2014 and 2013, these assets were not impaired. 118 | FASA 2014 Annual Report 14.2 DISMANTLING OF PROPERTY, PLANT AND EQUIPMENT 14.3 MOVEMENTS IN PROPERTY, PLANT AND EQUIPMENT The Company recognizes the cost of dismantling property, plant and Movements in property, plant and equipment during the years ended equipment, when this can be reliably measured, and which arise from December 31, 2014 and 2013, were as follows: obligations to disburse significant amounts in relation to the book value of the original investment. As of December 31, 2014 and 2013, no provision was required for dismantling costs. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MOVEMENTS DURING THE YEAR ENDED 12/31/2014 Opening balance as of January 1, 2014 Land 10,511,176 Additions Additions under business combinations Retirements MOVEMENTS INTRODUCTION Company Details Letter from the Chairman Depreciation Increase (decrease) due to exchange rate changes Impairment losses recognized in profit or loss Other increases (decreases) Total changes Closing balance as of December 31, 2014 Plant and Equipment, Net Buildings, Net Leasehold Motor Improvements, Vehicles, Net Net IT Equipment, Net Property, Plant and Equipment, Net 9,870,912 22,547,382 5,735,595 30,256 40,440,418 89,135,739 158,044 5,551,654 586,576 28,317 3,359,653 10,429,918 26,191 463,481 155,856 12,615 445,231 1,219,122 (1,299,960) (537,285) (1,463,129) - (3,371,189) (12,605,927) (145,467) (4,222,850) (1,463,554) (30,162) (5,186,160) (11,048,193) 34,772 1,425,784 51,380 880 717,145 2,367,782 - (472,801) - - (160,171) (632,972) - (5,025,080) 817,274 5,373 4,508,932 306,499 (4,935,121) (1,226,420) (2,817,097) (1,315,597) 17,023 313,441 (9,963,771) 5,576,055 8,644,492 19,730,285 4,419,998 47,279 40,753,859 79,171,968 119 | FASA 2014 Annual Report MOVEMENTS DURING THE YEAR ENDED 12/31/2013 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MOVEMENTS Opening balance as of January 1, 2013 Plant and Equipment, Net Buildings, Net Land IT Equipment, Net Motor Vehicles, Net Leasehold Improvements, Net Property, Plant and Equipment, Net 10,511,176 9,870,912 22,547,382 5,735,595 30,256 40,440,418 89,135,739 Additions - - 5,241,692 1,889,653 - 7,101,869 14,233,214 Retirements - (72,939) (69,247) (2,279) (7,982) (814,392) (966,839) Depreciation - (159,249) (3,529,558) (1,982,043) (35,975) (4,086,928) (9,793,753) 413,146 97,844 861,986 128,815 3,310 3,227,147 4,732,248 Impairment losses recognized in profit or loss - - (481,422) - - (72,938) (554,360) Other increases (decreases) - - (1,013,176) 128,507 - 884,669 - 413,146 (134,344) 1,010,275 162,653 (40,647) 6,239,427 7,650,510 10,511,176 9,870,912 22,547,382 5,735,595 30,256 40,440,418 89,135,739 Increase (decrease) due to exchange rate changes Total changes Closing balance as of December 31, 2013 14.4 GOODS TEMPORARILY OUT OF SERVICE NOTE 15 GOODWILL As of December 31, 2014 and 2013, there was no significant item of As of December 31, 2014 and 2013, goodwill was as follows: property, plant or equipment temporarily out of service. CURRENCY 12/31/2014 ThCh$ 12/31/2013 ThCh$ Business combination FASA Investment S.A. with Farmacias Benavides S.A. de C.V. MX$ 12,063,829 11,752,037 Business combination FASA Chile S.A. with GNC S.A. Ch$ 1,182,660 1,182,660 13,246,489 12,934,697 14.5 DEPRECIATED ASSETS IN USE CONCEPT As of December 31, 2014 and 2013, there was no significant item of property, plant or equipment fully depreciated but still in use. 14.6 COMMITMENTS TO PURCHASE OR SELL PROPERTY, PLANT AND EQUIPMENT TOTAL As of December 31, 2014 and 2013, neither the Company nor its subsidiaries had commitments to purchase or sell assets, except in the normal course of business. The variation in goodwill recognized under the business combination with Farmacias Benavides is the foreign currency translation 14.7 FULFILLMENT OF OBLIGATIONS As of December 31, 2014 and 2013, property, plant and equipment is not encumbered to guarantee the fulfilment of obligations. movement during the period. 120 | FASA 2014 Annual Report Impairment tests for goodwill and trademarks • Includes changes in working capital and maintenance investments; Impairment tests are applied to Cash Generating Units (CGUs). The • Discount rates in nominal pesos before tax (WACC) of 7.27% Company has selected its CGUs as the premises that comprise its chain of pharmacies, since these are the lowest level at which the As of December 31, 2014 and 2013, goodwill has not been impaired. trademark and goodwill can be reliably compared, either by value in use, or by market value less disposal costs. INTRODUCTION Company Details Letter from the Chairman Management has analyzed impairment losses based on value in use, as follows: NOTE 16 FINANCE LEASE DISCLOSURES (BY ASSET CLASS AND LEASEHOLDER) AND OPERATING LEASE DISCLOSURES • Cash flows approved by senior management; THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 16.1 FINANCE LEASES • Projected cash flows provided by management over a time horizon of 5 years, in nominal Mexican pesos for Farmacias As of December 31, 2014 and 2013, the Company has finance lease Benavides S. A. de C.V., and in Chilean pesos for GNC S.A. contracts for its commercial premises, computer equipment and store equipment. • Residual value with growth of 3.61% in line with long-term inflation for Farmacias Benavides S.A. de C.V. in Mexico. Institution Interamericana Interamericana Interamericana Interamericana Consorcio Nacional de Seguros S.A. Consorcio Nacional de Seguros S.A. IBM HP HP Asset Type Temuco store La Reina store Ñuñoa store Melipilla store Vitacura store Ñuñoa store Servers Servers Servers As of December 31, 2014, finance lease contracts were as follows: Contract Start Date 11/05/1999 12/24/1999 12/24/1999 12/24/1999 10/06/1999 12/23/1999 11/05/2009 07/27/2011 06/30/2013 Contract Currency UF UF UF UF UF UF US$ US$ US$ Contract Amount 28,457.24 24,088.87 21,144.89 18,557.92 38,800.00 27,160.00 636,893.98 198,000.00 1,491,807.52 Number of Installments 88 88 88 88 240 240 36 60 60 Purchase Option 533.66 447.50 373.70 341.20 246.50 176.90 17,369.83 3,957.74 29,817.08 121 | FASA 2014 Annual Report As of December 31, 2014 and 2013, finance leases for property, plant and equipment were as follows: LEASE CLASSES 12/31/2014 ThCh$ Property, plant and equipment under finance leases, net, total 3,342,437 3,721,395 Land under finance leases, net 1,980,771 1,980,771 643,977 658,658 Buildings under finance leases, net Plant and equipment under finance leases, net INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People IT equipment under finance leases, net 19,418 82,817 698,271 999,149 16.2 RECONCILIATION OF MINIMUM FINANCE LEASE PAYMENT, LESSEE 12/31/2014 MINIMUM LEASE PAYMENTS, FINANCE LEASE OBLIGATIONS Under one year One to five years Over five years Total GROSS ThCh$ INTEREST ThCh$ PRESENT VALUE ThCh$ 657,122 150,600 506,522 1,663,153 295,281 1,367,872 324,469 26,750 297,719 2,644,744 472,631 2,172,113 12/31/2013 MINIMUM LEASE PAYMENTS, FINANCE LEASE OBLIGATIONS PERFORMANCE Consolidated Indicators Investment and Financing Under one year GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Total FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2013 ThCh$ One to five years Over five years GROSS ThCh$ INTEREST ThCh$ PRESENT VALUE ThCh$ 620,679 167,369 453,310 2,145,050 442,629 1,702,421 282,010 20,890 261,120 3,047,739 630,888 2,416,851 122 | FASA 2014 Annual Report 16.3 MINIMUM FUTURE NON-CANCELLABLE LEASE PAYMENTS 12/31/2014 ThCh$ MINIMUM FUTURE NON-CANCELLABLE LEASE PAYMENTS Minimum future non-cancellable lease payments, under one year, lessees 37,727,267 33,839,548 Minimum future non-cancellable lease payments, one to five years, lessees 113,300,971 130,660,710 Minimum future non-cancellable lease payments, over five years, lessees 107,547,749 103,854,293 258,575,987 268,354,551 796,688 347,522 49,094,151 42,589,326 Minimum future non-cancellable lease payments, lessees, total INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Minimum expected future non-cancellable sub-lease payments receivable Lease and sublease installments recognized in profit or loss Minimum operating lease payments Sub-lease operating lease payments Lease and sublease installments recognized in profit or loss, total on a straight line basis throughout their term, except where a more 219,639 42,808,965 NOTE 17 DEFERRED TAXES representative distribution basis applies. Deferred tax is measured using the expected tax rates for the periods At the end of the operating lease contract period, any contract when the temporary differences reverse, using tax rates that apply at penalties or compensations required by the lessor are expensed in the reporting date, as follows. the year when the contract ended. YEAR 16.4 BASIS FOR CALCULATING CONTINGENT INSTALLMENTS As of December 31, 2014 and 2013, the Company has calculated contingent installments on contracts classified as onerous. This The contingency arises when a store is empty, but lease payments must continue to be paid until the contract expires. The liabilities recognized under onerous contracts are detailed in Note 21. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 241,020 49,335,171 Operating lease installments are recognized as operating expenses contingency is based on the total obligation stipulated in the contract. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 12/31/2013 ThCh$ SEMI-INTEGRATED SYSTEM 2014 21% 2015 22.5% 2016 24% 2017 25.5% 2018 27% 123 | FASA 2014 Annual Report As of December 31, 2014 and 2013, deferred taxes were as follows: Tax Assets TEMPORARY DIFFERENCES 12/31/2013 ThCh$ 12/31/2014 ThCh$ 12/31/2013 ThCh$ - - 2,756,334 1,537,883 Deferred taxes relating to provisions 8,757,530 2,866,401 - - Allowances for doubtful accounts 3,831,029 489,773 - - 483,285 369,535 - - Deferred taxes relating to depreciation INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Vacations 3,866,681 1,515,389 - - Obsolete inventories Pension plans 311,846 221,645 - - Other 264,689 270,059 - - Deferred taxes relating to property, plant and equipment 3,051,822 3,324,053 - - Deferred taxes relating to tax losses 4,436,467 4,063,904 - - Deferred taxes relating to other concepts TOTAL DEFERRED TAXES 688,964 164,204 902,599 865,816 16,934,783 10,418,562 3,658,933 2,403,699 The differences in deferred tax assets and liabilities caused by the instructions received from the SVS in their Official Ruling 856 dated increase in corporate income tax rates introduced by Law 20,780 October 17, 2014. Nevertheless, movements in deferred taxes that dated September 30, 2014, have been recognized in equity only once arise after this date are recognized in profit or loss for the year, in within retained earnings (amount of ThCh$334,594). This follows the accordance with the criteria described earlier. 17.1 MOVEMENTS IN CURRENT TAX EXPENSE WERE AS FOLLOWS. CURRENT INCOME TAX EXPENSE Current tax expense (taxable income) GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Tax Liabilities 12/31/2014 ThCh$ Other current tax expenses CURRENT TAX EXPENSE, NET, TOTAL Deferred income tax expense Deferred expense (income) for taxes on the creation and reversal of temporary differences Other tax expenses DEFERRED TAX EXPENSE, NET, TOTAL EXPENSE (INCOME) FOR INCOME TAXES ACCORDING TO THE STATEMENT OF INCOME 2014 ThCh$ 2013 ThCh$ (6,703,598) (5,948,869) - - (6,703,598) (5,948,869) - - 5,260,986 289,594 - - 5,260,986 289,594 (1,442,612) (5,659,275) 124 | FASA 2014 Annual Report 17.2 RECONCILIATION OF THE STATUTORY TAX RATE TO THE EFFECTIVE INCOME TAX RATE. THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 12/31/2013 ThCh$ % Tax expense using the statutory rate (profit (loss) for the year by rate) 2,153,759 21.00% (4,395,099) Tax effect of taxes in other jurisdictions INTRODUCTION Company Details Letter from the Chairman 12/31/2014 RECONCILIATION OF THE INCOME TAX EXPENSE USING THE STATUTORY RATE WITH THE TAX EXPENSE USING THE EFFECTIVE RATE. ThCh$ % (20.00%) (540,011) (5.27%) (1,706,859) (7.77%) Tax effect of non-deductible expenditures (1,016,880) (9.91%) (436,286) (1.98%) Tax effect of taxable income or expenses not accounted for (3,032,966) (29.57%) 999,655 4.55% - - - - Tax effect of changes in tax rates Other increases (reductions) in tax expenses 993,486 9.69% (120,686) (0.55%) (1,442,612) 14.06% (5,659,275) (25.75%) 12/31/2014 ThCh$ 12/31/2013 ThCh$ 15,853,147 13,230,547 4,845,701 3,600,666 20,698,848 16,831,213 12/31/2014 ThCh$ 12/31/2013 ThCh$ Income tax provision 10,786,821 8,646,744 Monthly tax prepayments (6,429,944) (3,632,207) 4,356,877 5,014,537 TAX EXPENSE AT THE EFFECTIVE RATE NOTE 18 CURRENT TAX ASSETS AND LIABILITIES 18.1 CURRENT TAX ASSETS As of December 31, 2014 and 2013, these were as follows: CURRENT TAX ASSETS Tax credits for sales taxes (VAT) Other recoverable taxes paid abroad TOTAL 18.2 CURRENT TAX LIABILITIES As of December 31, 2014 and 2013, these were as follows: GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility CURRENT TAX LIABILITIES TOTAL 125 | FASA 2014 Annual Report NOTE 19 INTEREST-BEARING OBLIGATIONS A. AS OF DECEMBER 31, 2014 AND 2013, THESE WERE AS FOLLOWS: BALANCES AS OF DECEMBER 31, 2014 CATEGORIES OF INTEREST-BEARING LOANS Bank loans INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Finance leases Bonds Hedging instruments (Note 7.2) TOTAL CURRENT ThCh$ 15,168,101 NON-CURRENT ThCh$ 8,270,484 BALANCES AS OF DECEMBER 31, 2013 CURRENT ThCh$ NON-CURRENT ThCh$ 7,137,858 13,445,276 506,522 1,665,591 453,310 1,963,541 12,644,653 47,934,608 12,030,916 56,494,802 6,450 655,529 - 258,638 28,325,726 58,526,212 19,622,084 72,162,257 The movement in bank loans during the year ended December 31, 2014, was as follows: 12/31/2014 CONCEPT OPENING BALANCE AS OF JANUARY 1, 2014 New loans CURRENT ThCh$ NON-CURRENT ThCh$ 7,137,858 13,445,276 26,696,782 - (25,313,948) - Transfer from non-current to current 5,174,792 (5,174,792) Interest 1,472,617 - 15,168,101 8,270,484 Loan repayments CLOSING BALANCE AS OF DECEMBER 31, 2014 As of December 31, 2014 and 2013, the Company's banking obligations were unsecured. 126 | FASA 2014 Annual Report B. AS OF DECEMBER 31, 2014, INTEREST-BEARING OBLIGATIONS BY CURRENCY AND MATURITY WERE AS FOLLOWS: Debtor Tax ID Debtor Name Debtor Country Creditor Tax ID Creditor Name Currency Amortization Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile INTRODUCTION Company Details Letter from the Chairman 93.767.000-1 Farmacias Ahumada S.A. Chile 97.004.000-5 Banco de Chile Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile US$ Annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile Euro Annually THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile Ch$ Annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile Ch$ Annually OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 97.004.000-5 Banco de Chile Creditor Country 93.767.000-1 Farmacias Ahumada S.A. Chile 97.030.000-7 Banco Estado Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 97.030.000-7 Banco Estado Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 97.030.000-7 Banco Estado Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.036.000-K Banco Santander Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.036.000-K Banco Santander Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 99.036.000-K Banco Santander Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Banco Bice Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Banco Bice Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.012.000-5 Consorcio Nacional de Seguros Chile UF Monthly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Interamericana Chile UF Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 92.040.000-0 IBM Chile US$ Monthly 93.767.000-1 Farmacias Ahumada S.A. Chile 96.989.610-9 HP Chile US$ Monthly 127 | FASA 2014 Annual Report Total Current Maturity Nominal Effective Interest Interest Rate Rate INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Up to 90 Days ThCh$ Total NonCurrent Maturity 90 days to 1 Year ThCh$ As of 12/31/2014 ThCh$ 1 to 2 Years ThCh$ 2 to 3 Years ThCh$ 3 to 4 Years ThCh$ 4 to 5 Years ThCh$ Over 5 Years ThCh$ As of 12/31/2014 ThCh$ - 1,010,000 1,010,000 - - - - - - 4.80% 4.80% 4.80% 4.80% - 1,212,000 1,212,000 - - - - - - 2.50% 2.50% 633,227 - 633,227 - - - - - - 2.50% 2.50% 36,707 - 36,707 - - - - - - 5.88% 5.88% - 5,214,038 5,214,038 - - - - - - 7.26% 7.26% 169,877 465,377 635,254 581,992 - - - - 581,992 5.54% 5.54% 169,334 500,000 669,334 - - - - - - 7.18% 7.18% - 444,384 444,384 440,000 220,000 - - - 660,000 6.94% 7.20% 235,665 192,046 427,711 397,926 875,828 - - - 1,273,754 7.98% 7.98% 1,450,433 1,255,751 2,706,184 2,478,233 2,456,259 - - - 4,934,492 7.98% 7.98% 240,458 208,385 448,843 411,818 408,428 - - - 820,246 5.95% 5.95% - 1,460,417 1,460,417 - - - - - - 8.34% 8.34% 98,231 95,833 194,064 - - - - - - 8.34% 8.34% 38,438 37,500 75,938 - - - - - - 8.30% 8.30% 34,991 73,635 108,626 95,207 103,276 112,029 104,904 - 415,416 8.30% 8.30% 22,716 70,896 93,612 101,574 110,587 120,204 130,658 297,719 760,742 3.15% 3.15% 39,937 62,785 102,722 - - - - - - 5.16% 5.16% 49,007 152,555 201,562 214,584 203,584 71,265 - - 489,433 Total 3,219,021 12,455,602 15,674,623 4,721,334 4,377,962 303,498 235,562 297,719 9,936,075 128 | FASA 2014 Annual Report C. AS OF DECEMBER 31, 2013, INTEREST-BEARING OBLIGATIONS BY CURRENCY AND MATURITY WERE AS FOLLOWS: INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Debtor Tax ID Debtor Name Debtor Country Creditor Tax ID Creditor Name Creditor Country Currency Amortization 93.767.000-1 Farmacias Ahumada S.A. Chile 97.004.000-5 Banco de Chile Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.004.000-5 Banco de Chile Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile US$ Annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.023.000-9 Banco CorpBanca Chile Euro Annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.030.000-7 Banco CorpBanca Chile Ch$ Annually 93.767.000-1 Farmacias Ahumada S.A. Chile 97.030.000-7 Banco Estado Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 97.036.000-K Banco Estado Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 97.036.000-K Banco Santander Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.036.000-K Banco Santander Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Banco Santander Chile Ch$ Semi-annually 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Banco Bice Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.012.000-5 Banco Bice Chile Ch$ Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 99.289.000-2 Consorcio Nacional de Seguros Chile UF Monthly 93.767.000-1 Farmacias Ahumada S.A. Chile 92.040.000-0 Interamericana Chile UF Quarterly 93.767.000-1 Farmacias Ahumada S.A. Chile 92.040.000-0 IBM Chile US$ Monthly 93.767.000-1 Farmacias Ahumada S.A. Chile 96.989.610-9 HP Chile US$ Monthly 96.809.530-7 FASA Chile S.A. Chile 97.030.000-7 Banco Estado Chile Ch$ Quarterly 129 | FASA 2014 Annual Report Total Current Maturity Nominal Effective Interest Interest Rate Rate INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Up to 90 Days ThCh$ Total NonCurrent Maturity 90 days to 1 Year ThCh$ As of 12/31/2013 ThCh$ 1 to 2 Years ThCh$ 2 to 3 Years ThCh$ 3 to 4 Years ThCh$ 4 to 5 Years ThCh$ Over 5 Years ThCh$ As of 12/31/2013 ThCh$ - 1,018,560 1,018,560 - - - - - - 6.96% 6.96% 6.60% 6.60% - 1,216,500 1,216,500 - - - - - - 2.50% 2.50% 336,244 - 336,244 - - - - - - 2.50% 2.50% 114,422 - 114,422 - - - - - - 7.26% 7.26% - 641,152 641,152 600,000 581,993 - - - 1,181,993 5.93% 5.93% - 672,377 672,377 666,667 - - - - 666,667 7.17% 7.17% - 446,143 446,143 440,000 440,000 220,000 - - 1,100,000 6.35% 6.35% - 1,423,946 1,423,946 - - - - - - 7.98% 8.29% - 223,995 223,995 - 2,482,000 2,482,000 2,443,280 - 7,407,280 7.98% 8.28% - 36,441 36,441 - 412,700 412,700 405,270 - 1,230,670 8.34% 8.34% - 390,527 390,527 191,669 - - - - 191,669 8.34% 8.34% - 152,815 152,815 75,000 - - - - 75,000 8.30% 8.30% 38,305 58,017 96,322 139,724 139,724 139,724 57,093 - 476,265 8.30% 8.30% 19,788 61,726 81,514 153,461 153,461 120,302 120,302 261,120 808,646 3.15% 3.15% 33,879 79,701 113,580 81,179 - - - - 81,179 5.16% 5.16% 39,361 122,533 161,894 174,277 185,533 176,024 61,617 - 597,451 7.20% 7.20% - 464,736 464,736 400,000 400,000 400,000 391,997 - 1,591,997 Total 581,999 7,009,169 7,591,168 2,921,977 4,795,411 3,950,750 3,479,559 261,120 15,408,817 130 | FASA 2014 Annual Report D. AS OF DECEMBER 31, 2014 AND 2013, BONDS WERE AS FOLLOWS: Series INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing E F TOTAL Nominal Amount Placed UF 1,800,000 2,200,000 4,000,000 Book Value, Current 12/31/2014 12/31/2013 ThCh$ ThCh$ 8,951,097 8,522,337 3,693,556 3,508,579 12,644,653 12,030,916 Book Value, Non-Current 12/31/2014 12/31/2013 ThCh$ ThCh$ 4,264,225 12,194,591 43,670,383 44,300,211 47,934,608 56,494,802 Maturity Date 5/15/2016 5/15/2029 Issuing Company Country Guaranteed (Yes/No) Chile Chile NO NO NOTE 20 TRADE AND OTHER PAYABLES, CURRENT As of December 31, 2014 and 2013, these were as follows: 12/31/2014 ThCh$ 258,977,325 227,091,323 31,886,002 20,258,935 1,644,406 7,293,410 7,780,507 1,481,385 2,059,227 279,236,260 ACCOUNTS PAYABLE, CURRENT Trade and other payables, current Suppliers Other trade payables Other liabilities, current Leases and consumables Withholding Administrative expenses Advertising Professional fees Vacation TOTAL 12/31/2013 ThCh$ 222,415,708 196,631,748 25,783,960 12,512,430 1,786,173 4,702,452 4,153,641 5,347 22,503 1,842,314 234,928,138 Suppliers analyzed by due date were as follows: Suppliers as of December 31, 2014: GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates SUPPLIERS NOT YET DUE FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility SUPPLIER TYPE Goods Services Other Subtotal not yet due Up to 30 Days ThCh$ 62,756,826 16,503,344 9,400,235 88,660,405 31-60 Days ThCh$ 48,862,965 12,042,711 60,905,676 AMOUNTS BY DUE DATE 61-90 Days 91-120 Days 121-365 Days Over 366 days ThCh$ ThCh$ ThCh$ ThCh$ 12,019,922 2,262,434 177,903 285 11,551,827 7,934,365 1,439,125 23,571,749 10,196,799 1,617,028 285 Total ThCh$ 126,080,335 49,471,372 9,400,235 184,951,942 Up to 30 Days ThCh$ 21,001,997 2,779,293 67,193 23,848,483 112,508,888 31-60 Days ThCh$ 4,450,329 213,359 568 4,664,256 65,569,932 AMOUNTS BY DUE DATE 61-90 Days 91-120 Days 121-365 Days Over 366 days ThCh$ ThCh$ ThCh$ ThCh$ 2,187,514 1,049,487 5,156,583 4,108,394 91,330 123,966 347,883 528,037 14,441 19,007 2,278,844 1,173,453 5,518,907 4,655,438 25,850,593 11,370,252 7,135,935 4,655,723 Total ThCh$ 37,954,304 4,083,868 101,209 42,139,381 227,091,323 SUPPLIERS PAST DUE SUPPLIER TYPE Goods Services Other Subtotal past due TOTAL SUPPLIERS 131 | FASA 2014 Annual Report Suppliers as of December 31, 2013: SUPPLIERS NOT YET DUE AMOUNTS BY DUE DATE SUPPLIER TYPE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Up to 30 Days ThCh$ 31-60 Days ThCh$ 121-365 Days ThCh$ Over 366 days ThCh$ Total ThCh$ 43,568,721 42,141,497 11,937,664 3,224,144 506,642 424 101,379,092 Services 14,313,781 19,465,507 6,750,976 5,321,043 5,632,847 - 51,484,154 Other Subtotal not yet due 5,417,130 68,001 1,493 - - - 5,486,624 63,299,632 61,675,005 18,690,133 8,545,187 6,139,489 424 158,349,870 SUPPLIERS PAST DUE AMOUNTS BY DUE DATE SUPPLIER TYPE Goods Up to 30 Days ThCh$ 61-90 Days ThCh$ 91-120 Days ThCh$ 121-365 Days ThCh$ Over 366 days ThCh$ Total ThCh$ 14,237,084 11,457,215 2,011,979 1,399,796 2,017,471 671,862 31,795,407 2,752,172 1,726,481 334,318 152,441 671,902 585,070 6,222,384 Services Other Subtotal past due 31-60 Days ThCh$ 159,761 6,033 - - 42,128 56,165 264,087 17,149,017 13,189,729 2,346,297 1,552,237 2,731,501 1,313,097 38,281,878 TOTAL SUPPLIERS 196,631,748 NOTE 21 PROVISIONS As of December 31, 2014 and 2013, these were as follows: Restructuring provision, current (1) Legal claims provision, current (2) Onerous contracts provision, current (3) Profit sharing and bonus provisions, current (4) FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 91-120 Days ThCh$ Goods PROVISIONS, CURRENT GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 61-90 Days ThCh$ Other provisions (5) TOTAL 12/31/2014 ThCh$ 12/31/2013 ThCh$ 42,376 37,670 33,291 25,755 186,491 228,132 1,642,861 1,616,630 572,717 224,692 2,477,736 2,132,879 (1) The Company records provisions for termination benefits, retention bonuses for executives and other additional benefits as a result of changes to the Company's structure. (2) The Company records provisions against the outcome of current lawsuits where an unfavorable result is probable. (3) The Company records provisions for those lease contracts in which the cost of complying with contractual obligations exceeds the financial returns from that property. (4) The Company records provisions for these commitments to executives. (5) These provisions are mainly for external consultancy fees. 132 | FASA 2014 Annual Report Movements in provisions during the year ended December 31, 2014, were as follows: Movements in Provisions, Current THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Legal Claims Onerous Contracts Profit Sharing and Bonuses Other Total Opening balance as of January 1, 2014 37,670 25,755 228,132 1,616,630 224,692 2,132,879 Increase (decrease) in existing provisions 4,706 7,536 (41,641) 26,231 348,025 344,857 4,706 7,536 (41,641) 26,231 348,025 344,857 42,376 33,291 186,491 1,642,861 572,717 2,477,736 Changes in provisions, total INTRODUCTION Company Details Letter from the Chairman Restructuring Closing balance as of December 31, 2014 NOTE 22 NON-CURRENT EMPLOYEE BENEFITS PROVISIONS 12/31/2014 ThCh$ 12/31/2013 ThCh$ Mexican pension plan liabilities (*) 6,034,487 4,381,768 Seniority bonus liabilities 1,140,961 895,636 7,175,448 5,277,404 TOTAL Mexican pension plan liabilities (*) OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility The interest rates and actuarial assumptions used to calculate the present values of the obligations and expected returns on the assets mentioned below use nominal rates, due to the Group's non-inflationary economic environment. EMPLOYMENT LIABILITIES 12/31/2014 ThCh$ 12/31/2013 ThCh$ Total present value of the obligations 7,175,448 5,277,404 Value of plan assets (636,772) (756,342) Net liability for employment obligations EXPENSE RECOGNIZED IN PROFIT OR LOSS 6,538,676 12/31/2014 ThCh$ 4,521,062 12/31/2013 ThCh$ Current service cost 326,301 320,278 Net interest cost 383,858 313,217 Staff transfer cost 240,149 66,399 Net cost for the year 950,308 699,894 CHANGES IN DEFINED BENEFIT OBLIGATIONS Opening balance of defined benefit obligations 12/31/2014 ThCh$ 12/31/2013 ThCh$ 5,277,404 4,799,869 147,205 420,265 Defined benefit obligations as of January 1 5,424,609 5,220,134 Benefits paid Exchange differences (201,559) (168,063) Current service cost 326,301 320,278 Interest cost 383,858 313,177 Staff transfer cost 240,149 691,147 Revaluation of the obligation 1,002,090 (1,099,269) DEFINED BENEFIT OBLIGATIONS AS OF DECEMBER 31 7,175,448 5,277,404 133 | FASA 2014 Annual Report CHANGES TO THE PLAN ASSETS 12/31/2014 ThCh$ - unlikely to occur, as changes in some of the other assumptions may Exchange differences 20,835 - be correlated. Estimated interest 47,724 - - 131,674 (157,867) - Assets transferred OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility rate while keeping all the other assumptions fixed. In practice, this is 756,342 Benefits paid THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility The previous sensitivity analysis was based on a change in the discount Assets as of January 1 Contributions INTRODUCTION Company Details Letter from the Chairman 12/31/2013 ThCh$ - 624,668 Revaluation of assets (30,262) - ASSETS AS OF DECEMBER 31 636,772 756,342 The methods and assumptions used for the sensitivity analysis are the same as last year. The average expiration of the defined benefit obligation is 10.8 years. The percentage integration of the plan assets is as follows: CONCEPT The total recognized in other items of comprehensive income are described below: Variable income (equities) 12/31/2014 ThCh$ Accumulated balance at the beginning of the year Exchange differences Revaluation of the obligation Revaluation of plan assets ACCUMULATED BALANCE AT THE END OF THE YEAR Total plan assets 12/31/2013 ThCh$ (1,069,439) 867 - (1,012,920) 1,099,269 17,463 - 964,760 29,830 100% 100% 0% 0% 100% 100% be invested in Federal Government securities or debt instruments and no more than 10% can be invested in Group shares. The Company has a retention plan for its senior executives, which has not affected profit as of the date these consolidated financial 12/31/2014 12/31/2013 Discount rate 7.00% 7.00% Rate of salary increase 4.20% 4.20% Rate of minimum wage increase 3.50% 3.50% The impact on the defined benefit obligation, due to a change in the discount rate, is shown below: Baseline scenario 12/31/2013 In accordance with the provisions of the plan assets, at least 30% must 29,830 The main actuarial assumptions were as follows: SENSITIVITY Fixed income (debt) 12/31/2014 12/31/2014 ThCh$ 12/31/2013 ThCh$ 7,175,448 5,277,385 Plus one percentage point 6,580,110 4,720,198 Less one percentage point 7,856,842 5,816,196 Plus one percentage point 9.5% (11%) Less one percentage point (8.39%) 10% statements were issued. 134 | FASA 2014 Annual Report NOTE 23 EQUITY 23.1 NET EQUITY Issued Capital The detail of and movements in equity accounts are disclosed in the As of December 31, 2014, the Company's issued capital is Statement of Changes in Net Equity. 1,500,000,000 common shares with no par value. All shares are fully subscribed and paid and have the same rights and obligations. Classes of common shares were as follows. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2014 12/31/2013 SINGLE SERIES SINGLE SERIES 1,500,000,000 1,500,000,000 59,274,176 59,274,176 Number of shares issued and fully paid by capital class in common shares 1,500,000,000 150,000,000 Number of shares issued by capital class in common shares, total 1,500,000,000 150,000,000 DESCRIPTION OF CAPITAL CLASSES IN COMMON SHARES Number of authorized shares by capital class in common shares Share capital by capital class in common shares ThCh$ (a) Translation Reserves Between 01.01.2013 and 12.31.2014 there were no movements. The Company does not have any treasury shares. This reserve reflects the cumulative exchange rate fluctuations that arise when the financial statements of foreign subsidiaries are There are no reserves, nor commitments to issue shares to cover converted from their functional currency into the Company's pre- option and sale contracts. sentation currency. 23.2 DIVIDENDS (b) Hedge Reserves According to the dividend policy referred to in Note 2.17, the minimum This reserve arises from applying hedge accounting to hedge in- dividend is 30% of profit for the year and an interim dividend is struments. It is the proportion of the hedge's fair value that has declared on December 31 of each year. not been taken to profit or loss to cover risks on the item hedged. 23.3 OTHER RESERVES (c) Pension Plan Reserves The movement in other reserves during the years ended December This reserve is the cumulative variation in pension plan liabilities 31, 2014 and 2013, was as follows: for employees at the subsidiary Farmacias Benavides S.A.B. de C.V. using the actuarial calculations required by the Amendment to OTHER RESERVES 12/31/2014 ThCh$ 12/31/2013 ThCh$ Translation reserves (a) 4,134,977 7,350,985 Hedge reserves (b) 1,051,274 539,326 Pension plan reserves (c) (697,939) 669,437 Other reserves (d) (315,213) - 4,173,099 8,559,748 TOTAL (*) (*) Movements during the year. IAS 19. (d) Other Reserves This reserve is the difference between the acquisition cost and the book value of net assets acquired in the business combination of entities under common control (Note 27). 135 | FASA 2014 Annual Report INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing 23.4 CAPITAL MANAGEMENT a. Investment Policy Company policy is to use equity capital and third party financing to The Company invests according to its growth plans and to optimize finance its business. its business. Therefore, the Company aims to maintain an adequate level of Management has sufficient authority to undertake business-related capitalization that permits access to financial markets for the investments based on the plans and projects approved by the board development of its medium and long term objectives, while optimizing and the returns sought by our shareholders. shareholder returns and safeguarding a solid financial position. b. Working Capital Management FASA's financing policy consists of paying for its short and longterm operating investments by efficiently managing working capital The Company aims to efficiently manage working capital through and generating cash from its normal business. In order to finance the careful and efficient collection of its accounts receivable. long-term investments, whose objective is to increase a stake in Furthermore, the Company has placed special emphasis on efficient any subsidiary or to create a new company, FASA evaluates the inventory management, and has invested in cutting-edge information various instruments available on the financial market including bank systems that enable it to significantly reduce stock levels at its borrowing, public bonds, etc., selecting the one that best suits the distribution centers and at stores, while ensuring product availability nature of the investment and its cash flow requirements. for customers. Moreover, the Company has established long-term relationships with its suppliers, and effectively manages payments within the agreed deadlines. 23.5 STATEMENT OF OTHER COMPREHENSIVE INCOME As of December 31, 2014 and 2013, other comprehensive income and expenses were as follows: OTHER INCOME AND EXPENSES CHARGED OR CREDITED TO NET EQUITY Cash flow hedges (1) Pension plan reserves GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates TAX ThCh$ NET BALANCE ThCh$ 1,330,727 (279,453) 1,051,274 (1,145,078) 400,777 (744,301) Translation adjustments (1) 4,288,293 - 4,288,293 Other comprehensive income and expenses as of December 31, 2014 4,473,942 121,324 4,595,266 (1) OTHER INCOME AND EXPENSES CHARGED OR CREDITED TO NET EQUITY FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility GROSS BALANCE ThCh$ Cash flow hedges (1) Pension plan reserves (1) Translation adjustments (1) Other comprehensive income and expenses as of December 31, 2014 (1) These concepts will be reclassified to the Statement of Income once they are settled GROSS BALANCE ThCh$ TAX ThCh$ NET BALANCE ThCh$ 674,158 (134,832) 539,326 1,077,082 (376,979) 700,103 7,762,168 - 7,762,168 9,513,408 (511,811) 9,001,597 136 | FASA 2014 Annual Report NOTE 24 CONTINGENCIES AND COMMITMENTS January 15, 2013, the first instance court ordered the judgment to be enforced. On March 4, 2013, FASA requested incidental compliance with the 24.1 CONTINGENT LIABILITIES judgment. On March 8, Cruz Verde filed opposition to incidental compliance. On March 15, FASA is notified of this opposition. On June 14, the Lawsuits or other relevant legal cases were as follows. court rejected the opposition from Cruz Verde and ordered enforcement of the judgment. On a) Lawsuits or other relevant legal cases in which Farmacias AhuINTRODUCTION Company Details Letter from the Chairman mada S. A. and its subsidiaries are involved. June 21, 2013, Cruz Verde filed an appeal against a.1) the ruling enforcing the judgment. On September Title : Farmacias Ahumada S.A. versus Sociedad Far- 30, the Court of Appeal accepted the appeal filed macéutica Cruz Verde Ltda. (Cruz Verde) by Cruz Verde, revoking the ruling ordering it to Court : 17th Civil Court of Santiago THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility comply with the judgment, stating that voluntary Case Number : 23.423-2007 Description : Lawsuit filed by Farmacias Ahumada S.A. against compliance by Cruz Verde had been sufficient. Sociedad Farmacéutica Cruz Verde Ltda. for the On October 17, 2014, FASA filed an appeal, which comparative advertising campaign called "Cruz is pending before the Supreme Court. Verde low prices without competition". The suit was founded on unfair competition by the defendant, as this campaign would be contrary to the principles of free competition, it would damage the image of Farmacias Ahumada S. A. and directly affect its financial statements by reducing their volume of customers. Amount : UF 494,000, equivalent to Ch$9,562,743,320 on the day the suit was filed (10-26-2007). a.2) Title : Sociedad de Transportes Damar Limitada versus Farmacias Ahumada S.A. Court : 3rd. Civil Court of Santiago Case Number : 25.635-2008 Description : Lawsuit filed by Transportes Damar Limitada seeking compensation for damages for terminating transport services between the two parties. Amount : Ch$152,200,000 Status : On June 30, 2010, the first instance court issued a Status : On May 14, 2012, the first-instance court passed final judgment accepting the suit for unfair com- judgement, which partially accepts the lawsuit, petition, but denying the compensation request- ordering FASA to pay Ch$27,000,000. On July ed. On July 13, 2010, Cruz Verde filed motions 25, 2012, FASA filed an appeal. On November 28, of appeal and cassation against this judgment, in 2013, the Appeal Court of Santiago confirmed the response to which FASA filed an appeal. On July judgment of the first-instance court. On Decem- 23, 2012, the Court of Appeals of Santiago ruled ber 13, 2013, FASA filed a motion for cassation on in favor of Farmacias Ahumada confirming the the merits of the case. On March 17, 2014, the first-instance judgment, with the proviso that the Supreme Court declared the appeal inadmissible defendant is exempted from payment of costs and thus confirmed the judgment. On June 17, for not having been completely defeated in the FASA was notified of the request for compliance trial. On August 9, 2012, Cruz Verde filed a mo- by summons. On June 25, 2014, FASA agreed to tion for cassation against this ruling on the merits incidental compliance. On July 22, FASA assigns of this case before the Supreme Court. On No- sufficient funds to pay the capital. A remaining vember 29, 2012, the Supreme Court rejected the balance is still pending following settlement of motion for cassation on the merits of this case Ch$262,395. filed by Cruz Verde. On December 3, 2012, Cruz Verde filed an administrative appeal against the judgment rejecting the appeal on the merits of this case. On December 13, 2012, the Supreme Court rejected the administrative appeal filed by Cruz Verde, and upheld the judgment that condemned Cruz Verde for unfair competition. On 137 | FASA 2014 Annual Report a.3) Title : Asociación de Consumidores de Santiago Court : 28th Civil Court of Santiago onciliation hearing took place. On September 14, 2011, the court issued a ruling to begin accept- Case Number : 6.452-2009 Description : Class action lawsuit filed by the Consumers' Asso- ing evidence, against which FASA filed an appeal. ciation of Santiago (ACOSAN) against Farmacias On January 17, 2012, the appeal filed by FASA was Ahumada S.A., for alleged infringement of the Law rejected, and the subsidiary appeal was granted 19,496 on Consumers Rights Protection, which to return the trial to the first-instance court. On arose from the known facts in the conciliation May 9, 2013, SERNAC asks the court to summon agreement concluded between Farmacias Ahu- the parties to hear judgment. On June 20, 2013, mada S. A. and the National Economic Prosecu- the court resolves to summon the parties to hear tor's Office (FNE) in the trial before the TDLC and, judgment. On October 10, 2013, the court pass- also, for not displaying price lists of medicines at es judgment by rejecting the lawsuit. On October Farmacias Ahumada S.A.'s premises. 25, 2013, SERNAC filed a motion for cassation in INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Amount : Indeterminate. form and a motion for appeal. On November 17, Status : On June 17, 2009, the Company was notified of 2014, the Appeal Court of Santiago accepted the the lawsuit. On July 17, 2009, the court ruled the appeal filed by SERNAC, overturning the first-in- lawsuit admissible. On July 21, 2009, the court stance court judgment, requiring FASA to pay received evidence in relation to the admissibility, Ch$610,000,000 plus costs and indexation from and FASA filed an appeal, which is still pending. the date the judgment became enforceable, and The case is currently closed due to inactivity by a fiscal fine of UTM 50. On December 4, 2014, the plaintiff. FASA and SERNAC filed motions for cassation on In the opinion of our legal advisors, the lawsuit the merits. The declaration of admissibility by the is likely to be rejected. Supreme Court is pending. In the opinion of our legal advisors, the sec- a.4) Title : National Consumer Protection Service (Servicio Nacional del Consumidor, SERNAC) versus Farmacias Ahumada S.A. Court : 1st. Civil Court of Santiago Case Number : 37.607-2009 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Description : Lawsuit filed by SERNAC against Farmacias Ahumada S.A. for the alleged infringement of Law 19,496 on Consumer Rights Protection, arising from the alleged breach of the Compensation FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility published a notice allowing consumers to join the lawsuit. On August 11, the response and rec- (ACOSAN) versus Farmacias Ahumada S.A. and Reimbursement Plan prepared by Farmacias Ahumada S.A. Amount : Ch$1,010,000,000 plus fines, interest and indexation. Status : On December 22, 2009, FASA was notified of this collective lawsuit and its admissibility, and responded on January 5, 2010. On January 21, 2010, the court declared the case admissible and accepted the request for 77 consumers to be part of the lawsuit. On January 26, 2010, Cruz Verde filed an appeal against the ruling that declared the case admissible. On August 26, 2010, the Appeal Court of Santiago confirmed the ruling of the first-instance court. On April 14, 2011, SERNAC ond-instance judgment will be upheld. 138 | FASA 2014 Annual Report a.5) Title : Farmacias Cruz Verde S.A. versus Farmacias Ahumada S.A. Court : 30th Civil Court of Santiago Case Number : 20.716-2011 Description : Lawsuit filed by Farmacias Cruz Verde S.A. against INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility a.6) Title : Servicio Nacional del Consumidor (SERNAC) versus Farmacias Cruz Verde S.A., Salcobrand S.A. and Farmacias Ahumada S.A. Court : 10th Civil Court of Santiago Case Number : 1.940-2013 Farmacias Ahumada S.A. for alleged breach of Description : Class action lawsuit filed by the National Consum- Article 4 (c) of Law 20,169 that regulates unfair er Protection Service (SERNAC) against Farmacias competition. In the opinion of Farmacias Cruz Cruz Verde S.A., Salcobrand S.A. and Farmacias Verde, the settlement agreement between FASA Ahumada S.A. for alleged infringement of Law and the FNE - which was approved by the Fair 19,496 on Consumer Rights Protection, arising Competition Defense Court (TDLC) and the Su- from the judgment by the Fair Competition De- preme Court - contained a false assertion by FASA fense Court (TDLC), and upheld by the Supreme against Cruz Verde, as the agreement inferred that Court, which condemned Cruz Verde and Salco- Cruz Verde and Salcobrand S. A. illegally colluded brand for colluding over price rises for medicines, in breaching DL 211. basing their lawsuit on Article 30 of DL 211, which Amount : Ch$11,011,300,685 plus indexation, interest and costs. Status : On August 19, 2011, FASA was notified of the law- enables it to sue for compensation those entities who have been convicted of collusion. Amount : Indeterminate. suit. On August 23, 2011, FASA filed an inciden- Status : On February 8, 2013, FASA was notified of the tal plea of lack of jurisdiction, also requesting the lawsuit. On January 26, 2010, FASA filed an ap- suspension of the response and reconciliation peal for reversal against the ruling that declared hearing decreed for August 25. On August 24, the the case admissible. On May 10, 2013, the first-in- court agrees to suspend the hearing and orders stance court accepted the appeals submitted by notification of Cruz Verde of the incidental plea FASA and the other defendants, and declared the of lack of jurisdiction. On August 26, Cruz Verde lawsuit filed by SERNAC inadmissible. On May 17, was notified of plea. The court rejected the plea SERNAC filed various appeals. On May 24, the of lack of jurisdiction, so FASA filed an appeal court rejected one appeal, but accepted a subsid- before the Appeal Court of Santiago. On August iary appeal. On June 7, 2013, FASA filed an appeal 21, the response and reconciliation hearing took of fact to declare inadmissible the appeal filed by effect. Cruz Verde requested that the court de- SERNAC. On December 2, 2013, the Appeal Court termine the substantial, relevant and controversial of Santiago rejected the appeal of fact filed by facts which the parties shall substantiate with evi- FASA. On the same date, it accepted the appeal dence and begin receiving evidence. On April 13, filed by SERNAC, overturning the ruling that had the court ruled that evidence could begin to be declared the collective lawsuit inadmissible. On received. On June 22, 2012, the Court of Appeals December 6, 2013, FASA filed a remedy of com- dismissed an appeal by FASA filed against the rul- plaint against the judges who had rejected its ap- ing that rejected the plea of lack of jurisdiction. peal of fact. On December 16, 2013, the Supreme The ruling on the submission of evidence has not Court declared the remedy of complaint inadmis- been notified to the parties, so the evidence pe- sible. On March 5, 2014, SERNAC requested pre- riod has not started. The case is currently closed cautionary measures to preserve documents and due to inactivity by the plaintiff. invoices; and prohibit contracts on real estate and In the opinion of our legal advisors, an unfavor- trademarks. On March 11, the Court partly granted able final judgment is unlikely. the measures requested, without prior notification to the parties, accepting the measures that prohibit contracts for real estate and transfers of any trademark rights. SERNAC filed various appeals in relation to the measures not granted. On March 20, the Court denied the motion for reversal and 139 | FASA 2014 Annual Report granted the appeal to return the case to the lower a.7) Court : 3rd Local Police Court of Valparaiso. of Santiago. On March 20, 2014, FASA responded to the collective lawsuit. On the same day, the INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Title : Lagos Lizana, Mauricio, et al versus FASA Chile S.A. court, which is still pending in the Appeals Court Case Number : 1.999-2013 Court ordered SERNAC to publish a notice in a Description : Lawsuit and criminal complaint filed by Mauricio national newspaper, inviting affected consumers Lagos Lizana, for alleged infringement of the Law to join the case or reserve their rights. Finally on on Consumer Rights Protection (LPC), for not the same day, the Court summoned the parties providing a medicine promptly, which he had paid for in advance. to a reconciliation hearing within five days of the Amount : Ch$260,014,000 plus interest, indexation and last notification. On March 23, 2014, FASA filed fines. several appeals against the ruling that granted the precautionary measures. On March 28, SER- Status : On March 4, 2013, FASA was notified of the law- NAC published the notice ordered by the court suit. On March 13, the investigatory hearing took in the newspaper El Mercurio, inviting affected place. On April 18, the response, conciliation and consumers to join the case or reserve their rights. evidence hearing took place. On May 30, 2013, On May 8, the Court rejected an appeal filed by the position acquittal hearing took place. On De- FASA, but accepted the subsidiary appeal. On July cember 30, the first-instance court totally rejected 17, 2014, the reconciliation hearing was held, with the complaint and lawsuit. That judgment is final no agreement between the parties. On October and enforceable in favor of FASA. 6, 2014, the evidence stage began and a notification to the parties is currently pending. Subsequent events after December 31, 2014: On January 23, 2015, the Court of Appeals upheld the appeal on the precautionary measures granted by the first-instance court, rendering them null and a.8) Title : Carrasco Conejeros, Jorge versus FASA Chile S.A. Court : 19th Civil Court of Santiago Case Number : 28.260-2012 Description : Lawsuit for termination of contract, eviction and void with respect to FASA. compensation for damages, based on alleged In the opinion of our legal advisors, an unfavor- breaches by FASA Chile S.A., who had not duly able final judgment is unlikely. paid the rent, common expenses and utilities with respect to the lease on store number 529. Amount : UF GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 7,446.76 plus interest and indexation. (US$362,831) Status : On March 25, 2013, FASA was notified of the lawsuit. On April 2, the response, conciliation and evidence hearing took place. On April 30, the first-instance court accepted the entire lawsuit, stating that the contract was terminated and condemning FASA to pay UF7.061,76. On June 11, FASA filed various appeals. On June 12, the Court accepted the motions for appeal and ordered them to be sent to the Court of Appeals. On July 11, the Court of Appeals declared the motion for cassation in form inadmissible, but left another appeal pending. On August 28, the plaintiff requested compliance with the judgment. On September 12, FASA filed a plea of payment. On September 30, the plaintiff filed a request for the seizure of FASA property. On October 2, 2013, money in FASA's current account at Banco Santander was 140 | FASA 2014 Annual Report impounded. On October 7, the plaintiff requested a.9) Court : 27th Civil Court of Santiago filed a plea to annul the embargo. On October 18, the annulment filed by FASA was rejected. On Case Number : 26.797-2012 October 22, the plaintiff requested an extension Description : Ordinary lawsuit for compensation for damag- to the embargo. On October 24, FASA filed an es for alleged liability on the grounds of effec- appeal against the ruling that denied the annul- tive dismissal, which a labor court had found non-existent. ment, which is still pending. On November 11, INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Title : Zaud Azar, Pamela versus Farmacias Ahumada S.A. and FASA Chile S.A. an extension to the embargo. On October 9, FASA Amount : Ch$75,000,000 plus interest and indexation. 2013, FASA assigned sufficient funds to pay the credit, and requested substitution of the imposed Status : On April 2, 2013, the lawsuit was filed. On April 19, embargo. On December 10, 2013, the Court ac- FASA responded to the lawsuit. On October 3, the cepted the substitution of the embargo. On April reconciliation hearing was held, with no agree- 4, 2014, the Appeal Court of Santiago accepted ment between the parties. On November 12, the appeal filed by FASA, overturning the judg- 2013, the evidence stage began. On April 17, 2014, ment, and accordingly rejecting the entire lawsuit. all relevant evidence was presented. On October On April 24, 2014, the plaintiff filed a motion for 20, 2014, the first-instance court pronounced cassation in form and merit. On July 17, 2014, the judgement, and partially accepted the lawsuit, or- Supreme Court rejected the appeal filed by the dering FASA to pay Ch$30,000,000. On Decem- plaintiff. On July 21, the plaintiff filed an appeal ber 1, 2014, FASA was notified of the judgment. for reversal against the ruling that rejected their On December 12, FASA filed an appeal, which is appeal, which was rejected by the court. On De- pending before the Appeal Court. The plaintiff has cember 3, 2014, Ch$163 million was recovered by also filed an appeal. FASA, which had been assigned as a replacement In the opinion of our legal advisors, an unfavor- for the embargo. Case closed. able final judgment is unlikely. a.10) Title : Trufello Campodónico, Dino versus Farmacias Ahumada S.A. Court : 2nd Civil Court of Viña del Mar. Case Number : 3.516-2013 Description : Lawsuit for termination of contract, eviction and GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility compensation for damages, based on alleged breaches by FASA Chile S.A., who had not duly paid the rent on store number 499. Amount : UF 24,000 plus interest and indexation. Status : On September 24, 2013, FASA was notified of the lawsuit. On September 30, 2013, the response, conciliation and evidence hearing took place. On March 20, 2014, the first-instance court passed judgment and rejected the lawsuit. On March 26, the parties were notified of the judgment. On April 8, 2014, the plaintiff filed appeals. On April 10, the first-instance court accepted the appeal process and referred them the Appeal Court of Valparaiso. On September 12, 2014, the Appeal Court of Valparaiso rejected the appeals filed by the plaintiff, and upheld the first-instance court's judgment. On October 2, the plaintiff filed an appeal before the Supreme Court. On December 22, 2014, the 141 | FASA 2014 Annual Report Supreme Court rejected the appeal, upholding the a.12) closed. Title : Pony Chile S.A. versus Farmacias Ahumada S.A. Court : 15th Civil Court of Santiago judgment that entirely rejected the lawsuit. Case Case Number : 3.933-2013 Description : Lawsuit for compensation for damages arising a.11) Title : Farmacias Ahumada S.A. versus Servicio de Im- from a prior case between the parties, where the puestos Internos (IRS). plaintiff reserved implementation of the judgment, Court : 1st Tax and Customs Court of the Metropolitan pending the calculation of damages, and now requests assessment through this new lawsuit. Region INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing Amount : Ch$227,841,903 with indexation and interest. Case Number : GR-15-00427-2013 Description : Claim submitted by Farmacias Ahumada S.A. Status : On April 9, 2013, the lawsuit was filed. On June against tax assessments 37 and 38 issued by the 11, 2013, the proceedings began. On April 8, 2014, Internal Revenue Service - in relation to the item: FASA was notified of the lawsuit. On April 28, Expenditure relating to the Reconciliation Agree- 2014, FASA responded to the lawsuit. On May 12, ment with the FNE, which generated alleged dif- the plaintiff replied. On May 19, 2014, the recon- ferences in the tax of Subparagraph 3, Article 21 of ciliation hearing took place. The evidence stage is Income Tax Law and the reinstatement of Article pending. The case is archived. 97 of the same law, for a total of Ch$476,876,069. In the opinion of our legal advisors, an unfavorable final judgment is unlikely. Amount : Ch$476,876,069 Status: On December 20, 2013, FASA presents a claim against the assessments 37 and 38 before the 1st Tax and Customs Court of the Metropolitan Region. On January 2, 2014, the claim was accept- a.13) Title : Rojas Hernández, Camila versus FASA Chile S.A. Court : Letters and Warranty Court of Lota. Case Number : 164-2014 ed and the court orders the defendant to be no- Description : Lawsuit for compensation for damages on the tified. On January 24, 2014, the SII is notified. On termination of a lease contract, based on struc- March 24, FASA requests certain considerations tural damage when FASA returned shop 513 to its to be taken into account, in addition to requesting that the court begin to receive evidence. On owner. Amount : Ch$99,000,000 with indexation and interest. November 7, 2014, the evidence stage began. Ev- Status : On July 4, 2014, FASA was notified of the lawsuit. idence was submitted, and on December 11, the On July 14, 2014, the response, reconciliation and court ordered the parties to hear the judgment. evidence hearing took place. On August 8 and 11, GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 2014, the testimonial evidence and personal in- FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility the return of the guarantee. On October 27, 2014, spection hearing took place. On October 13, the court passed judgment and rejected the principal claim, accepting the countersuit from FASA for the main plaintiff filed an appeal that is still pending before the Appeal Court of Santiago. In the opinion of our legal advisors, an unfavorable final judgment is unlikely. 142 | FASA 2014 Annual Report a.14) Title : Mesías Vidal, Sergio versus FASA Chile S.A. a.16) Court : Local Conciliation and Arbitration Board in Tor- Case Number : 16.625-2014 Description : Ordinary lawsuit for forced compliance with a reón, Coahuila. Register : 478/2000. contract and compensation for damages on an PERFORMANCE Consolidated Indicators Investment and Financing Description : Employment lawsuit was presented in which con- the company agreed in good faith to collaborate stitutional compensation and lost wages were with the former executive if he decided to request claimed for alleged wrongful dismissal by the agreement. A discussion regarding the damages Status : In March 2006 an arbitral award was issued ab- was requested to take place after a favorable judg- solving the company of the claim by the plaintiff. ment or under a different lawsuit. However, the plaintiff appealed under the pro- Amount : Indeterminate. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility tection of the federal judiciary, which set aside Status : On September 3, 2014, FASA was notified of the the award and the actions taken. Hearing all the lawsuit. FASA filed dilatory pleas within the legal evidence is still pending, as the plaintiff has not deadline. On October 10, the court accepted the located the witnesses for the prosecution. plea of lack of jurisdiction, and declared itself in- In the opinion of our legal advisors, an unfavor- competent to hear this case. On October 16, the able final judgment is likely. plaintiff filed an appeal with Appeal Court of Santiago. On December 23, 2014, the Appeal Court a.17) Title : Ana María Uresti Sanchez versus Servicios Op- of Santiago accepted the appeal, and rejected the eracionales Benavides S.A. de C.V. and/or Far- plea of lack of jurisdiction filed by FASA. The trial macias Benavides, S.A.B. de C.V. will continue in the civil courts. Court : Local Conciliation and Arbitration Board in Monterrey, Nuevo León. a.15) Title : Organización de Consumidores y Usuarios de Chile (ODECU) versus Farmacias Cruz Verde S.A., Salcobrand and Farmacias Ahumada S.A. Court : 25th Civil Court of Santiago Case Number : 10.351-2013 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates company. Amount : Ch$46,474,456 ing tax on compensation agreed in a collective THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People employment termination agreement, whereby from the Chilean IRS repayment of withhold- INTRODUCTION Company Details Letter from the Chairman Title : María Guadalupe Tovar Sánchez versus Droguería Benavides S.A. de C.V. Court : 26th Civil Court of Santiago Description : Class action lawsuit filed by the Chilean Con- Register : 5904/i/10/2007. Description : Employment lawsuit was presented in which constitutional compensation and lost wages were claimed for alleged wrongful dismissal by the company. Amount : Ch$44,325,961 sumers and Users Organization (ODECU) against Status : In January 2009 an arbitral award was issued ab- Farmacias Ahumada S.A. for alleged infringement solving the company of various benefits only con- of Law 19,496 on Consumer Rights Protection, demning it to proportional payments. The plaintiff arising from the judgment by the Fair Competi- appealed under the protection of the federal jus- tion Defense Court (TDLC), and upheld by the Su- tice system. A new arbitral award was issued con- preme Court, which condemned Cruz Verde and demning the company, and an appeal was filed Salcobrand for colluding over price rises for med- which is pending resolution. icines, basing their lawsuit on Article 30 of DL 211, In the opinion of our legal advisors, an unfavor- which enables it to sue for compensation those able final judgment is likely. entities who have been convicted of collusion. Amount : Indeterminate. Status : On June 3, 2014, FASA was notified of the lawsuit. The other defendants need to be notified, before the period to respond to the lawsuit can begin. 143 | FASA 2014 Annual Report a.18) Title : María Del Socorro Martínez Martínez versus Ser- a.21) cios Operacionales Benavides S.A. de C.V. and/ or Farmacias Benavides, S.A.B. de C.V. or Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in No- Court : Local Conciliation and Arbitration Board in No- gales, Sonora. gales, Sonora. Register : 55/2005. Register : 0951/2011. Description : Employment lawsuit was presented in which con- Description : Employment lawsuit was presented in which con- stitutional compensation and lost wages were stitutional compensation and lost wages were claimed for alleged wrongful dismissal by the claimed for alleged wrongful dismissal by the INTRODUCTION Company Details Letter from the Chairman company. company. Amount : Ch$40,271,897 Amount : Ch$58,773,365 Status : A pronouncement by the board is pending. Status : The evidence stage has begun, pending hearing THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility of confessionals and testimonials of the plaintiff. In the opinion of our legal advisors, an unfavor- In the opinion of our legal advisors, an unfavor- able final judgment is likely. able final judgment is likely. a.22) a.19) Title : Teresa Muñoz Gutierrez versus Servicios Operacionales Benavides S.A. de C.V. and/or Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Guadalajara, Jalisco. Register : 839/2010. Title : Luis Edmundo Cruz Martinez versus Servicios Operacionales Benavides S.A. de C.V. and/or Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Mexicali, Baja California. Register : 180/2008. Description : Employment lawsuit was presented in which con- Description : Employment lawsuit was presented in which con- stitutional compensation and lost wages were stitutional compensation and lost wages were claimed for alleged wrongful dismissal by the claimed for alleged wrongful dismissal by the company. Amount : Ch$146,580,896 PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Title : Maria Antonia Hernandez Ochoa versus Servi- vicios Operacionales Benavides S.A. de C.V. and/ Status : The board passed judgment accepting the law- Status : The evidence stage has begun, pending hearing of confessionals and testimonials of the plaintiff. suit. An appeal was filed, which is pending ruling. In the opinion of our legal advisors, an unfavor- In the opinion of our legal advisors, an unfavor- able final judgment is likely. able final judgment is likely. a.20) company. Amount : Ch$53,693,870 Title : Luis Enrique de Lira Hernandez versus Servicios Operacionales Benavides S.A. de C.V. and/or Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Monterrey, Nuevo León. Register : 5651/i/10/2009. Description : Employment lawsuit was presented in which constitutional compensation and lost wages were claimed for alleged wrongful dismissal by the company. Amount : Ch$50,321,215 Status : The evidence stage has begun, pending hearing of confessionals and testimonials of the plaintiff. In the opinion of our legal advisors, an unfavorable final judgment is likely. 144 | FASA 2014 Annual Report a.23) Title : Gabriela Gonzalez Mancilla versus Servicios Op- a.26) eracionales Benavides S.A. de C.V. and/or Far- macias Benavides, S.A.B. de C.V. macias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Her- Court : Local Conciliation and Arbitration Board in Mon- mosillo, Sonora. terrey, Nuevo León. Register : 199/2009. Register : 5870/i/10/2009. Description : Employment lawsuit was presented in which con- Description : Employment lawsuit was presented in which con- stitutional compensation and lost wages were stitutional compensation and lost wages were claimed for alleged wrongful dismissal by the claimed for alleged wrongful dismissal by the INTRODUCTION Company Details Letter from the Chairman company. company. Amount : Ch$45,971,450 Amount : Ch$49,290,465 Status : The evidence stage has begun, pending hearing Status : The evidence stage has begun, pending hearing THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People a.24) FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility of confessionals and testimonials of the plaintiff. of confessionals and testimonials of the plaintiff. In the opinion of our legal advisors, an unfavor- In the opinion of our legal advisors, an unfavor- able final judgment is likely. able final judgment is likely. Title : Irma Najera Sanchez versus Servicios Operacio- a.27) Title : Paloma Cortina Zapata versus Servicios Opera- nales Benavides S.A. de C.V. and/or Farmacias cionales Benavides S.A. de C.V. and/or Farmacias Benavides, S.A.B. de C.V. Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in San Court : Local Conciliation and Arbitration Board in Mon- Luis Potosí, San Luis Potosi. terrey, Nuevo León. Register : 9903/2010. Register : 15295/i/10/2009. Description : Employment lawsuit was presented in which con- Description : Employment lawsuit was presented in which con- stitutional compensation and lost wages were stitutional compensation and lost wages were claimed for alleged wrongful dismissal by the claimed for alleged wrongful dismissal by the company. company. Amount : Ch$41,889,680 Amount : Ch$43,091,988 PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Title : Juan Carlos Celada Chavez versus Servicios Op- eracionales Benavides S.A. de C.V. and/or Far- Status : The evidence stage has begun, pending hearing Status : An appeal was filed against award, which is pend- a.25) ing resolution. of confessionals and testimonials of the plaintiff. In the opinion of our legal advisors, an unfavor- In the opinion of our legal advisors, an unfavor- able final judgment is likely. able final judgment is likely. Title : Beatriz Natalia Perez Muñoz versus Servicios a.28) Title : Elsa Nely Moreno Lopez versus Servicios Opera- Operacionales Benavides S.A. de C.V. and/or cionales Benavides S.A. de C.V. and/or Farmacias Farmacias Benavides, S.A.B. de C.V. Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Torreón, Coahuila. Register : 2137/2009. Court : Local Conciliation and Arbitration Board in Piedras Negras, Coahuila. Register : 78/2011. Description : Employment lawsuit was presented in which con- Description : Employment lawsuit was presented in which con- stitutional compensation and lost wages were stitutional compensation and lost wages were claimed for alleged wrongful dismissal by the claimed for alleged wrongful dismissal by the company. Amount : Ch$43,015,424 Status : The evidence stage has begun, pending hearing company. Amount : Ch$43,256,661 Status : The evidence stage has begun, pending hearing of confessionals and testimonials of the plaintiff. of confessionals and testimonials of the plaintiff. In the opinion of our legal advisors, an unfavor- In the opinion of our legal advisors, an unfavor- able final judgment is likely. able final judgment is likely. 145 | FASA 2014 Annual Report a.29) Title : Gonzalo Ismael Soto Vazquez versus Servicios TUCION DE BANCA MULTIPLE, GRUPO FINANCIERO SANTANDER MEXICO versus FARMACIAS Mochis, Sinaloa. Register : 22/2011. Description : Employment lawsuit was presented in which con- OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility rey, Nuevo Leon. Register : 614/2013. Description : This is an ordinary commercial trial, which claims claimed for alleged wrongful dismissal by the the following: (i) Hostile Takeover Bid to purchase company. shares in the capital of the Trust F/2112346-1 of Amount : Ch$45,941,476 Banco Santander. (ii) Judicial annulment (sic) of each and every one of the corporate agreements of confessionals and testimonials of the plaintiff. and decisions taken with respect to FARMACIAS In the opinion of our legal advisors, an unfavor- BENAVIDES, S. A.B. de C.V., since November 10, able final judgment is likely. 2010, in relation to the company through exercising the corresponding rights to shares acquired a.30) Title : Pablo Gamaliel Ponce Aguilar versus Servicios indirectly by Grupo Casa Saba, as well as the Operacionales Benavides S.A. de C.V. and/or retroactive destruction of all the effects of these Farmacias Benavides, S.A.B. de C.V. agreements and decisions, as a direct result of not Court : Local Conciliation and Arbitration Board in Los Mochis, Sinaloa. Register : 481/2011. having made the Hostile Takeover Bid to purchase shares, with respect to the capital of the Trust. (iii) Payment of the sum that it has the "right" to re- Description : Employment lawsuit was presented in which con- ceive from the Trust, in relation to the shares it stitutional compensation and lost wages were holds, on the occasion of the Hostile Takeover claimed for alleged wrongful dismissal by the Bid to purchase shares. (iv) Payment of damages company. caused to the Trust, for not agreeing to the Hos- Amount : Ch$68,029,500 PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates BENAVIDES, S.A.B. de C.V. and others. Court : First Court of Concurrent Jurisdiction in Monter- stitutional compensation and lost wages were Status : The evidence stage has begun, pending hearing THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Title : BANCO SANTANDER (MEXICO), S.A. INSTI- Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in Los INTRODUCTION Company Details Letter from the Chairman a.32) Operacionales Benavides S.A. de C.V. and/or Status : The evidence stage has begun, pending hearing tile Takeover Bid to purchase shares. v) Payment of damages caused to the Trust, for unlawful acts of confessionals and testimonials of the plaintiff. committed by making agreements and making In the opinion of our legal advisors, an unfavor- financial decisions with regard to the assets of able final judgment is likely. the company mentioned previously in conflict of interest, due to the acquisition of a property a.31) Title : Cesar Aron Ramirez Vazquez versus Servicios in the municipality of San Nicolas de los Garza, Operacionales Benavides S.A. de C.V. and/or Nuevo Leon, and for the purchase of Farmacias Farmacias Benavides, S.A.B. de C.V. ABC de México S.A. de C.V. and all those trans- Court : Local Conciliation and Arbitration Board in Hermosillo, Sonora. Register : 3952/2009. Description : Employment lawsuit was presented in which constitutional compensation and lost wages were claimed for alleged wrongful dismissal by the company. Amount : Ch$82,688,002 Status : The board issued a judgment condemning the company for the amount claimed. An appeal was filed, which is pending ruling. In the opinion of our legal advisors, an unfavorable final judgment is likely. actions carried out and not carried out on open market terms between Farmacias Benavides and Grupo Casa Saba. (vi) Payment of legal costs and expenses. Amount : Indeterminate. Status : On July 26, 2013, the company was notified of the lawsuit, and responded on August 19, 2013. The plaintiff's response was examined. Evidence was submitted by both parties during the prescribed period. 146 | FASA 2014 Annual Report a.33) Title : BANCO SANTANDER (MEXICO), S.A. INSTI- Board was declared incompetent. Therefore, this TUCION DE BANCA MULTIPLE, GRUPO FINAN- case has been transferred to the Federal Concilia- CIERO SANTANDER MEXICO versus FARMACIAS tion and Arbitration Board. BENAVIDES, S.A.B. de C.V. and others. In the opinion of our legal advisors, an unfavorable Court : Second Court of Concurrent Jurisdiction in Monterrey, Nuevo Leon. Register : 429/2014. iaries have not been legally notified of the existence of any legal claims against them, other than the following: (i) Judicial annulment (sic) of each those indicated in the preceding paragraphs, seek- and every one of the corporate agreements and ing amounts over ThCh$35,000. decisions taken with respect to FARMACIAS BENAVIDES, S. A.B. de C.V., since November 10, 2010, which have involved the exercise of the THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility rights pertaining to the shares acquired indirectly by Controladora Casa Saba, as well as the retroactive destruction of all the effects of these agreements and decisions. (ii) Judicial declaration that Grupo Casa Saba and Controladora Casa Saba cannot exercise their corporate rights arising from the shares in the issued capital of Farmacias Bena- OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People vides, as they were acquired in violation of Article 98 of the Securities Market Act (sic). (iii) Payment of damages caused to the Trust by all those transactions carried out and not carried out under the terms of the Securities Market Act. (iv) Payment of legal costs and expenses. Amount : Indeterminate. PERFORMANCE Consolidated Indicators Investment and Financing Status : The company was notified of the lawsuit, and responded on September 30, 2014. Examination of the plaintiff's response is still pending. Evidence FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Farmacias Ahumada S. A. and its Chilean subsid- Description : This is an ordinary commercial trial, which claims INTRODUCTION Company Details Letter from the Chairman GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates final judgment is unlikely. was submitted by both parties during the prescribed period. a.34) Title : Pedro Alejandro Sadurni Gómez versus Servicios Operacionales Benavides S.A. de C.V. and/ or Farmacias Benavides, S.A.B. de C.V. Court : Local Conciliation and Arbitration Board in the Federal District. Register : 2154/2014. Description : Employment lawsuit was presented in which constitutional compensation and lost wages were claimed for alleged wrongful dismissal by the company. Amount : Ch$6,645,658,457 Status : The company was notified of the reconciliation hearing on December 5, 2014. The hearing was delayed and finally took place on January 20, 2015. The Local Conciliation and Arbitration 147 | FASA 2014 Annual Report 24.2 DETAIL OF GUARANTEES As of December 31, 2014 and 2013, the principal guarantees were as follows: Debtor Guarantee Creditor Name Relationship Guarantee Type Farmacias Ahumada S.A Lessor Performance bond None 24,627 Urbanizaciones Kalos SC de RL Farmacias Ahumada S.A Lessor Performance bond None 151,338 147,264 Comisión Federal De Electricidad Farmacias Benavides S.A Lessor Performance bond None 136,175 132,508 Servicio Pan Americano Farmacias Benavides S.A Lessor Performance bond None 132,028 128,474 Integral Surveillance de México S.A. Farmacias Benavides S.A Lessor Performance bond None 43,704 4,527 Aeropuerto Internacional de La Farmacias Benavides S.A Lessor Performance bond None 71,953 - Urbanizaciones Beta S.A. de C.V. Farmacias Benavides S.A Lessor Performance bond None 22,418 21,815 Cesar Luis Beltran Guerrero Farmacias Benavides S.A Lessor Performance bond None 22,423 15,801 Sistemas De Administración Planeada S.A. de C.V. Farmacias Benavides S.A Lessor Performance bond None 14,007 15,400 Juan Martinez Vázquez Farmacias Benavides S.A Lessor Performance bond None 14,018 13,641 Banco JP Morgan, S.A. Institución De Banca Múltiple Farmacias Benavides S.A Lessor Performance bond None 13,583 13,217 José María Garza Trevino Farmacias Benavides S.A Lessor Performance bond None 13,566 13,201 Ricardo Zambrano Sánchez Farmacias Benavides S.A Lessor Performance bond None 13,441 13,079 Droguería y Farmacia El Fénix, S.A de C.V. Farmacias Benavides S.A Lessor Performance bond None 13,224 12,867 Roger Bernardo Daniel Louis Farmacias Benavides S.A Lessor Performance bond None 12,369 12,036 Deutche Bank México Farmacias Benavides S.A Lessor Performance bond None 12,369 12,036 Inmobiliaria Palma de Detil S.A. Farmacias Benavides S.A Lessor Performance bond None 11,457 11,148 Inmobiliaria Aros S.A. de C.V. Farmacias Benavides S.A Lessor Performance bond None 11,155 10,855 Gerardo Armando Gonzalez Navarrete _ Multipack Farmacias Benavides S.A Lessor Performance bond None 11,065 10,767 Aeropuerto Internacional Servicio Salud Metropolitano Central INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Assets 12/31/2013 12/31/2014 Committed ThCh$ ThCh$ 23,310 Farmacias ABC S.A. de C.V. Lessor Performance bond None 18,851 - Cencosud Shopping Centers S.A FASA Chile S.A. Lessor Performance bond None 33,104 106,084 Comercializadora Costanera Center Spa. FASA Chile S.A. Lessor Performance bond None 78,998 74,772 Chilena Consolidada Seguros de Vida S.A. FASA Chile S.A. Lessor Performance bond None 112,493 106,475 Hospital Militar de Santiago FASA Chile S.A. Lessor Performance bond None 26,597 - Plaza Estación S.A. FASA Chile S.A. Lessor Performance bond None 32,154 12,600 Walmart Chile Inmobiliaria S.A. FASA Chile S.A. Lessor Performance bond None 10,538 15,892 Nuevos Desarrollos S.A. FASA Chile S.A. Lessor Performance bond None 52,998 45,136 Inmobiliaria Mall Calama S.A FASA Chile S.A. Lessor Performance bond None 67,995 64,358 Plaza Del Trébol S.A FASA Chile S.A. Lessor Performance bond None 63,966 41,895 Plaza La Serena S.A FASA Chile S.A. Lessor Performance bond None 28,167 26,660 Plaza Tobalaba S.A. FASA Chile S.A. Lessor Performance bond None 12,304 11,646 Plaza Oeste S.A FASA Chile S.A. Lessor Performance bond None 51,126 27,459 Centros Comerciales Vecinales Arauco Express S.A. FASA Chile S.A. Lessor Performance bond None TOTAL 10,721 - 1,344,932 1,144,923 148 | FASA 2014 Annual Report NOTE 25 EARNINGS PER SHARE The following table summarizes the consideration paid for the acquisition of Farmacias ABC S.A. de C.V., together with the difference DISCLOSURES ON EARNINGS PER SHARE between the consideration paid and the book value of the net assets: Basic earnings (loss) per share are calculated as profit (loss) for the Business Combination - Farmacias ABC S.A. de C.V. year attributable to the Company divided by the weighted average Consideration paid (7,209,700) Net assets acquired 6,894,487 number of issued common shares during that period, excluding the average number of shares of the Company, if applicable. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 2014 ThCh$ 2013 ThCh$ (315,213) The assets and liabilities acquired in the business combination were as follows: Earnings (loss) attributable to owners of the parent company (11,877,713) 15,819,396 179,112 496,823 1,500,000,000 1,500,000,000 Basic earnings available to common shareholders Basic average weighted number of shares (*) Effect on other reserves, in equity ThCh$ Basic earnings (loss) per share (7.92) 10.55 Identifiable Assets and Liabilities Acquired Cash and cash equivalents 1,083,741 Inventories, net 7,780,065 Intangible assets (Note 13) diluting effect, that would result in diluted earnings per share being Deferred tax assets different from basic earnings per share. Other assets NOTE 26 SHARE-BASED PAYMENT POLICIES 514,226 Net trade and other receivables, current Property, plant and equipment (Note 14) As of December 31, 2014, there are no transactions that generate a ThCh$ 1,219,122 5,356,780 748,931 6,809,093 Trade payables (10,151,274) Other liabilities (6,466,197) Total identifiable net assets acquired 6,894,487 In 1998 Farmacias Ahumada S.A. created a plan for certain executives to acquire shares in the Company. The plan was for the Company NOTE 28 SEGMENT REPORTING to give executives options to buy those shares, obligating it to absorb the difference in the event that the sale value of the shares was less The Company manages its business by geographical area, setting than the value of the debt. the objectives and control measures for each country. Therefore, management sends monthly reports to the directors at a country On December 31, 2014, these shares were fully liquidated, and this level and the board analyzes these, makes decisions and controls the share based plan was terminated. business by geographical area. NOTE 27 BUSINESS COMBINATIONS On June 3, 2014, all the shares of Farmacias ABC de México, S.A. de C.V. were acquired for MX$170,000,000, equivalent to ThCh$7,209,700 on the acquisition date, by Farmacias Benavides, S.A.B. de C.V. and its subsidiary Servicios Operacionales Benavides, S.A. de C.V. leaving these companies with 99.99% and 0.01%, respectively. This acquisition is a business combination of entities under common control and was recognized in accordance with the policy described in Note 2.22. 149 | FASA 2014 Annual Report As of December 31, 2014 and 2013, the operating segments used by FASA to manage its operations were as follows: a) Information on Assets and Liabilities as of December 31, 2014 and 2013 INFORMATION ON ASSETS AND LIABILITIES CHILE INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MEXICO BRAZIL ELIMINATED TOTAL 12/31/2014 ThCh$ 12/31/2013 ThCh$ 12/31/2014 ThCh$ 12/31/2013 ThCh$ 12/31/2014 ThCh$ 12/31/2013 ThCh$ 12/31/2014 ThCh$ 12/31/2013 ThCh$ 12/31/2014 ThCh$ 12/31/2013 ThCh$ 12,380,787 11,460,540 31,563,577 19,108,475 255,044 84,025 - - 44,199,408 30,653,040 Net trade and other receivables, current 24,815,901 20,926,003 9,845,222 8,862,916 387,354 491,698 - - 35,048,477 30,280,617 Inventories 64,809,361 60,796,636 105,023,979 87,552,867 396,383 2,115,632 (322,751) (363,477) 169,906,972 150,101,658 Property, plant and equipment, net 32,690,234 37,337,087 46,544,946 53,325,323 449,357 422,606 (512,569) (1,949,277) 79,171,968 89,135,739 Other assets by segments 521,253,907 363,686,260 192,924,081 88,814,972 490,899 619,044 (583,134,982) (287,409,219) 131,533,905 165,711,057 Assets by segments Cash and cash equivalents 655,950,190 494,206,526 385,901,805 257,664,553 1,979,037 3,733,005 (583,970,302) (289,721,973) 459,860,730 465,882,111 Other financial liabilities, current 28,325,726 19,622,084 - - - - - - 28,325,726 19,622,084 Trade and other payables, current 124,788,796 115,843,689 153,533,694 117,232,634 913,770 1,851,815 - - 279,236,260 234,928,138 Other liabilities by segments 271,380,817 228,039,632 113,547,378 25,815,014 7,738,873 2,908,769 (315,091,477) (125,030,861) 77,575,591 131,732,554 Liabilities by segments 424,495,339 363,505,405 267,081,072 143,047,648 8,652,643 4,760,584 (315,091,477) (125,030,861) 385,137,577 386,282,776 150 | FASA 2014 Annual Report b) Information on profit (loss) by operating segment for the years ended December 31, 2014 and 2013: INFORMATION ON PROFIT (LOSS) CHILE 2014 ThCh$ Revenue INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility MEXICO 2013 ThCh$ 2014 ThCh$ BRAZIL 2013 ThCh$ 2014 ThCh$ ELIMINATED 2013 ThCh$ 2014 ThCh$ TOTAL 2013 ThCh$ 2014 ThCh$ 2013 ThCh$ 420,517,865 390,426,368 547,024,198 473,867,104 853,274 398,901 (26,381,004) (19,557,823) 942,014,333 845,134,550 Finance income 2,386,704 4,864,350 666,380 1,027,036 19,295 3,087 - - 3,072,379 5,894,473 Finance cost (5,411,223) (5,703,780) (593,145) (916,123) (582,722) (301,184) - - (6,587,090) (6,921,087) Depreciation and amortization (4,236,179) (4,479,892) (8,196,283) (5,934,395) (124,958) (69,849) - - (12,557,421) (10,484,136) 12,545 552,913 - - - - - - 12,545 522,913 Profit (loss) by segment (9,685,736) 527,722 4,069,999 11,362,781 (6,082,868) 4,425,716 - - (11,877,717) 16,316,219 Income tax benefit (expense) 511,925 (286,960) (1,930,123) (5,363,534) (24,413) (8,781) - - (1,442,611) (5,659,275) Share of income (loss) from associates c) Information on the cash flow statement by segment for the years ended December 31, 2014 and 2013. INFORMATION ON THE CASH FLOW STATEMENT CHILE 2014 ThCh$ Cash flows from operating activities MEXICO 2013 ThCh$ 30,884,810 2014 ThCh$ 10,817,978 23,420,243 2013 ThCh$ 26,634,737 BRAZIL 2014 ThCh$ TOTAL 2013 ThCh$ (3,502,793) 2014 ThCh$ 2013 ThCh$ (5,003,389) 50,802,260 32,449,326 Cash flows from investing activities (6,258,743) (11,048,633) (6,091,945) (8,832,672) - (732,301) (12,350,688) (20,613,606) Cash flows from financing activities (23,705,820) (2,982,460) (5,400,221) (11,559,805) 3,673,812 5,768,724 (25,432,229) (8,773,541) 920,247 (3,213,115) 11,928,077 6,242,260 171,019 33,034 13,019,343 3,062,179 - - 527,025 1,034,988 - - 527,025 1,034,988 Increase (decrease) in cash and cash equivalents Effect of exchange rate changes on cash and cash equivalents Increase (decrease) in cash and cash equivalents 920,247 (3,213,115) 12,455,102 7,277,248 171,019 33,034 13,546,368 4,097,167 Cash and cash equivalents at the beginning of the period 11,460,540 14,673,655 19,108,475 11,831,227 84,025 50,991 30,653,040 26,555,873 Cash and cash equivalents at the end of the period 12,380,787 11,460,540 31,563,577 19,108,475 255,044 84,025 44,199,408 30,653,040 151 | FASA 2014 Annual Report NOTE 29 LOCAL AND FOREIGN CURRENCIES 29.1 CURRENT AND NON-CURRENT ASSETS BY CURRENCY WERE AS FOLLOWS: CURRENT ASSETS Cash and cash equivalents INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People 12/31/2014 ThCh$ 12/31/2013 ThCh$ Other assets 183,448,377 178,526,839 23,237,004 20,010,464 121,846,343 120,492,391 35,214,360 37,857,605 3,150,670 166,379 30,653,040 25,905 Other currencies 31,818,621 19,192,500 Chilean pesos Chilean pesos 12,265,431 11,434,635 Other currencies 3,118,173 411 UF 11,856 411 Related party receivables - 49,530,977 - - US dollars - - Chilean pesos Financial assets, current US dollars Chilean pesos UF 3,106,317 - 35,048,477 30,280,617 63,470 961 Other currencies 10,232,575 9,354,613 Chilean pesos 24,752,432 20,925,043 156,988 5,216,012 Net trade and other receivables, current US dollars Related party receivables - - Other currencies - 5,216,012 156,988 - 193,889,307 171,674,215 461,650 212,971 - 185,419 122,347,657 104,319,353 71,042,215 66,956,472 Chilean pesos US dollars UF Chilean pesos Euros Total current assets 37,785 - 276,412,353 237,824,295 652,332 240,248 Other currencies 164,398,853 138,082,478 Chilean pesos 108,217,066 99,316,150 3,106,317 185,419 37,785 - UF Euros US dollars Total non-current assets (2) US dollars US dollars US dollars FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility NON-CURRENT ASSETS 115,356 Other currencies GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates 12/31/2013 ThCh$ 44,199,408 US dollars Other current assets (1) PERFORMANCE Consolidated Indicators Investment and Financing 12/31/2014 ThCh$ (1) Includes: Other current non-financial assets, inventories and current tax assets. Other currencies Chilean pesos UF Total assets US dollars Other currencies Chilean pesos UF Euro - 49,530,977 183,448,377 228,057,816 23,237,004 20,010,463 35,214,360 37,857,605 121,846,343 170,023,368 3,150,670 166,379 459,860,730 465,882,111 23,889,336 20,250,711 199,613,213 257,262,521 230,063,409 188,017,078 6,256,987 351,800 37,785 - (2) Includes: Other non-current non-financial assets, investments accounted for using the equity method, intangible assets other than goodwill, goodwill, property, plant and equipment, non-current deferred tax assets. 152 | FASA 2014 Annual Report 29.2 CURRENT AND NON-CURRENT LIABILITIES BY CURRENCY WERE AS FOLLOWS: CURRENT LIABILITIES 12/31/2014 12/31/2013 Up to 90 Days Other financial liabilities, current US dollars INTRODUCTION Company Details Letter from the Chairman Other currencies THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility Euros OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People Chilean pesos UF Trade and other payables US dollars Euros 12/31/2014 12/31/2013 91 Days to 1 Year ThCh$ ThCh$ ThCh$ ThCh$ 3,618,142 728,622 1,016,410 24,707,584 18,605,674 409,486 215,343 202,233 - - - - 2,402,435 - 12,095,731 6,687,192 450,378 492,503 12,396,510 11,716,249 36,707 114,421 - - 263,269,476 230,478,940 15,966,784 4,449,198 26,892 1,853,737 - 1,821,415 30,534 283 103,998 - Other currencies 154,409,199 116,606,185 - - Chilean pesos 106,833,242 113,845,524 13,775,151 4,402,737 UF 175,086 56 233,898 46,461 Related party payables, current 529,603 8,799,359 - - US dollars - - - - Other currencies - 8,188,389 - - Chilean pesos Other current liabilities (1) US dollars PERFORMANCE Consolidated Indicators Investment and Financing Other currencies GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Total current liabilities FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Chilean pesos UF US dollars 529,603 610,970 - - 6,837,632 7,383,517 245,461 532,965 - 10,847 - 532,965 72,172 4,914,744 - - 6,758,588 2,333,233 245,461 - 124,693 - 6,872 274,254,853 247,678,226 40,919,829 23,587,837 2,550,037 447,225 2,069,080 735,198 67,241 114,704 103,998 - Other currencies 154,481,371 129,709,318 - - Chilean pesos 116,523,868 116,789,727 26,116,343 11,089,929 632,336 617,252 12,630,408 11,762,710 Euros UF (1) Includes: Other provisions, tax liabilities, provisions for employee benefits and other non-financial liabilities, current. 153 | FASA 2014 Annual Report NON-CURRENT LIABILITIES 12/31/2014 12/31/2013 12/31/2014 1 to 3 Years ThCh$ Other financial liabilities, non-current US dollars Chilean pesos Other currencies INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates UF Other liabilities, non-current (2) US dollars Other currencies UF Chilean pesos Total non-current liabilities US dollars ThCh$ 12/31/2014 ThCh$ 12/31/2013 Over 5 Years ThCh$ ThCh$ ThCh$ 20,791,502 33,002,942 7,311,513 22,302,180 30,423,197 418,168 678,633 71,265 - - 8,270,484 13,703,912 - - - - - - - - - - 12,102,850 18,620,397 7,240,248 22,302,180 30,423,197 16,857,135 11,182,986 14,548,665 - 23,028,387 253,697 5,277,404 - - - 13,895,014 - - 7,841,055 - - 6,128,092 - 5,277,404 - - - - - - 3,341,931 14,548,665 - 3,005,281 253,697 - 31,974,488 47,551,607 7,311,513 45,330,567 30,676,894 22,134,539 418,168 678,633 71,265 13,895,014 - - 16,857,135 Other currencies 7,841,055 - - 6,128,092 - 5,277,404 Chilean pesos 11,612,415 28,252,577 - 3,005,281 253,697 - 12,102,850 18,620,397 7,240,248 22,302,180 30,423,197 16,857,135 UF (2) Includes: Deferred tax liabilities and other liabilities, non-current. NOTE 30 EVENTS AFTER THE REPORTING PERIOD NOTE 31 ENVIRONMENT Given the nature of its business, which does not adversely affect the On January 22, 2015, a material event was reported that on January environment, the Company has no expenditures associated with 21, 2015, the board agreed to summon an extraordinary shareholders' caring for the environment. meeting for February 24, 2015, at the Company's offices located at Miraflores 383, floor 6, Santiago, at 10:00am, to address the following matters: 1) Approve the voluntary delisting of FASA shares in the SVS FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 12/31/2013 3 to 5 Years NOTE 32 FINANCIAL STATEMENT APPROVAL Securities Register and in the Chilean stock exchanges, in accordance with Subparagraph 6, Article 2 of Law 18,046 on Corporations, and The consolidated financial statements of Farmacias Ahumada S. A. the approval of this delisting shall give the dissident shareholders a and subsidiaries were approved by the board on March 25, 2015. right to withdraw. (2) Approve the remaining agreements necessary to comply with the decisions of this meeting. 3) Delegate sufficient authority to the board and/or the Chief Executive Officer to process all of the details that may arise in relation to the agreements approved at this extraordinary shareholders' meeting. 154 | FASA 2014 Annual Report MATERIAL EVENTS INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing During 2014, the Company reported to the Superintendency of It was further reported that the documents supporting the decisions Securities and Insurance and the stock exchanges the following requiring a shareholder vote, including information on the proposed material events: external auditors for 2014, and all corresponding supporting information, will be available for shareholders on the Company's i) On April 11, 2014, a material event was reported that the board of web site: www.fasa.cl. Summons notices will be published in the Farmacias Ahumada S.A. agreed to summon an ordinary share- newspaper El Mostrador on April 14, 22 and 28, 2014. The consolidated holders' meeting for April 30, 2014, at 12:00am in the Company's financial statements as of December 31, 2013, have been published offices located at Miraflores 383, floor 6, Santiago, with the pur- on the Company's website: www.fasa.cl, Investors Section, or via pose of addressing the following matters: the following link: http://www.fasa.cl/fasacorp/fasacorp/doc/fecu/ fecu_consolidado_dic2013.pdf. The shareholders registered in the 1. Reviewing the Company's financial situation and approve the Company shareholder registry on midnight of the fifth day prior annual report, consolidated financial statements and the in- to the meeting date, which is April 24, 2014, shall have the right to dependent auditors' report for the year ended December 31, participate in that meeting. The Company will send a digital copy of 2013. the Annual Report for 2013 to the Superintendency of Securities and 2. Approving the adjustments to the Company's consolidated financial statements as of December 31, 2012, that were re3. Approving the distribution of dividends from 2013 earnings. ii) On April 11, 2014, a material event was reported that at an ex- 4. Approving the dividend policy for 2014. traordinary board meeting of Farmacias Ahumada S.A. held on the 5. Electing the board of directors. same date, the board agreed to propose to the ordinary share- 6. Approving the directors compensation for 2014. holders' meeting scheduled for April 30, 2014, the distribution 7. Reviewing the report on board expenses for 2013. of the final minimum mandatory dividend of Ch$4,745,818,874, 8. Appointing the independent auditors and risk-rating agencies which is Ch$3.16388 per share to be paid on May 30, 2014, to the for 2014. registered shareholders at midnight of the fifth business day prior to that date. 10. Receiving the account of the transactions required by Article 147 of Law 18,046 on Corporations. 11. Conducting any other business appropriate for this ordinary shareholders' meeting. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility with General Rule 30. quested by the Superintendency of Securities and Insurance. 9. Selecting a newspaper for legal publications. GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates Insurance through the Superintendent's SEIL module, in compliance iii) On April 11, 2014, a material event was reported that at an extraordinary board meeting of Farmacias Ahumada S.A. held on the same date, the board agreed to summon an extraordinary shareholders' meeting for April 30, 2014, after the ordinary shareholders' meeting scheduled for the same day, in the Company's offices located at Miraflores 383, floor 6, Santiago, in order to approve the following amendment to its bylaws: Complement the corporate purpose described in the fourth article of the Company's bylaws, by adding: "The purchase, sale, distribution and marketing of all games of chance, instant lottery tickets, etc., available to it as an agent, official agent, distributing agent or wholesale agent, and everything related to this business, now or in the future." 155 | FASA 2014 Annual Report iv) On April 30, 2014, a material event was reported that: v) On May 6, 2014, and complemented on May 9, 2014, an material event was reported to the Superintendency of Securities and In- I. At an ordinary shareholders' meeting held on this date, the follow- surance, that Grupo Casa Saba S.A.B. de C.V. ("GCS") has report- ing matters were addressed: ed that on the same date it reached an agreement with Alliance Boots ("AB"), through its subsidiary Controladora Casa Saba S.A. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 1. The balance sheet, the consolidated financial statements, the de C.V., to transfer its entire shareholding in Farmacias Ahuma- annual report and the independent auditors' report for the da S.A., for the price of MX$5.5162 (five point five one six two year ended December 31, 2013, were approved. Mexican pesos) per share, valuing FASA at approximately MX$8.3 2. The shareholders were advised of the adjustments to the billion. This agreement requires the fulfillment of conditions prec- Company's consolidated financial statements as of Decem- edent such as the corresponding corporate approvals and other ber 31, 2012, that were requested by the Superintendency of approvals that normally apply in these circumstances. When these Securities and Insurance, and these reissued consolidated fi- conditions precedent agreed by the parties have been fulfilled, nancial statements were approved. Alliance Boots GmbH itself or any of its affiliates, will launch a 3. The distribution of a final minimum mandatory dividend of takeover bid (OPA) in Chile for 100% of FASA's issued shares. Con- Ch$3.16388 per share to be paid on May 30, 2014, was ap- troladora Casa Saba, S.A. de C.V. is a subsidiary of GCS that owns proved. 97.89% of FASA's shares, and is irrevocably committed to selling 4. The dividend policy for 2014 was approved, so remains as distributing at least 30% of profit each year. those shares in the OPA. This transaction has been approved by the boards of Grupo Casa Saba S.A.B. de C.V. and Alliance Boots 5. All the directors were revoked and a new board elected with a GmbH. It is estimated that this transaction will be closed during term of office of 3 years, and consisting of the following seven the third quarter of 2014. Reporting this material event to the SVS members: Manuel Saba Ades, Alberto Isaac Saba Ades, Pedro revealed the confidential event reported on April 10 and 26, 2014. Alejandro Sadurni Gómez, Marco Antonio Vera Olvera, Joaquin López Dóriga López Ostolaza, Stephen Martin Clifford and Julián Silva Brisset. vi) Complementary to an material event reported on September 3, 2013, the SVS was informed on June 27, 2014, about the acquisi- 6. The director's compensation was approved. tion of the Mexican company Farmacias ABC de México, S.A. de 7. PricewaterhouseCoopers Consultores, Auditores y Compañía C.V. by Farmacias Benavides, S.A.B. de C.V. ("Farmacias Benavides") Limitada (PWC) were appointed as external auditors for 2014. which was the subject of an material event reported to the SVS on 8. El Mostrador was appointed as the electronic newspaper August 30, 2012. The parties negotiated an agreement to acquire where the summons for shareholders' meetings must be pub- 100% control of Farmacias ABC de México, S.A. de C.V. which was lished, as appropriate, and other legal publications that the owned by the Mexican companies Grupo Casa Saba S.A.B. de C.V. Company is required to publish. and Inmuebles Visosil S.A. de C.V. for a price of MX$170,000,000 through the acquisition by Farmacias Benavides S.A.B. de C.V. and II. At the extraordinary shareholders' meeting held after the ordinary its subsidiary Servicios Operacionales Benavides S.A. de C.V. of shareholders' meeting on this date, it was agreed to: Approve the 99.99% and 0.01%, respectively of its shares. On June 25, 2014, amendment to the bylaws, which amends the corporate purpose these securities were transferred, as the agreed contractual terms described in the fourth article of the Company's bylaws, by adding and conditions for the purchase of these shares dated June 3, the following: "The purchase, sale, distribution and marketing of 2014, had been fulfilled. This acquisition adds the ABC chain of all games of chance, instant lottery tickets, etc., available to it as pharmacies to the Company's business in Mexico, expanding an agent, official agent, distributing agent or wholesale agent, and the existing pharmacy network, and opening new customer seg- everything related to this business, now or in the future." ments. 156 | FASA 2014 Annual Report vii) On August 11, 2014, the following material event was reported: 4. The director Mr. Juan José Ricardo Guerra was appointed chairman of the board. - On July 9, 2014, Alliance Boots Chile SpA (the "bidder") published a notice to initiate a takeover bid ("OPA"), of the 1,500,000,000 5. The board of directors is now composed of the following individuals: issued, subscribed and paid shares in Farmacias Ahumada S.A., being 100% of its share capital. This notice was published in the Juan José Ricardo Guerra Chairman newspapers El Mercurio de Santiago and La Tercera and rectified Marc Dench Director by notices dated July 23 and August 6, 2014, published in those Marcello Ferrari Director Michele Antonio Ingravallo Director newspapers. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People - On August 11, the bidder published in the newspapers El Mercurio de Santiago and La Tercera, a notice announcing the success of the OPA, and reporting that in accordance with Article 212 of GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility tive Officer. Law 18,045 on Stock Markets and General Rule 104 issued by the SVS, the bidder would acquire 1,490,833,059 shares in Farmacias Ahumada S.A., representing 99.39% of its share capital. 7. Finally, the board agreed to inform the Superintendency of Securities and Insurance of these matters as material events, delegating authority to the Chief Executive Officer and other Therefore, on August 11, the bidder acquired 1,490,833,059 shares, specially designated proxies to carry this out. representing 99.39% of the share capital of Farmacias Ahumada S.A. ix) On September 24, 2014, a material event was reported that at Alliance Boots Chile SpA is controlled indirectly by Alliance Boots a board meeting on this date it was agreed to summon an ex- GmbH, which in turn is controlled indirectly and jointly by Alliance traordinary shareholders' meeting for October 21, 2014, at the Santé Participations SA and by three investment vehicles related to Company's offices located at Miraflores 383, floor 6, Santiago, KKR and Co. L.P. at 10:00am, to approve the following: Appoint the auditing firm KPMG Auditors Consultores Limitada ("KPMG") as the new inde- viii) Also, on August 11, 2014, the following material event was reported: PERFORMANCE Consolidated Indicators Investment and Financing 6. Mr. Marcelo Weisselberger Araujo was ratified as Chief Execu- pendent auditors. This proposal was made at the request of the controlling shareholder Alliance Boots Chile SpA, in accordance with Article 58, number 3 of Law 18,046 on Corporations. - On August 11, 2014, at an extraordinary board meeting of Farmacias Ahumada S.A., the following matters were addressed: x) On September 30, 2014, a material event was reported that confirmed the material event reported on September 24, 2014, that 1. The directors Messrs. Alberto Isaac Saba Ades and Pedro Ale- the board of Farmacias Ahumada S. A. agreed to summon an jandro Sadurní Gómez resigned, appointing to the board as extraordinary shareholders' meeting for October 21, 2014, at the replacement directors Messrs. Juan José Ricardo Guerra and Company's offices located at Miraflores 383, floor 6, Santiago, at Marc Dench, respectively, who accepted their appointments 10:00am, to address the following: Approve the change of the at the same meeting. Company's independent auditors for the current year by appoint- 2. The directors Messrs. Joaquin Lopez Doriga López Ostolaza ing KPMG, Auditores Consultores Limitada (“KPMG”) to replace and Stephen Martin Clifford resigned, appointing to the board PricewaterhouseCoopers Consultores, Auditores y Compañía as replacement directors Messrs. Marcello Ferrari and Michele Limitada. The documents supporting this proposal will be avail- Antonio Ingravallo, respectively, who accepted their appoint- able for shareholders at the Company's web site: www.fasa.cl. ments at the same meeting. Summons notices will be published in the newspaper El Mostra- 3. The directors Messrs. Manuel Saba Ades, Marco Antonio Vera dor on October 3, 9 and 16, 2014. The shareholders registered in Olvera and Julian Silva Brisset offered their resignation, which the Company shareholder registry on midnight of the fifth day was accepted by the board. The board agreed not to appoint prior to the meeting date, which is October 15, 2014, shall have their replacements, as these vacancies do not affect the quo- the right to participate in that meeting. rum for board meetings, and at the next ordinary shareholders' meeting the board will need to be entirely renewed, in accordance with Article 32 of the Law on Corporations. 157 | FASA 2014 Annual Report xi) On October 21, 2014, a material event was reported that at the extraordinary shareholders' meeting held on this date, the change xiv) On December 15, 2014, the following material event was reported: in the Company's independent auditors for the current year was approved and KPMG, Auditores Consultores Limitada (“KPMG”) re- 1.- At an extraordinary board meeting held on December 13, 2014, placed PricewaterhouseCoopers Consultores, Auditores y Com- the board approved a re-organization and merger plan be- pañía Limitada. tween FASA, its subsidiaries FASA Chile S.A. ("FASA Chile") and FASA Investment Limitada ("FASA Investment"), and Alliance INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People xii) On October 29, 2014, a material event was reported that at an or- Boots Chile SpA ("Alliance Boots Chile"), which owns over dinary board meeting held on this date, Mr. Dean Thompson was 99% of the shares of FASA. The main objective was to reduce appointed director, covering one of the existing vacant positions. regulatory, legal and administrative costs associated with the The board of directors is now composed of the following individ- current corporate structure, and re-organize these companies uals: Juan José Ricardo Guerra, Chairman; Marc Dench, Director; in the most efficient manner, always respecting the rights and Marcello Ferrari, Director, Michele Antonio Ingravallo, Director interests of FASA minority shareholders. and Dean Thompson, Director. At the next ordinary shareholders' 2.- On this date, FASA, FASA Chile, FASA Investment and Alliance meeting the board will need to be entirely renewed, in accor- Boots Chile (collectively the "Parties"), signed a Letter of Un- dance with Article 32 of the Law on Corporations. derstanding to place on record their mutual understanding with respect to the Merger Plan, which comprises implement- xiii) On November 13, 2014, the following material event was report- ing the following proceedings in an orderly and sequential ed: manner: 1.- That at a meeting on this date, the board approved the interim i) Alliance Boots Chile will initiate and conclude, as soon as consolidated financial statements as of September 30, 2014. possible, a simplified takeover bid to acquire all remaining 2.- That as of September 30, 2014, these consolidated financial FASA shares currently held by minority shareholders, at the statements report a loss of ThCh$10,372,067, compared to price per share that Alliance Boots Chile already offered when profit of ThCh$10,654,521 reported for the period ended Sep- it took control of FASA, in order to give all FASA shareholders tember 30, 2013. a new opportunity to sell their shares, in the light of the new 3.- This reduction in earnings with respect to the same period last Merger Plan. PERFORMANCE Consolidated Indicators Investment and Financing year is mainly due to adjustments to the consolidated finan- ii) As soon as possible, FASA shall begin all the corporate and cial statements that have resulted in extraordinary charges to legal processes to delist the FASA shares from the SVS Secu- profit or loss of approximately ThCh$19,300,000, in provisions rities Registry and the stock exchanges in Chile, including but GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates for doubtful accounts, obsolete inventories, litigation and le- not limited to the timely summons of an extraordinary share- gal expenses. holders' meeting to approve such delisting. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility 4.- Notwithstanding the foregoing, the Company fully complies iii) The potential advance payment and/or repurchase of the with its obligations referred to in its Series E and F bond con- FASA corporate bonds currently placed and outstanding, un- tracts, registered on the SVS Securities Registry. less the FASA board deems that this will not benefit FASA and 5.- That despite the loss reported in the interim consolidated financial statements due to the accounting adjustments referred to above, the financial situation of Farmacias Ahumada S.A. remains strong and stable. its shareholders. 158 | FASA 2014 Annual Report iv) The summons by FASA and Alliance Boots Chile of extraordi- 4.- The FASA extraordinary shareholders' meetings referred to nary shareholders' meetings to approve this merger by incor- above, which are necessary to complete the Merger Plan, porating the former into the latter, on the basis of the audited shall be convened when appropriate as the Merger Plan pro- accounts for both companies as of December 31, 2014, or gresses, and on each occasion shall fully comply with all rele- at a later date. In the event that it had not been possible to vant laws and regulations, especially the provisions of the Law delist the FASA shares registered in the Securities Registry and the stock exchanges, and/or that the FASA board deems the advance payment and/or repurchase of the FASA corporate INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility and Regulations on Corporations. 5.- It is expected that the Merger Plan should be completed during 2015. bonds to be unbeneficial, it will be proposed that the merger 6.- It is currently not possible to quantify the effect that the mat- is subject to the condition precedent that Alliance Boots Chile ters reported in this material event will have on the consolidat- be transformed into a corporation and register its shares in the ed financial statements of FASA. SVS Securities Registry in the first case, or is registered as an issuer of public securities, in the second case. xiv) On December 31, 2014, a material event was reported that on v) Once the merger of FASA and Alliance Boots Chile has been this date Walgreens Boots Alliance, Inc., a corporation incorpo- completed, the merger of FASA Chile and Alliance Boots Chile rated under the laws of the State of Delaware ("Walgreens Boots will proceed through the purchase of one share that FASA In- Alliance"), acquired control of Alliance Boots GmbH, a private lim- vestment has in FASA Chile, which will enable FASA Chile to ited liability company incorporated under the laws of Switzerland be dissolved and absorbed into Alliance Boots Chile, as all its ("Alliance Boots"). Alliance Boots indirectly owns 100% of Alliance shares will be held by one entity. Boots Chile SpA, which in turn owns 99.396% of FASA's share capital. Therefore, Walgreens Boots Alliance became the new indirect controller of the Company with effect from December 31, 2014. 159 | FASA 2014 Annual Report Material events reported after December 31, 2014: - On January 22, 2015, a material event was reported that on January 21, 2015, the board agreed to summon an extraordinary shareholders' meeting for February 24, 2015, at the Company's offices located at Miraflores 383, floor 6, Santiago, at 10:00am, to address the following matters: 1) Approve the voluntary delisting of FASA shares in the SVS Securities Register and in the Chilean stock exchanges, in accordance with Subparagraph 6, Article 2 of Law 18,046 on Corporations, and the approval of this delisting INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility shall give the dissident shareholders a right to withdraw. (2) Approve the remaining agreements necessary to comply with the decisions of this meeting. 3) Delegate sufficient authority to the board and/or the Chief Executive Officer to process all of the details that may arise in relation to the agreements approved at this extraordinary shareholders' meeting. - On February 24, 2015, a material event was reported that at an extraordinary shareholders' meeting held on this date 99.41% of shareholders voted to approve the voluntary delisting of the FASA shares registered on the SVS Securities Registry and the stock ex- OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People changes in Chile, in accordance with Subparagraph 6, Article 2 of Law 18,046 on Corporations. This has given the dissident shareholders the right to withdraw from the Company, following payment by the Company for their shares. Dissident shareholders are those present at this meeting who were opposed to this agreement that gave them withdrawal rights, or that were not present PERFORMANCE Consolidated Indicators Investment and Financing and expressed their dissent in writing to the Company within 30 GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates their shares, being Ch$54.55718. FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility days of this meeting. The Company will pay the dissident shareholders who exercise their right to withdrawal, the book value of - On February 25, 2015, a material event was reported that at an ordinary board meeting held on this date Mr. Dean Thompson resigned from his position as director and was immediately replaced by Ms. Elizabeth Fagan, and that at the next ordinary shareholders' meeting the board will need to be entirely renewed, in accordance with Article 32 of the Law on Corporations. 160 | FASA 2014 Annual Report STATEMENT OF RESPONSIBILITY The directors of Farmacias Ahumada S. A. and the Chief Executive Officer as indicated below have signed this statement and have legally sworn to the accuracy of all the information provided in this annual report, in compliance with General Rule 30 issued by the Superintendency of Securities and Insurance. INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Juan José Ricardo Guerra Elizabeth Fagan Chairman Director Chilean ID: Foreigner Chilean ID: Foreigner Marc Dench Michele Antonio Ingravallo Director Director Chilean ID: Foreigner Chilean ID: Foreigner Marcello Ferrari Marcelo Weisselberger Director Chief Executive Officer Chilean ID: Foreigner Chilean ID: 10,032,623-K Santiago, March 2015 INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility Editing FASA Department of Pricing and Business Planning Design and development: INTRODUCTION Company Details Letter from the Chairman THE COMPANY History Walgreens Boots Alliance Regional Presence Business Units Creation and Development of Owned and Licensed Brands Corporate Social Responsibility OWNERSHIP AND MANAGEMENT Shareholders Board of Directors Corporate Management Regional Management Corporate Structure Training Our People PERFORMANCE Consolidated Indicators Investment and Financing GENERAL INFORMATION Regarding Shareholders and the Board of Directors Subsidiaries and Associates FINANCIAL STATEMENTS Consolidated Financial Statements Material Events Statement of Responsibility www.fasa.cl Farmacias Ahumada S.A. Miraflores 383 - Floor 6 Santiago - Chile